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ABSTRACT
Recent developments in the field o f  stationary phases for liquid chromatography 
and their use as solid-phase extraction(SPE) materials are discussed in chapter 1. In 
chapter 2, the use o f  a mixed-mode stationary phase (C18/SCX) for HPLC and its 
retention properties was then examined by variation o f a number o f parameters, including 
pH, ionic strength and buffer cation. A  comparison was also carried out using a 
conventional Cl 8 column.
The use o f  this mixed-mode column was further investigated in chapter 3 for the 
simultaneous determination o f propranolol and furosemide in human plasma. 
Development o f  the chromatography and the extraction procedures from first principles 
are also described. Two sample clean-up procedures were examined: liquid/liquid 
extraction and column switching. Each o f these methods was validated and a comparison 
o f the methods was carried out.
Chapter 4 then describes how “molecular imprinting” was used to create a chiral 
environment which would allow the separation o f  one enantiomer from the other, and 
which might find application in the area o f solid-phase extraction and capillary zone 
electrophoresis. This work was based on the monomer most commonly used in 
molecular imprinting, i.e. methacrylic acid. It was then decided to modify this monomer 
and incorporate a chiral group, and use this monomer for polymerization against the 
target molecule propranolol. Polymers were also prepared using methacrylic acid to 7- 
hydroxy-coumarin (7-OHC) under a number o f conditions.
In chapter 5, the polymer prepared to 7-OHC was packed into cartridges and 
applied to the determination o f 7-OHC in urine by capillary zone electrophoresis (CZE). 
The polymer prepared to S-propranolol was also used as an additive in the buffer to 
enhance the CZE separation between the R- and S- enantiomers o f the parent drug
The thesis concludes with a critical appraisal o f the work carried out in the 
thesis and suggestions for future research.
CHAPTER ONE
STATIONARY PHASES AND 
PSEUDO-STATIONARY PHASES
1.1 INTRODUCTION
Chromatography was first reported as early as 1903, when Tswett
separated chlorophylls from plants employing a calcium carbonate bed with
1 2 petroleum as an eluting system. Thin-layer chromatography (TLC) was then
developed, and following this, Martin first described the method of liquid/liquid
partition chromatography and laid the foundation for gas-liquid chromatography
(GLC).3 Liquid chromatography developed further during the sixties due to the
onset of high performance (or pressure) liquid chromatography (HPLC).4 During
the late 60's and early 70's, with the advent of solid-phases onto which moieties
could be chemically bonded, the dominant position of inorganic oxides as
stationary phases declined considerably. HPLC technology then evolved around
the production of support materials which offered improved rates of mass transfer
by reducing the distance over which solutes have to diffuse. Impervious glass
beads were coated with the stationary phase resulting in shorter diffusion paths,
and the second method involved the production of particles which were totally
porous, but of smaller diameter (about 40 fim). Porous particles have lead the
way forward, and today, columns contain particles in the range 3-10 (am in
diameter. Many studies on the technology of bonding to a variety of stationary
phases occurred with Halasz producing the first bonded phase by reacting silica
with alcohols5 and amines.6 The 1980's saw a refinement in bonding procedures,
especially with regard to phase reproducibility. Today, a wide range of bonded
supports can be tailored to suit a variety of analytical needs, and the use of
specialized phases has become more prominent, in particular for the separation of
chiral compounds (i.e. different enantiomers). Other specialized phases have
been developed, such as shielded hydrophobic phases, internal surface reversed
phases and molecularly imprinted polymers (MIP’s).
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1.2 MECHANISMS IN HPLC
HPLC is a natural progression from classical column liquid 
chromatography and can encompass almost all types of chromatography, i.e. 
adsoiption, partition, ion-exchange and size exclusion. Chromatography is a 
physical method of separation in which the compounds to be separated are 
distributed between a mobile phase and a stationary phase. The chromatographic 
process occurs as a result of repeated sorption onto and desorption from the 
stationary phase by sample components as they traverse the column bed. 
Separation occurs between individual components due to the differences in their 
distribution coefficients between the two phases. Components migrate at 
different rates due to differences in polarity, solubility, ionic charge or size.
1.2.1 Liquid-Solid Chromatography
The principle of adsorption chromatography is the same as the basis of 
classical column and thin layer chromatography. Separation occurs by the 
reversible adsorptive interaction of the solute with a solid adsorbent. It is 
dependent on the relative polarities of the solute and adsorbent. The stationary 
phases for liquid-solid chromatography (LSC) most commonly used are silica, 
alumina glass beads and polymer beads. It’s main uses are for components which 
are soluble in non-polar or moderately polar solvents (e.g. heptane, hexane and 
methylene chloride).
1.2.2 Reversed-phase Chromatography
In this technique a hydrophobic stationary phase is bonded onto a solid 
support to produce a non-polar surface and used in conjunction with a polar
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hydro-organic mobile phase. The name “reversed-phase” refers to the fact that 
the relative polarity of the stationary and mobile phases are opposite to those used 
in LSC. This particular type of chromatography is the most common, and is 
widely applicable to the separation of solutes of different polarity, molecular 
weight and chemical functionality. Reversed-phase (RP) chromatography has 
found a number of uses in recent years, including the trace analysis of basic drugs 
in biological fluids. Another factor in the widespread use of RP-HPLC is the 
convenience, versatility and high efficiency of silica-based, microparticulate, 
bonded-phase chromatographic supports. However, the selectivity of reversed- 
phase systems is insufficient for a number of reasons; severe peak tailing 
associated with the separation of basic compounds which has been attributed to 
polar interactions of the amino-functionalities of the analyte to active sites, 
notably unreacted silanol groups on the modified silica surface, and poor column 
efficiencies are commonly encountered problems. This chromatographic 
behaviour means that basic compounds are retained on modified silica by means 
other than lipophilic retention mechanisms. It is possible to improve selectivity 
for polar and ionic molecules by manipulation of secondaiy chemical equilibria. 
These equilibria are affected by changes in the mobile phase composition, the use of 
buffers and the adjustment of pH (ion suppression), and the addition of ion-pair 
reagents (ion-pairing). Complexing agents and chiral reagents can also be added to 
the mobile phase to achieve selectivity between optically active isomers.
1.2.2.1 Reversed-phase Ion Suppression
For organic compounds which contain ionisable groups, the method of 
choice has traditionally been reversed-phase chromatography employing a 
buffered mobile phase to control the degree of ionization, and hence the retention 
of the compound on the hydrophobic stationary phase. For separation of weak
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acids by reversed-phase techniques, it is necessary to lower the pH and thus suppress 
ionization of the acid and drive the equilibrium of the reaction below to the left.
RCOOH + H20  -  RCOO" +  H30
For basic compounds the equilibrium is driven to the right, as shown in the equation 
below.
RNH3+ +  OH' RNH 2 +  H20
This technique is suitable for the determination of weak acids and bases in the 
pH range 2-8.  At pH values below 2, stripping of the bonded phase occurs while at 
high pH dissolution of the silica packing occurs.
1.2.2.2 Ion-Pair Chromatography
Strong acids and bases cannot be separated by ion suppression. However, by 
forming an ion-pair with a suitable counter-ion, ionic or ionizable compounds can be 
converted to electrically neutral and non-polar compounds, and therefore can partition 
into the respective non-polar phase. A large organic counter-ion is added to the 
mobile phase (at a low concentration of the order 0.005 M) to form a reversible ion- 
pair complex with the ionized sample. The ion-pair reagent is itself ionized, and one 
ion of the reagent is retained by the stationary phase then providing the otherwise 
neutral stationary phase with its charge. This charged stationary phase can retain and 
separate organic solutes ions of the opposite charge by the formation of a reversible 
ion-pair complex. The following equilibrium represents the coulombic association 
species formed between two ions of opposite electrical charge with the ionized 
sample:
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RCOO' + R4N1 -  [ R / ,  OOCR]0 ion-pair complex
Therefore, by using a suitable counterion, ionic (or ionizable) compounds can be 
converted to electrically neutral compounds that will partition between the mobile and 
non-polar stationary phases, while simultaneously allowing the non-ionized organic 
substances to interact with the stationary phase. Ion-pairing, despite its flexibility and 
popularity, has a number of disadvantages associated with it, including long 
equilibration times, sample contamination from foreign ions, the inability to apply 
solvent gradients, decreased column lifetimes, and sometimes poor reproducibility. 
The most important factor to consider is the pH of the mobile phase, as it is necessary 
that both the counterion and solute are ionised. It is also necessary that the counterion 
should be univalent, aprotic and soluble in the mobile phase. Charged surfactants at 
concentrations below the critical micelle concentration are widely used as mobile 
phase modifiers in ion pairing chromatography. Bidlingmeyer et al. have used ion- 
pairing to separate a number of ionic compounds, including phenacetin, 
phenylpropanolamine and pyrilamine.
1.2.2.3 Micellar Liquid Chromatography
Separation of compounds depends on the ability to control the analyte-solvent 
interactions by changing the composition of the mobile phase. One method of 
modifying the mobile phase is by the addition of surfactants at low concentrations to 
enhance the separation of oppositely charged solutions. When surfactant solutions 
are present at high concentrations and micelles co-exist with monomers and dimers, 
this can offer a further degree of selectivity to separations because of the possibility of 
interaction between the analyte and the micelle. This is known as micellar liquid 
chromatography.
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Surfactants exist in a number of different forms in which the hydrophobic end 
varies from 8-20 carbon atoms and the hydrophilic portion can be a partially 
dissociable carboxylate ion, a fully-ionised moiety (such as anionic sulphate or 
cationic tiimethylammonium ions), plus counterion, or an uncharged species such as 
polyethylene glycol. They can also vary in their- charge type (zwitterionic, positive, 
negative or neutral), but the nature of the hydrophobic portion can also vary (single, 
double or multiple bonds). At low concentrations in aqueous solution, surfactant 
molecules are dispersed as monomers, and to a lesser extent as dimers and trimers. 
Above a certain concentration the monomers aggregate into micelles which are 
roughly spherical in shape, and consist of approx. 60-100 monomers (the aggregation 
monomer). As the surfactant concentration is increased above the critical micelle 
concentration (CMC), more micellar assemblies are formed with the monomer 
concentration remaining approximately constant and equal to the CMC. The most 
commonly used in chromatography are sodium dodecyl sulphate and 
cetyltrimethylammonium bromide. For instance, Armstrong et a l% employed aqueous 
based mobile phases, containing 0.1 - 0.2 M sodium dodecyl sulphate (SDS) to 
separate a range of phenols and polynuclear aromatic hydrocarbons. They showed 
that the presence of micelles in the mobile phase provides a hydrophobic site for 
interaction with the solute, and that surfactant solutions overcome the need for 
traditional organic modifiers, e.g. acetonitrile or methanol. In micellar systems, 
additional interactions of an electrostatic, hydrophobic and steric nature can occur, 
and these additional interactions can add an added degree of selectivity to the 
separation of a ding or other analytes by HPLC.
It has been found that retention of analytes generally decreases with increases 
in surfactant concentr ation, but the rate of decrease is strongly analyte dependent and 
this frequently produces reversals in orders of retention. These inversions are the 
result of two competing equilibria, solute-stationary phase interactions and solute- 
micelle interaction. Micellar liquid chromatography has found particular application
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for the direct analysis of drugs in biological fluids by HPLC. For instance, Cline- 
Love et a l9 determined a number of drugs in urine by direct injection. The surfactant 
used for the determination of furosemide, hydrochlorothiazide and propranolol was 
polyoxyethylene 23 lauryl ether (Brij 35). It was found suitable for the simultaneous 
determination of both hydrophilic and hydrophobic substances.
1.2.3 Ion Exchange Chromatography
While reversed-phase separation of charged analytes may be accomplished 
by ion-pairing techniques, recently, separations of charged species have been 
carried out on highly efficient HPLC phases, specifically designed to act as ion 
exchangers. Cations are separated on phases modified with a fixed sulphonic acid 
group [-C6H4S03"H+] with cationic mobile counter ions, while anions are 
separated on phases modified with quaternary ammonium group [-(CH2)I1NR3+X'] 
with anionic mobile counter ions. The mechanism by which these systems work 
is based on displacement of the counter ions from the charged sites. The analyte 
binding may be modulated by the inclusion of competing cations in a buffered 
aqueous mobile phase.
1.2.4 Size Exclusion Chromatography
This form of chromatography is essentially a separation method, based on 
the relative molecular mass of different molecules. The stationary phase consists 
of a pore structure of controllable size. Small molecules can enter these pores and 
will be retained longer, while larger molecules which cannot enter the pores will 
elute more quickly. Molecules which are of intermediate size will be moderately 
retained. These phases are mainly used for the separation of compounds which 
have molecular masses above 2000 daltons e.g. polymers and large biomolecules.
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1.3 COLUMN PACKING SUPPORTS
A number of inorganic supports exist; however, the use of silica gel-based 
packings still dominates. The major limitation of silica gel, however, is that it 
cannot be used in systems (of pH above 8.0). This has encouraged the 
development of alternative materials, including alumina, carbon and polymer- 
based packings.
1.3.1 Alumina
Alumina is normally basic in nature, but with suitable processing acidic 
and neutral types can also be prepared, the latter finding use in adsorption 
chromatography. Alumina has also found application as an ion-exchange material 
and due to its amphoteric nature; basic alumina has found use as a weak cation 
exchanger while the acidic form is used for anion exchange. This material finds 
application at extremes of pH where silica is unsuitable, in particular for the 
determination of strongly basic compounds at pH values as high as 12. Retention 
can be controlled by a number of parameters including ionic strength, nature of 
the counter-ion and pH. The selectivity of ion-exchange chromatography can be 
substantially improved by addition of organic solvents to the aqueous mobile 
phase. It is more prone to chemisorption problems than is silica, particularly 
when acidic components are involved and tailing may result. It has, however, 
fewer theoretical plates than comparable silica columns.
Laurent et al,10 used aluminium oxide as a cation-exchange material, by 
the addition of competing ions to a mobile phase consisting of an aqueous buffer 
and an organic modifier (acetonitrile or methanol). Determination of protonated 
amines was achieved with this type of ion exchange system. Although the 
discriminating power of the aluminium oxide system is comparable with that of
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silica gel-based systems, the retention behaviour of organic cations is more 
complex, and therefore not easily predictable. This can be explained by the 
substantial number of parameters that influence the retention and the pronounced 
amphoteric character of aluminium oxide. Aluminium oxide shows anion- 
exchange properties at pH values below its zero point of charge (ZPC), and 
cation-exchange behaviour above this pH value. This means that for the analysis 
of positively charged compounds, the pH of the mobile phase must be higher than 
the ZPC.
1.3.2 Carbon Sorbents
Carbon sorbents11 have a number of advantages in comparison with silica 
gels, including their high chemical resistance to most mobile phases and their 
total inertness towards separated substances. Both glassy carbon and porous 
graphitic carbon have proved to be very strong adsorbents; however, this can be 
moderated by a number of methods, including use of a properly chosen mobile 
phase composition, a polymer coating, or by chemical modification of the surface. 
The rate of mass transfer within carbon-based sorbents is usually somewhat lower 
than obtained within silica gels. Other advantages of carbon is that it has a wide 
pH range, that it shows good retention for polynuclear aromatic hydrocarbons, it 
exhibits different selectivity from reversed-phase silica, and is relatively inert. It 
has a number of disadvantages, however, including its lack of rigidity, and its 
poor inefficiency for strongly retained components.
1.3.3 Polymer-based sorbents
The use of rigid macroporous copolymers for HPLC has its origins in the 
work carried out by Peterson.12 They described how proteins could be adsorbed
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by diethylaminoethyl (DEAE) derivatized cellulose under certain conditions and 
then subsequently eluted by increases in the ionic strength of the mobile phase. 
Moore13 synthesized macroporous poly(styrene-divinylbenzene) materials with a 
high percentage of crosslinked, divinylbenzene. The polymerization was carried 
out in the presence of a porogen, a compound which is soluble in the monomers 
but not in the polymer. This produced rigid spherical particles containing large 
pores/voids. The polymers were prepared by mixing the monomer, the 
crosslinker and the initiator in the presence of a suitable porogen. The mixture is 
stirred rapidly with water to produce organic phase droplets equivalent to the 
particle size of the polymer bead required. The polymerization proceeds in the 
droplets of the organic phase, with the growing polymer chains precipitating in 
the droplet as they reach a critical size. The crosslinker functions to produce a 
three-dimensional structure. The porogen voids in the polymer network are 
macropores; therefore by suitable choice of the porogen the pore size, pore size 
distribution and pore geometry can be optimised for HPLC separations.
The driving force behind the development of polymeric columns is the 
inherent pH instability of silica-based columns, especially above pH 7, which 
places severe limitations on their practical use. Rigid macroporous copolymers of 
styrene and divinylbenzene have been developed which have the high physical 
/mechanical stability necessary to operate under HPLC conditions of pressure and 
flow rate. These matrices can be produced in a range of porosities 10 to 400 nm 
each, with the controlled uniform pore geometry and pore size distribution 
essential for high efficiency separations. The unmodified form can be used for 
HPLC separations of small molecules or for the analysis of biological 
macromolecules by increasing the pore size. Polystyrene-divinylbenzene (PS- 
DVB) packings permit operation over a wide pH range (1 - 13), but give poorer 
efficiency an equivalent than silica-based packing.
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Over the last decade a number of polymer stationary phases have been 
prepared, but these differ in the way they are prepared. In recent years, there has 
been much interest in molecularly imprinted polymers (MIP’s). This concept was 
first developed by Wulff,14 and involves polymerization of the monomer in the 
presence of the target molecule, and once the polymer is prepared, the target 
molecule is removed. The resulting polymer has a rigid structure with an affinity 
for the original print molecule. The MIP can then be used as a HPLC stationary 
phase, solid-phase extraction material or as a sensor. These polymers have found 
application for a large number of compounds including amino acids, amino acid 
derivatives and a number of drug components. Further discussion of this concept 
is given in Chapter 4.
1.4 SILICA
1.4.1 Unmodified Silica
The surface of silica is covered with a layer of silanol (Si-OH) groups and 
reactions at these sites are used to introduce organic groups onto the adsorbent 
surface. Numerous attempts have been made to improve the pH stability of silica- 
based columns, including the use of bulky silane reagents and the coating of 
polymers on the surface of the silica. Instead of trying to eliminate the surface 
contribution to retention on bonded columns, an unmodified silica column can 
also been employed in conjunction with a reversed-phase eluent. As first reported 
by Jane,15 the amine-silanol interaction is exploited in this situation, and efficient 
separations were obtained using a buffered aqueous methanol-rich mobile phase 
at high pH in a chromatographic mode which has since been described as "pseudo 
reversed-phase" chromatography. This system was found suitable for the analysis 
of basic drugs of abuse, including opium and heroin, indicating the potential of
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separating drugs containing amino functionalities. The retention mechanisms of 
such polar separations on unmodified silica with aqueous eluents have not been 
fully explained, and seem to be multi-functional in nature. It has, however, been 
suggested that ion-exchange interactions with silanol groups on the silica surface 
are the most prominent interaction.
The effects of the variation of pH, methanol concentration, ionic strength 
and nature of the ion in aqueous methanol mobile phases on the k' (Section 2.2.5) 
values of various amino compounds, e.g.amprolium, amylocaine benzocaine, 
butacaine and cocaine, were studied using both silica and a silica surface 
modified by treatment with trichloro(octadecyl)silane (ODS-silica).16 The 
retention mechanisms of the species are complex, and involve ion-exchange with 
the proton of a surface silanol site (particularly in the case of amprolium), ion- 
pair partition and salting-out effects. The addition of a salt to an aqueous 
methanol mobile phase employed in RP-HPLC has been shown to have a 
significant effect on the capacity ratios of amines. Both the nature and 
concentration of the added salt influence retention characteristics, and with 
careful control of pH, the separation of species can be optimized. The retention 
mechanism is complex but may involve both ion-pair partition and participation 
of unsilanized surface silanol groups.
Law et al. have also described a method using a silica column and a 
methanol-aqueous ammonium nitrate eluent for the determination of two classes 
of drugs. These drugs include the narcotic analgesics (including antagonists, 
metabolites and analogues) and drugs structurally and pharmacologically related 
to amphetamine.17 Different k' values were obtained depending on the brand of 
silica used, but the elution order remained the same.
Flanagan et a ln examined the addition of ionic modifiers at low 
concentrations to non-aqueous, primarily methanolic eluents for the determination 
of basic compounds on silica columns. Characteristics of this type of system
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were that basic compounds were retained under conditions where they were 
appreciably ionized and increases in the ionic strength of the buffer produced 
decreases in retention. The pH was also found to influence the selectivity of the 
system and the retention volumes of individual analytes. Changing the organic 
solvent can give useful changes in the selectivity. These non-aqueous systems 
show high efficiency, stability and reproducibility and give long column life.
Flanagan et al.19 examined further the factors influencing retention and 
peak shape while using a silica column in conjunction with a non-aqueous ionic 
eluent and found that retention occurred mainly by cation-exchange with surface 
silanols. At constant ionic strength, changes in eluent pH influence retention via 
ionization of surface silanols and protonation of basic analytes. Conversely, at 
constant pH, increases in the ionic strength result in decreases in the retention 
times, as would be expected for a cation exchanger. Further studies have shown 
that silica columns in combination with non-aqueous, primarily methanolic, 
eluents modified by ionic compounds which are highly dissociated in organic 
media provide a stable yet flexible system for the analysis of basic drugs.
1.4.2 Modified Silica
A number of modified silicas exist and these have been prepared by 
chemical modification of the bare silica. These modifications can be 
accomplished by one of two methods: a) by a reaction known as “surface 
modification” between an organosilane and the silicate or by b) hydrolytic 
polycondensation of organosilanes. The former method is more often employed, 
as the latter method is often difficult to perform, is uncontrollable, and gives rise 
to undefined support materials. The method of surface modification can be 
further divided into three groups; modifications using (i) hydrophobic chains 
including octadecyl (Ci8), Cg and C2 functionalities, (ii) polar groups, including
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cyanopropyl, glycol and aminopropyl functionalities and (iii) ionic groups 
including amino, quaternary ammonium and sulphonic acid groups. These phases 
are prepared by a reaction of the organic groups with the silanol sites on the silica 
surface. They can be prepared by a number of methods including
(a) esterification of the silanol group with an alcohol ROH5 where R may be an 
alkyl or any other functional group:
Si — OH + ROH OR
(b) reaction with thionyl chloride SOCl2 which produces a chloride, which can 
then combine with an amine6 to give an Si-N bond:
Si-OH+ SOCI2 Si— Cl
Si— Cl + RNH2 S i-  N— R
H
* * * 20 21 * *(c) reaction of the silanol groups with a mono- or dichlorosilane " to give an Si-
O-Si-C bond. Octadecylsilane, in which R= -(CH2)i7 CH3, is the most widely
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used of these, and has been the preferred choice for reversed-phase 
chromatography:
fS
Si — OH + Cl — Si— R
CH
CH
I 3
S i - O  — S i — R + HC1 
CH
2The surface of the silica has about five -OH groups per nm which 
corresponds to 8 - 9 |_imol/m2, and it is impossible to react all of them completely, 
even while using compounds of relatively small size, e.g. trimethylsilane. Colin 
et a l22 found that the maximum concentrations of trimethylsilyl, octadecylsilyl 
and triphenylmethylsilyl are found to be about 4.5, 3.5 and 1.5 pmol/m 
respectively, indicating that at best about half the available -OH groups can be 
reacted. As a number of these sites remain unreacted and accessible to analyte 
molecules, interaction with these residual groups can lead to poor 
chromatographic results; which is an ongoing problem with modified silica.
Triethylamine (TEA) has been used by Roos et al.23 as a competing base 
for retention control and peak shape improvement in the reversed-phase HPLC 
analysis of a number of components. The alkylamine moiety acts primarily by 
nitrogen bonding to non-derivatised silanol sites, thereby reducing adsorption and 
ion-exchange effects. The addition of an alkylamine compound to a mobile phase 
can cause improvement in peak shape with little loss of retention. In addition to 
their ability to reduce peak tailing, alkylamines have useful selectivity-enhancing 
effects. Normalization of the retention behaviour of a solute can be achieved by 
incorporating TEA24 in the eluent to serve as a competing base for masking
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accessible surface silanol groups and to provide heterogeneity on the RP bonded 
surface. Short chain tertiary amine modifiers such as TEA are highly effective in 
reducing or eliminating silanophilic interactions.
RP-HPLC on chemically bonded phases has become the most popular 
technique in HPLC finding use in pharmaceutical and biological chemistry. 
However, it is unfortunate that standardization of RP-HPLC materials is not 
possible when developed on column packing materials from different 
manufacturers, even though they are in theory identical chemically bonded phases 
(e.g. octadecylsilyl). As different k' values were obtained depending on the brand 
of silica used, a technique was developed which involved ‘in-situ’ modification of 
the silica.25 Bare silica was obtained from different manufacturers and the silica 
surfaces were dynamically modified with long-chain quaternary ammonium ions 
generating the reversed-phase system. High reproducibility of selectivity could be 
obtained with these types of phases with good peak symmetries been obtained for 
amine compounds chromatographed on these systems. The amount of CTMA 
(cetyltrimethylammonium) adsorbed on the silica surface increases with 
increasing alkyl chain length of the alkyl-trimethylammonium ion. As the amount 
of quaternary ammonium ions in the eluent is increased, a plateau is ultimately 
attained. The point at which this occurs coincides with the critical micellar 
concentration (CMC) of the ammonium ions in the eluent used and above this 
value the concentration in the eluent is constant.
When chromatographing basic analytes on chemically bonded phases, 
severe tailing problems are often seen in connection with poor reproducibility. 
These problems may also be solved by using dynamically modified silica, due to 
the deactivation of the active silanol groups. This technique wasfound to be 
superior to RP chromatography on chemically bonded phases with regard to 
reproducibility of selectivity. It should therefore be taken into consideration
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when high reproducibility is needed, as such in the stability testing of drugs over 
long periods of time, and the international standardization of methods.
Hansen26 examined a number of other parameters associated with this 
technique including varying the concentration or nature of the quaternary 
ammonium ion, the ionic strength or the pH of the buffer, or by changing the 
concentration or nature of the organic modifier. He found that retention and 
selectivity could be controlled by manipulation of these parameters. Other 
retention mechanisms such as ion exchange and ion-pair formation were found to 
be involved in the separation of analytes. Long-chain quaternary ammonium salts 
have been used in water rich eluents, with silica as the support, giving 
chromatographic separations similar to those obtained with chemically bonded 
reversed-phase materials.
Hansen et al. then examined a number of silica packings which were 
dynamically modified with cetyltrimethylammonium bromide27. Thirteen 
different silica packings exhibited the same selectivity towards a test mixture 
which included acids, bases and non-ionic compounds. As the selectivities 
obtained were the same regardless of origin of the column material, it was thus 
demonstrated that it is possible to standardize an HPLC system using dynamically 
modified silica.
Further work involved examining the influence of the nature of quaternary 
ammonium28 compounds on retention in HPLC. Adsorption isotherms were 
determined on bare silica using four alkyl trimethyl ammonium bromides and two 
symmetrical tetra alkylammonium bromides, each containing 15 - 21 carbon 
atoms. It was found that only the long-chain quaternary ammonium ions are 
adsorbed on to the silica surface in appreciable amounts, and that the affinity for 
the silica increases with increasing number of carbons in the alkyl chain. 
Dynamic coating has the advantage over chemically bonded phases in that only
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slight variations in selectivity are observed for different brands of column 
material.
A retention model based on the distribution of ion-pairs to the solid 
stationary phase was proposed by Crommen.29 The ion-pair reversed-phase 
system was suitable for various kinds of drugs and other compounds of biological 
interest. Samples of widely different hydrophobic character could be 
chromatographed with suitable retention on the same silica columns by changing 
the composition of the aqueous mobile phase. It has been shown that the 
retention of ionic samples can be increased by the addition of hydrophobic 
counterions to the mobile phase. This “ion-pairing” effect was used to regulate 
the retention of the most hydrophilic analytes. The retention of hydrophobic 
samples is more conveniently regulated by the addition of a competing ion or 
uncharged compound to the mobile phase.
1.5 MODIFIED POLYMERS
There has been an increasing demand for packing materials more stable 
than Cis materials in RP-HPLC, and this has prompted the recent development of 
new classes of materials, in particular polymer-coated silica packings30’31 and 
organic polymer-based32 packing materials. These include polymers such as 
poly(styrene-divinylbenzene) (PS), esterified poly(vinyl alcohol) (PVA), poly 
(alkylmethacrylate) (PAM), alkylated poly(acrylamide) and poly(hydroxyalkyl 
acrylate or methacrylate) (PHA). These have all been substituted for silica-based 
Cig materials under appropriate conditions. In the same way as a silica matrix can 
be derivatised and/or coated to alter surface characteristics, so can a polymeric 
support. However, when a chemically stable polymer is coated it is possible to 
use functionalities which are themselves exceptionally stable. Thus a HPLC 
adsorbent is produced which is capable of with standing aggressive eluents and
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extremes of pH. Porous poly(styrene-divinylbenzene) packings (PS-DVB) have 
the advantage over silica-based materials of much greater chemical stability. The 
totally organic adsorbents are operable over a much wider pH range, typically 1-
14. However, styrene-divinylbenzene copolymers do have the disadvantages of 
the appearance of micropores caused by the penetration of solutes into the 
polystyrene matrix. A new copolymer has been obtained by the copolymerisation 
of two cross-linking agents: a mixture of 1,4 and l,5-di(methacryloyloxymethyl) 
naphthalenes (DMN) and divinylbenzene (DVB). This polymer has already 
found use as a stationary phase in gas chromatography and in solid-phase 
extraction (SPE).
The hydrophobic character of the poly(styrene-divinylbenzene) matrix is a 
serious limitation to its suitability for macromolecule separations other than in a 
reversed-phase mode. Even after derivatisation, the hydrophobic interactions 
between polymers and proteins can be sufficiently strong that the protein may be 
denatured either when adsorbed onto the surface of the stationary phase or when 
subsequently eluted. Therefore it is essential that the hydrophobic character of 
the poly(styrene-divinylbenzene) matrix is masked for the chromatographic 
separation of biological macromolecules in all retention modes except reversed- 
phase separations.
Tanaka et al,33 examined the performance and retention characteristics for 
a variety of hydrocarbons in aqueous-organic mobile phases using a number of 
polymer-based packing materials with alkyl backbones, including poly(styrene- 
divinylbenzene), poly(alkyl methacrylate) and esterified poly(vinyl alcohol) by 
reversed-phase liquid chromatography. Materials with alkyl backbones showed 
performance comparable with Cig materials under optimized conditions. All of 
the polymer based packing materials showed preferential retention of aromatic 
analytes, in particular those with a rigid planar structure rather than those with 
flexible bulky groups. The molecular shape, rigidity and aromatic character of
20
the analytes as well as the organic solvents were found to effect the performance 
of the column.
A spherical porous polymer for RP-HPLC was prepared from vinyl ether 
(Figure 1.1) derivatives by Hirayama et a l34 by suspension copolymerization of 
alkylvinyl ether with tricthyleneglycol divinyl ether. By changing the monomer 
ratio, the hydrophobicity of the packings could be easily adjusted. The packings 
showed the usual reversed-phase HPLC properties, but did not show abnormal 
retention, tailing and broadening of peaks, or irreversible adsorption of ionic and 
aromatic substances. This was due to the lack of ionic or aromatic groups. In 
addition, the packings were found to be stable in alkaline solutions because of the 
relative alkali stability of C-O-C as compared with CO-O and Si-O-C bonds in 
conventional packings.
CH CH CH = C H
I 2
0(CH ) CH 0(CH ) CH
2 3 3 2 17 3
n Bulylvinyl ether Q -Octadccylvinyl ether
CH CH CH CH
0(CH CH O) CH CH O
2 2 2 2 2
Triethyleneglycol divinyl ether
Figure 1.1: Vinyl ethers used in polymerization reactions.
Poly(vinylpyrrolidone) (PVP) has been immobilized on both small and 
large-pore silicas by Kohler by a number of methods including thermal tr eatment,
c
or peroxide-initiated polymerization, or by y-radiation. These phases were
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found to be hydrolytically stable compared to phases prepared by the chemical 
reaction of silica with a pyrrolidone ethyl dimethylchlorosilane silanization 
reagent. Columns of these particular PVP-silica packings have found application 
in several modes including: a) under normal-phase conditions as a polar bonded 
stationary phase, b) under RP conditions, for the separation of organic proton- 
donor and hydrogen-bonding compounds, c) for the aqueous size exclusion 
chromatography of proteins, and d) with salt gradients for the hydrophobic 
interaction chromatography of proteins. The use of a double-layer polymer has 
also been examined.
A thin layer of the organic polyamine was adsorbed onto the surface of the 
silica through ion-pair formation between the silanols and amine groups, and 
subsequent cross-linking has been used to produce silica-based anion-exchangers 
for protein chromatography.36 The PL-SAX strong anion exchange material has 
been produced by coating PLRP-S poly(styrene-divinylbenzene) matrices, which 
have been shown to have the required pore geometry for high efficiency 
separations of biological macromolecules, with polyethyleneimine. This coating 
is then cross-linked in position to give chemical stability and quatemized to 
provide the strong anion-exchange functionality. The chemical stability of the 
matrix coupled with the quaternary amine functionality which is ionized over a 
broad pH range, enables anion-exchange separations to be performed over a wider 
pH range than previously achieved using weak ion-exchangers based on a silica 
matrix. With this polymer system it is possible to strip denatured proteins from 
the column or suppress the ionization of the quaternary amine group by flushing 
the column with strong alkali (sodium hydroxide) or acid (hydrochloric acid). As 
the coating is not only adsorbed onto the surface of the matrix but covalently 
cross-linked in position, organic modifiers can also be used in the eluent or for 
column clean-up. A strong cation-exchange material, PL-SCX, has been 
produced with sulphonic acid functionalities and a masked hydrophobic surface.
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Other coating experiments involved preparing a polymer with a double 
layer. These were carried out using PVP-silica covered with poly (methyl 
octadecylsiloxane) and have been used to study diffusion and shielding effects of 
different polymer layers in the stationary phase. It appears that by coating the 
silica with various polymers of different polarities and properties, the retention 
and selectivity properties could be adjusted. Depending on separation conditions, 
either polymer may govern the retention process; however, the homogenity of the 
different films are difficult to control.
Figge et al,37 coated silicas with a number of polymers of different 
polarities. They were synthesised by equilibration of different mixtures of 
methylhydropolysiloxanes with octamethyltetrasiloxane, with subsequent 
hydrosilylation of 1-alkenes of different chain length. The amount of the coating 
polymer to be deposited on the surface can be varied. This results in the 
preparation of stationary phases of different phase ratios. The efficiency and 
sample capacity of the column obtained with these phases were comparable with 
efficiency and sample capacity obtained with silanized silica.
1.5.1 XAD Resins
Amberlite XAD-2 resin is a macroporous styrene-divinyl benzene 
copolymer which has found application as a versatile liquid chromatographic 
packing. XAD-2 is nonionic but is capable of adsorbing both neutral and ionic 
species.38 Columns of this material have been prepared with 20,000 plates per 
metre (15 cm length); however, it is necessary to use slower flow rates. It has
• ■ 39found application in the analysis of preservatives and active drugs in 
pharmaceutical syrups40. It has also been used in the separation of a variety of 
organic acids41, bases, nitro- and chloro-phenols and other aromatic compounds, 
peptides, amino acids, nucleosides and nucleotides. It is suitable for analysis over
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a wide pH range (0 - 14), is compatible with virtually all solvents and has 
relatively strong adsorbent properties. Its hydrophobic surface which finds use in 
a number of separations that can be normally carried out on reversed-phase 
materials. The XAD resin has also been used for ion-pair chromatography, in 
particular- for the determination of anionic samples while using a large quaternary 
ammonium ion. However, there a number of disadvantages associated with this 
material; in particular it has a relatively low permeability which translates into 
either longer analysis time or higher operating pressure. XAD-2 has been used by 
Hux et al.42 for the determination of methaqualone from blood plasma. The pre­
column allowed the direct injection of a relatively large volume ( 0 - 4  ml) of 
undiluted plasma. A high pH buffer was used to wash out plasma components 
and detection limits in the region 1 -2  ng/ml were obtained.
1.6 MIXED MODE CHROMATOGRAPHY
Stationary phases in HPLC are usually accepted as functioning by a single 
mode, i.e. that chromatographic separations on these phases are achieved through 
one simple retention mechanism. For reversed-phase materials, this mechanism is 
normally based on hydrophobic interactions, whereas retention in normal-phase 
materials is via hydrophilic, such as dipole-dipole and adsorption interactions, 
with the polar stationary phase. Ion-exchange phases separate ionized solutes on 
the basis of their interactions with the charged sites on the stationary phase.
The preparation of these phases, however, can lead to differing 
functionalities on the chromatographic matrix compared to the support. Free 
silanol groups on the silica gel-based matrices are known to affect resolution. In 
the case of the ion-exchange materials, where the charged site is linked to the 
support by an alkyl chain, hydrophobic interactions can alter retention. The 
premise is that better chromatographic separations are achieved on unimode
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phases. Steps are often taken therefore to minimize the effect of residual silanols 
by endcapping reversed-phase materials and to maximize the exchange capacity 
on ion-exchange phases. These steps aim to remove the so called deleterious 
presence of secondary retention mechanisms. In some situations, however, a 
separation may actually be enhanced by use of a more heterogeneous support. 
Several workers have examined this enhanced separation by supports which show 
retention mechanisms other than that expected for their monofimctional phase.
This work led to the preparation of multifunctional phases to achieve a 
better degree of separation, Hydrophobic and ionic interactions were the most 
commonly investigated. The direct approach to the preparation of a 
chromatographic material that contains sites for both these interactions involves 
modifying a matrix containing one class of residues with a second functionality in 
order that it takes on the necessary multifunctional character. However, this can 
cause problems with batch-to-batch reproducibility. Mixed-mode columns may 
also be prepared by mixing together individual phases which exhibit little batch- 
to-batch variation and also contain the appropriate functionalities to obtain a 
mixed-bed with the required properties.
The combination of separation modes would hopefully both increase the 
number of parameters that could be varied to optimize retention and resolution, 
and in addition enable the separation of non-ionic and ionic compounds 
simultaneously. Mixed-mode chromatoraphy will be discussed in greater detail in 
Chapter 2.
1.7 DUAL ZONE CHROMATOGRAPHIC MATERIALS
Most types of columns and adsorbents, regardless of the separation mode 
or of the pore diameter, must be periodically renewed after exposure to large 
concentrations of protein. Injection of clarified plasma or serum onto RP-HPLC
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columns for drug analysis is especially problematic. Rapid efficiency loss occurs 
because the high organic content of the mobile phase usually required during RP- 
HPLC chromatography also causes the highly concentrated proteins to coagulate 
and block the column. Furthermore, even when such coagulation can be avoided 
by lowering the organic content of the mobile phase, the serum protein rapidly 
builds up as an adsorbed layer on the reversed-phase adsorbent. This problem has 
been overcome by the use of dual zone materials.
Dual zone materials are those in which one type of organosilane group is 
attached to the external zone and another to the internal zone. Attachment of a 
first residue occurs primarily in the external zone. This is followed by a second 
reaction with another silylating agent which finds few unreacted exterior silanols, 
and hence reacts preferentially with the internal silanols. Candidates for the 
weakly adsorptive external group include the non-ionic, hydrophilic groups used 
for gel filtration. In the first instance, a packing is chosen with small mesopores 
so that large solutes are excluded by a steric exclusion mechanism. At the same 
time, the outer surface bears hydrophilic ligands which interact weakly with the 
proteinaceous constituents. The stationary phase on the inside of the particles has 
a different surface chemistry bearing ligands which interact selectively with the 
analytes. In the second case, the surface barrier is located at the interface 
between the stagnant mobile phase and the stationary phase, and functions as a 
semi-permeable surface or interface. The packings allow access of the analytes to 
the stationary phase and exclude the high molecular weight proteins. The internal 
surface exerts a dual chemical functionality with hydrophilic ligands externally 
and hydrophobic or ionic ligands internally, embedded in a polymer network. 
These phases are suitable for analysis of low-molecular weight, biologically 
active analytes which need to be separated in complex mixtures.
To overcome the problems of these techniques, new packing materials 
were designed which retained the analytes of interest while eluting the water
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soluble proteins in or near the void volume. Exclusion of the larger proteins from 
the pores of the packing was the first approach tried. If the retentive interaction 
could be made to occur only inside the pores, then the excluded proteins would 
elute unretained, while the smaller analytes would be retained and eluted later. 
The principle behind the internal surface reverse-phase (ISRP) is to confine the 
hydr ophobic partitioning phase exclusively to the internal particulate region of the 
porous silica, with the external surface being maintained hydrophilic and non- 
adsorptive to proteins. As the pores have small diameters, the analytes are 
capable of penetrating the particulates and interacting with the internal 
hydrophobic partitioning phase while all the proteinaceous substances are eluted 
in the void volume. These supports have found use as extraction pre-columns or 
HPLC columns. They have a number of advantages over alkyl bonded pre­
column methods, notably in allowing for the complete passage of proteins. 
Additionally, the use of small particulates (5 |im) allows the direct injection of 
serum or plasma samples onto HPLC ISRP separation columns. A further 
advantage of these supports is the use of polypeptide partitioning phase which is 
relatively weak in comparison. This allows the use of a lower proportion of 
organic modifier in the mobile phase used to elute drugs, thus ensuring against 
protein precipitation. Mobile phases with 20% or less have been used.
The first support was developed by Hagestam and Pinkerton,43 who 
developed the internal surface reversed-phase (ISRP) silica support. This 
suppport consisted of a hydrophobic oligopeptide phase and a hydrophilic diol 
phase bound to silica with a pore size of less than 80 A as internal and external 
surfaces respectively. This was prepared by derivatization of the silica with 
glycerylpropyl silane followed by the attachment of glycine-L-phenylalanine or 
glycine-L-phenylalanine-L-phenylalanine to a given fraction of the glycerylpropyl 
groups, using carbonydiimidazole as a coupling reagent. The phenylalanine 
moieties were then removed from the external surface of the silica particulates by
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treatment with carboxypeptidase. The pore diameters are kept small to exclude 
proteins from the internal surface region. This support was found suitable in the 
analysis of hydrophobic drugs in serum or plasma by direct injection. An ISRP 
analytical column has also been found suitable for the determination of an 
anticonvulsant drug mixture in serum by direct injection.
In another method for the preparation of these supports, the hydrophobic 
partitioning phase (butoxy-L-phenylalanine, Boc-L-Phe) was bound to the silica 
via an amine spacer.44 This hydrophobic partitioning moiety was then cleaved 
from the external surface using a-chymotrypsin, thereby leaving the amine 
spacer. By attaching glycol groups to the freed amino spacers, this leaves the 
external surface non-adsorbtive to proteins. With this approach greater 
partitioning phase capacity can be achieved due to the high yield of silanization 
reactions. This stationary phase has found use in the determination of phenytoin, 
carbamazepine and phenobarbital; however, it has the disadvantage that it can 
retain almost no hydrophilic drugs such as amphoteric drugs, cephalosporins and 
penicillins within the recommended eluent pH range (6.0 - 7.5).
To overcome this problem a new support has been developed. The 
external surface has a Ar-(2,3-di-hydroxypropyl)aminopropyl phase (which is a 
nonadsorptive surface for proteins) and the internal surface has a N- 
octanoylaminopropyl phase (Figure 1.2). The average pore diameter of the ISRP 
silica is 50 A, particles of this size being small enough to exclude macromolecules 
such as serum proteins, while still allowing access for hydrophilic and 
hydrophobic drugs from plasma without the destructive accumulation of the 
proteins in the pH range 3 - 7 .  Cleavage of the A^-octanoylaminopropyl group 
from the external surface was achieved using a novel enzyme, polymyxin acylase. 
Results obtained demonstrated that it is suitable for direct injection analysis of 
hydrophilic and hydrophobic drugs in serum or plasma without destructive 
accumulation of proteins over the eluent pH range 3-7.
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Internal surface ^  External surface
HO—
3-Aminopropyl trimethoxysilane
OSi(CH ) NH 
2 3 2
H N(CH ) SiO 
2 2 3
CH (CH ) COCI 
3 2 6
OSi(CH ) NHCO(CH ) CH 
' 2 3 2 6 3
H C(CH ) CONH{CH ) SiO 
3 2 6 2 3
Polymyxin acylase
OSi(CH ) NH 
2 3 2
H C(CH ) CONH(CH ) SiO 
3 2 6 2 3 5
Glycidol
OSi(CH^)^NHCH^CH(OH)CH^(OH)
H C(CH ) CONH(CH ) SiO 
3 2 6 2 3
Figure 1.2: Synthetic scheme for preparation of the ISRP silica support.
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The recovery of drugs from serum was almost 100 %, regardless of the difference 
in their protein binding. A method for the analysis of barbital, sulfamethoxazole 
and lidocaine has also been described by Haginka et al.45 These columns were 
found to be stable even after continuous use at low pH values.
1.7.1 Shielded Hydrophobic Phase Columns
Shielded hydr ophobic phases (SHP’s) are similar to ISRPs, but consist of a 
different chemistry, in that the same phase covers all the support, while the 
restricted-access phases have a dual phase. This is a relatively new concept for 
direct analysis of biological fluids using HPLC developed by Gisch et a l46 which 
excludes proteins while interacting with small molecules. The support material 
consists of a polymeric bonded phase containing a hydrophobic region (a phenyl 
group) enclaved by a hydrophilic poly(oxyethylene)network (Figure 1.3). The 
hydrophilic network forms a water-solvated interface which operates as a 
shielding barrier for the lipophilic groups through which small analytes, such as 
drugs, penetrate and interact with the hydrophobic groups. At the same time, 
larger water-solvated molecules, such as proteins, are prevented from such 
interactions by hydrophilic shielding. This results in the bulk of the protein 
matrix being eluted virtually unretamed in the void volume without affecting the 
retention of the smaller analytes.
The technique has been used in the analysis of carbamazepine and 
phenobarbital in human plasma. The bulk of the proteins were eluted unretained 
from the serum and plasma matrices. Retention of the low molecular mass 
components of such matrices was adjusted by modifying mobile phase conditions. 
A number of mobile phases have been used, with the portion of the organic 
component being rarely greater than 15 - 20%. As the shielded hydrophobic 
phases are based on silica, the pH range is limited to 2.5 - 7.0.
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Figure 1.3: A typical shielded hydrophobic phase. R = hydrophobic pocket, P 
= hydrophilic network, G = large unretained protein and A = small retained 
analyte.
Gisch et a l41 developed SHPs and by two separate methods creating both 
bonded micellar and embedded polymeric phases. In the first method the bonded 
hydrophobic alkyl ligands are substituted at the co position with a polar 
hydrophilic group. This phase resembles a low-density micellar phase bonded to 
the support through the hydrophobic tails. By the latter method a polymeric 
hydrophilic network embeds hydrophobic moieties. A number of other SHP’s 
were prepared by varying the shielding group R, which could be basic or acidic in 
nature, or bind any other group giving rise to additional selectivity. Further 
selectivity and retention could be achieved by the use of ion-pair groups, in 
particular for analyses where hydrophobic retention alone is insufficient. In an 
attempt to solve the problems inherent in the use of surfactant-coated n-alkyl 
silica, micellar bonded phases were prepared by Gisch et a l41 A 10 nm pore size 
silica with N,N-bis-(2’-methoxyethyl)-ll-silylundecamide [=Si(CH2)ioCON 
(CH2CH2OCH3)2] groups was prepared. The bonded micellar layer was
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composed of -CON(CH2CH2OCH3 ) 2  groups with hydrophilic properties and 
decamethylene groups with hydrophobic properties. Wang et al,48 used a SHP to 
determine catecholamines in urine by direct injection. The HISEP™ SHP, 
allowed the retention of the drug components while eluting the proteins to waste. 
Uno et a l49 also used a HISEP column to analysis sulphamonomethoxine (SMM) 
and its metabolite in blood serum by direct injection. This HPLC method allowed 
rapid analysis without prior sample pretreatment.
Williams and Kabra50 proposed a further synthetic route for the synthesis 
of a dual zone material (DZM) with a hydrophilic external and a lipophilic 
internal surface. In the first step, perflurobutylethylenedimethylsilyl (PFB) 
groups were bound exclusively at the external surface of a 6 nm pore size silica. 
Pe rflurobutyl ethyl en edirnethyl sily 1 -iV-methylacetamide groups were employed as 
the silylating reagent, which was found to react rapidly with silica leaving N- 
methylacetamidyl groups. In the second step the remaining unreacted internal 
surface was covered with n-octadecyl groups using n-octadecyldimethyl 
chlorosilane as a reagent. As with the previously described packings, proteins are 
prevented from reaching the bonded phase by a size exclusion mechanism.
Kimata et al.51 employed an approach in which a reversed-phase silica was 
subjected to a controlled acid treatment, whereby the bonded n-alkyl groups were 
hydrolytically cleaved exclusively at the external surface. After washing, the 
rejuvenated external surface was treated with 3-glycidoxypropylsilane to 
introduce a diol functionality. These phases posess the properties of ISRP 
packing materials.
Boos et a l52 prepared tailor-made bonded packings based on polyvinyl- 
copolymers and glycerol-coated porous glasses as pre-column materials. Due to 
the small pore size the packings showed steric exclusion properties and excluded 
the proteinaceous constituents. Depending on the desired selectivity, a family of
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packings were synthesized with distinct internal stationary phases such as n- 
octadecyl, phenyl and boronic acid.
1.8 CHIRAL STATIONARY PHASES
The determination of enantiomers is of great importance for the 
pharmaceutical industry, as it is necessary to determine the purity of both 
enantiomers. For the synthesis of new drug components it is essential for them to
• . . .  » 53be separated in order to subject them to individual pharmaceutical testing. 
Therefore it is essential to have reliable methods for the determination of the 
optical purity of both the enantiomers. It is possible to have different intensities 
of activity and in some cases opposite activities; a well known example being 
thalidomide where one isomer is dangerous (mutagenic) while the other shows no 
adverse effects. A number of drugs are marketed as racemates, although only one 
enantiomer may contribute to virtually all of the therapeutic activity. In a few 
instances, the less active isomer happens to be the toxic one.
The enantiomers can be separated by a number of methods, including (1) 
reacting the enantiomers with a suitable derivatizing agent, (2) a chiral stationary 
phase and (3) the use of a chiral additive in the mobile phase. The first method 
involves derivatization with a suitable reagent forming a pair of diastereomers, 
which may be then separated on a non-chiral phase.54 There are a number of 
problems associated with this method, including a requirement for the optical 
purity of the reagent to be known (it must be 100 % pure). In addition, the 
reaction between the enantiomer and the reagent must go to completion (or at 
least 99.99 %), otherwise differences in product yields may result in large errors. 
The last factor to take into condsideration is the distance between the two chiral 
centres in the derivatives; they should be as close as possible to each other to 
maximise the difference in chromatographic properties. A number of derivatizing
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agents have been used, which include N-carboxy anhydrides for determination of 
amino acids, isocyanates for the determination of amines and amide and ester 
derivatives for determination of carboxylic acids.
It is also possible to determine these enantiomers without prior 
derivatisation; a number of stationary phases exist today which allow the direct 
determination of a number of compounds as their enantiomers (one of the 
enantiomers been selectively retained by the chiral stationary phase over the 
other). These phases have been prepar ed based on the theory of the “three point 
interaction” introduced by Dalgleish55 in 1952. According to this theory, chiral 
discrimination is obtained when three simultaneous points of interaction occur 
between the enantiomer and the chiral stationary phase. The types of interaction 
that can occur include hydrogen bonding, as well as ionic or dipole attraction; 
these effects been enhanced by non-polar solvents, whereas hydrophobic 
interactions may be important in aqueous media.
There are a number of different types of stationary phases including those 
based on ligand exchange process, protein phases, polymers, chiral cavity phases 
and brush-type phases. The first type consists of an immobilized chiral ligand 
forming a co-ordination complex with a transition metal ion. Resolution of 
enantiomers by ligand-exchange chromatography occurs through the formation of 
a diastereomeric mixed-ligand complexes using an optically active ligand. This is 
bonded to the support and is co-ordinated to a transition metal ion, resulting in 
resolution of the enantiomers. The stability difference between the mixed-ligand 
complexes affects the chiral discrimination of the two enantiomeric molecules. 
Only components which have two polar functional groups with the correct 
distance between them are capable of interacting with the metal. Carunchio et 
al.56 used this method to prepare three stationary phases by grafting silica gel with 
(-)-trans-1,2-cyclohexanediamine. These were used for the resolution of amino
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acids, and separation was due to the addition of an eluent containing a constant 
concentration of copper (II) acetate.
It is possible to bind proteins to silica and obtain a valuable class of CSPs, 
that are mainly suitable for the separation of chiral drugs. There are a number of 
protein phases available and these have numerous bonding sites for smaller 
molecules and different degrees of bonding affinity with many enantiomers. The 
more commonly used proteins are bovine serum albumin (BSA), human serum 
albumin (HSA),57 ovomucoid, cellulase and a-acid-glycoprotein. These phases 
differ in their chromatographic and enantioselective properties, due to the 
differences in their biological functions and size, shape and isoelectric point. 
These phases are expensive and delicate in handling, with low performance and 
loadability; however, they can offer excellent enantioselectivity.
a  1-Acid glycoprotein columns58,59have found use in a number of 
applications including the determination of (3-blockers.60 These phases were 
capable of tolerating organic solvents as well as high temperatures,61 and were 
suitable over a wide pH range without been denatured.
Mano et al.62 described a phase which was prepared from conalbumin- 
conjugated silica gel (from chicken egg white) and used for the determination of 
racemic azelastine, an antiallergic drug. The column was found to be stable and 
capable of separating the enantiomers using an aqueous mobile phase. The
63disadvantage of this phase, however, is its lability to heat and acid. Miwa el al. 
prepared a phase based on ovomucoid-acid glycoprotein (obtained from chicken 
egg white) which has been used in the resolution of both acidic and basic 
compounds. It was found to be resistant to variation in pH and organic solvents 
and demonstrated some degree of heat resistance.
The synthesis of a chiral stationary phase based on human serum albumin 
(HSA) was described by Domenici et al.M The phase was synthesized “in situ” 
by covalent immobilization of HSA. The protein was immobilized on a
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commercially available diol column which had first been activated with 1,1- 
carbonyldiimidazole (Figure 1.4). The phase was found to be suitable for chiral 
separation of enantiomeric analytes and the effects of mobile phase composition 
and temperature on the stereochemical resolutions was examined. Drugs like 
benzodiazepines, warfarin and leucovorin can be resolved using this method.
OH OH 
ImCOIm
▼
OH OCOlm
HSA
f
OH OCOHSA
Figure 1. 4: The synthesis of the HSA-CSP using 1,1-carbonyldiimidazole 
(ImCOIm) activation of a commercially available diol HPLC column.
Thelohan et a l have described the immobilization of enzymes onto 
supports and used them as chromatographic phases for HPLC. A new stationary 
phase was synthesized by first covalently bonding a hydrophilic polymer to silica 
particle.65 Glutaraldehyde was then covalently attached to the polymer. This 
resulted in a surface of negligble hydrophobic character. Trypsin (TRYP) was 
then immobilised on this support through covalent binding to the glutaraldehyde 
moieties. The hydrolytic activity of the immobilized enzyme was 72% of the 
activity of an equivalent molar amount of free TRYP. The initial
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chromatographic studies indicated that this phase could be used for chiral 
separations of enantiomeric O- and N, O-derivatised racemic amino acids which 
are natural substrates on TRYP and that the stereochemical resolutions are a 
result of the activity of the enzyme. Separations were due to the enzymatic 
activity of the support. Although selectivity is high for these protein phases, 
normally the efficiency of these is quite low resulting in broad peaks.
A number of helical polymers have been used including cellulose66 and 
derivatives of cellulose67’68 and these were found to retain enantiomers to different 
degrees between the layers of the helix. The underivatised form was used by 
Gubitz et a l69 to separate A /,-tryptophan, A^-5-hydroxytryptophan and D,L- 
dopa; however, it was necessary to use extremely low flow rates (0.1 ml/min). 
Derivatization of the -OH groups of cellulose does not destroy the helical 
structure and forms a tertiary structure, and these chiral cavities are able to 
include molecules stereoselectively. Helical polymers are suited for the 
resolution of enantiomers of twisted molecules; however, a number of flat 
molecules may also be resolved.
The phases described as cavity phases can be divided into two classes, 
namely cyclodextrins and crown ethers. They can form host-guest complexes 
with small molecules if they are capable of fitting into the ring structure; this 
needs too be stereochemically controlled for enantioselectivity. Cyclodextrins are 
oligoglucose derivatives with six, seven or eight units, linked through a 1,4- 
glycosidic linkage. Glucose itself is chiral, and the cyclodextrins form a hollow 
truncated cone with a cavity diameter determined by the number of glucose units. 
At one opening, the secondary hydroxy groups of the glucose are found. The 
interior of the cavity contains no hydroxy groups and is rather hydrophobic, while 
the external surface is hydrophilic. Chiral recognition based on the inclusion of 
an aromatic into the hydrophobic cavity. The chiral centre must be close to the 
cavity entrance and it is necessary to have interaction between the analyte and the
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mouth of the cyclodextrin, i.e. that is from the hydrogen bonding to the chiral 
hydroxyl moieties. Cyclodextrins 70,71 have been bound to silica, and found use 
for the separation of a range of chiral compounds, but it is difficult to predict their 
suitability for a given compound. There are a number cyclodextrin derivatives 
(Figure 1.5) available and a number of these have found use as stationary phases.
Figure 1.5: Structures of (1) j3-cyclodextrin, (2) 2,6-dimethyl-j3-cyclodextrin 
and (3) 2-hydroxypropyl-p-cyclodextrin.
Chiral crown ethers of the 18-crown-6 type have found use for the 
resolution of amino acids. The interaction occurs between the amino protons and 
the crown ether oxygens (Figure 1.6). The R and R' groups of the crown ether72 
need to be large and rigid in order to force the small guest molecules into a well 
defined interaction with the host.
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Figure 1.6 : Structure of a typical crown ether.
The final type of chiral stationary phase is the brush-type, and these phases 
are based on silica gel which may be derivatized with almost any functional group 
and the resulting monomer structures being known as “brushes”. The most
73widely characterised chiral stationary phases are those developed by Pirkle et al. 
These phases are derived from Af-(3,5-dinitrobenzoylphenylglycine (DNBPG))74 
(Figure 1.7). This molecule has two amide groups which are rigid (planar), which 
allows the chiral moiety a limited number of conformations, which is important 
for chiral recognition. The amide groups can undergo dipole-dipole interaction as 
well as hydrogen bonding. The dinitrobenzoyl group acts as a 7i-acceptor and will 
interact with k donors, e.g. anilines and napthalenes. This interaction is assumed 
to be the most important for the separation of enantiomers, which will not occur 
unless they have this type of group. In most cases, however, it is necessary to 
introduce these groups by derivatisation steps. Separations carried out using these
7 Sphases are normally in the normal phase mode.
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Figure 1.7: Structure of 3,5-dinitrohenzoylphenylglycine used in the
preparation of Pirkle phases.
If a chiral additive is capable of forming a complex, ion-pair, or any other 
adduct with the enantiomers in the sample, and is added to the mobile phase, 
there is a chance that the distribution coefficients of the diastereomers formed 
between the mobile and stationary phases will be different and, therefore, these
76 77 78 i • •can be separated using a non-chiral phase. ’ ’ The chiral additive does not 
need to be optically pure and there is no restrictions on the stationary phase used. 
One disadvantage is that the enantiomers exists as diastereomeric associates after 
separation, whose dissociation may be impossible.
1.9 SAMPLE PREPARATION
The analysis of drugs in biological media has developed over the last 30 
years, as the number of drug compounds introduced yearly onto the market 
increases. It is also necessary to determine these compounds at increasingly 
lower levels, hence, the methods for their determination are stretched to their
H
NH
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fullest. The number of matrices which can be used as a source of these 
compounds is expanding, and these include serum, plasma, urine, tissue (kidney, 
liver) cerospinal fluid.
HPLC analysis is often encounters problems by interferences from 
endogenous compounds and a number of different approaches can be applied to 
overcome these problems. These include changes in the eluent, or the column 
packing materialor even chemical derivatization to enhance the relative detector 
response of the drug. An alternative and more commonly used approach involves 
a sample preparation, removing the interferents prior to the analysis. It is 
therefore neccessary to carry out some clean-up/pre-concentration step(s), and 
there are a number of these available which include liquid/liquid extraction and 
solid-phase extraction.
Liquid/liquid (partitioning) extraction was for a long time the standard
79method for isolation of drug components from biological matrices. This 
technique is based on the extraction of an analyte depending on its partition 
between an aqueous and an immiscible organic phase. The components are 
extracted according to their acidity/alkalinity and their pKa values; basic 
compounds are extracted by increasing the pH of the solution to a value 1 - 2 pH 
units above their pKa, whereas for acidic compounds the pH is adjusted to a value 
which is I - 2 pH units below the pKa value of the component in question. This 
method permits concentration of the analyte, however, it is well known that 
repeated extraction (2 or more times) with small portions of solvent can recover 
much more analyte than a single batch extraction. For practical purposes, 
however, an extraction procedure would involve no more than 2 extractions. 
There are disadvantage is relatively time-consuming and is unsuitable for 
components with various chemical properties or of polar origin. A number of 
salts have also been used to increase the selectivity of the extraction by increasing 
the transfer of a drug from the aqueous to the organic phase.
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In order to achieve higher efficiency new techniques were developed, e.g. 
solid-phase extraction. The extraction is carried out in small columns or 
cartridges packed with a suitable sorbent e.g. silica gel, bonded silica, ion 
exchange materials, polymers and mixed functional phases (MFP). Columns 
containing restricted access packings are also available, these materials being 
particularly suitable for the determination of plasma samples due to the surface 
barrier which allows proteins to be eluted in the void volume. These phases 
(previously mentioned) include ISRP, SHP and DZP. The sample is applied to 
the column and any interferents present are removed by a washing procedure. 
This is then followed by an elution step which removes the component(s) of 
interest. They have the advantage that they can be easily automated, have low 
solvent usage and less time consuming.
SPE can be further divided into two areas of off-line and on-line 
extraction. Off-line SPE deals with cartridges packed with a suitable material for 
the component(s) of interest. These columns have a high sample loading 
capacity, and single use analysis as components may be retained on the column 
from a previous sample. The most commonly used phases are the reversed-phase 
materials, Qg and Cg. Whereas on-line involves the use of a pre-concentration 
column positioned between the injection valve and the analytical column. The 
column is usually prepared with the same material as the analytical column, but of 
larger particle size (usually in the range 30 to 50 jjm). A dual pump system 
allows the components to be absorbed onto the pre-column, while interfering 
compounds are eluted to waste. On switching the injection valve, the drug can be 
transferred from the precolumn to the analytical column by means of the mobile 
phase. The advantages of this method are the high speed of analysis, simplicity 
and accuracy. Efficiency and reproducibility are as good, or better than those of 
liquid/liquid extraction. SPE also may be preformed on compounds which are 
difficult to extract at any pH e.g. antibiotics.
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CHAPTER TWO
RETENTION STUDIES ON A 
MIXED-MODE COLUMN IN 
HIGH PERFORMANCE LIQUID 
CHROMATOGRAPHY
2.1 INTRODUCTION
The basic principle behind mixed-mode chromatography has been 
described briefly in chapter 1, while this chapter will detail mostly with the 
applications of such phases.
Prior to the use of mixed-mode phases, Halfpenny et al} utilized column 
switching to combine two modes (an ion-exchange and a reversed-phase). 
However, this system involved the use of two analytical columns coupled by a 
number of switching valves thus allowing the isolation of either column during 
the analysis. In this manner the simultaneous determination of purine and 
pyrimidine nucleotides, nucleosides and bases was achieved in one analysis. The 
nucleotides were separated on the anion-exchange column and the nucleosides 
and bases on the reversed-phase C18 column. As only one analysis was required 
instead of two, smaller amounts of sample were required. The analysis times 
using this system were in the region of one hour.
Difeo et a l2 also used a tandem system of a LCSCX and a Novapak for the 
determination of RG-14620 and its potential impurities/ degradation products in a 
topical formulation. The analytes were eluted using a gradient firstly from a 
Supelcosil LC-SCX cation exchanger and were then further purified on a Nova- 
Pak dimethyloctadecylsilyl analytical column. This system was found useful 
when the mixture under analysis contained a large number of components of 
vaiying polarity.
Johnson et al.3 used coupled column chromatography (CCC), with 
exclusion chromatography as the preliminary step and reversed-phase 
chromatography as the secondary step. This system was found suitable for the 
determination of (a) additives in compounded rubber, (b) a pesticide (malathion) 
in vegetable matter and (c) limonin in grapefruit peel. This system could be used 
by either of two methods; on-line or off-line. The off-line is carried out by
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collection of the analytes as they exit from the detector and these are then injected 
onto the second column, however, this is complicated and tedious. On-line is 
achieved by coupling the second column via a switching valve. The valve can 
serve to trap a defined volume of collected sample, usually in a loop, and direct it 
onto the second column. It can also divert the mobile phase containing the 
analyte of interest from the first column to the second column for a defined period 
of time. Although on-line would be the preferred method, it is not always 
suitable for the application at hand. A number of complex plant extracts4 were 
separated by combining GPC and reversed-phase chromatography.
Solid-phase extraction may also be carried out in tandem; Mills et a l5 
have used two resins in tandem to determine triazine metabolites from soil and 
aquifer sediments. The samples are initially applied to a Cjg phase, then after 
elution of the components of interest they are applied to an anion-exchanger to 
remove any further interfering components. It was possible to automate this 
method and hence make it a viable method for studying triazine metabolites in the 
environment.
In recent years a number of new types of selective bonded phases with 
mixed functional groups have been introduced. Polar and non-polar groups can 
be bonded onto the same sorbent, introducing separation of sample components 
depending on both adsorption and partition chromatography. The preparation of 
these phases can be achieved by various modification methods, such as (a) the 
bonding of a multifunctional reagent, (b) by multistep modification of the silica 
gel; different functional groups being bonded in each step and finally (c) by 
modification using mixtures of reagents.
Crowther et a l6 has prepared phases which consist of chemically 
dissimilar ligands bonded to silica supports. The aim was to balance the ionic and 
hydrophobic properties of the stationary phase in a reproducible maimer, 
producing stationary phases which are similar to ion-pairing in selectivity, but
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more like reversed-phase packings in stability, reproducibility and efficiency. 
These phases are mainly reversed-phase in nature, but also contain significant 
ion-exchange properties. Mixed retention mechanisms were created by bonding 
ionic and hydrophobic groups in the correct proportions resulting in a unique 
selectivity; Figure 2.1 shows a schematic of the synthesis of this mixed-mode 
phase. The ratio of ionic to hydrophobic content could be varied during the 
synthesis step and hence allowed changes in the separation other those obtained 
by varying the mobile phase only. The selectivity could be enhanced without the 
use of strong buffer salts or contamination due to ion-pair reagents. The 
preparation of both anionic and cationic/ reversed materials has been described. 
They have been used in the simultaneous separation of nucleosides and 
nucleotides, and also for the separation of the catecholamines. A number of
phases were also prepared which found use in the determination of
• 1oligonucleotides.
i  OSi(CH ) CH (CH ) CH
Si 3 2 2 2 6 3
CH2CH2 \  , 3
+
Support |  OSi(CHJCH^R' where R1 = CH2CH2|J(CH3):
CH
3' 2   2 2| 3 2
■ OSi(CH ) CH (CH ) CH
3 2 2 2 6 3
2
Figure 2.1: Schematic of a “mixed-mode” stationary phase synthesised hy 
bonding both functionalised ionic (R) and reversed-phase groups onto the 
silica support. The result is a stationary phase with well-defined hydrophobic 
and ionic characteristics.
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Colmsjo et a/.8 examined a number of different cyano/ODS polymeric 
modified silica gel phases. These were prepared by the simultaneous bonding of 
octadecylsilane and cyanoalkylsilanes. This modified silica was suitable for 
separation in both normal and reversed-phase modes and found use for the 
determination of PAH’s with MW’s over 300. A significant decrease in retention 
time was observed for these compounds compared to the values obtained on a 
single phase polymeric ODS phase.
A number of mixed-mode sorbents have found use as solid-phase 
extraction materials since the multiple interactions have found use in the isolation 
and purification of analytes. Patel et a l9 described a mixed-mode poly(styrene- 
divinylbenzene) sorbent containing both Qg (reversed-phase) and sulfonic acid 
sites, and this was compared with a silica-based sorbent that also showed mixed­
mode behaviour. Two different test compounds were used to assess each of the 
functionalities; valerophenone was used to test the reversed-phase interaction 
while phenylpropanolamine was used to measure the cation-exchange 
interactions. This phase was found to be suitable for the determination of 
barbituates from urine by reversed-phase chromatography, while the cation- 
exchange interaction was used for the determination of antihistamines in cough 
syrups and also for preconcentrating triazine herbicides from water. Pheniramine 
was used to test reusability of the polymeric sorbent, and it was found that the 
polymeric mixed-mode sorbents have a much higher reversed-phase and cation- 
exchange capacity than silica-based mixed-mode sorbents. The polymer-based 
sorbents are also stable from pH 0 - 14 and are suitable for isolating organic 
amines with high pKa values by cation exchange chromatography.
Chen et a/.10 used a mixed-mode bonded-phase silica column at pH 6 for 
the isolation of acidic, neutral and basic drugs from whole calf blood. The 
cartridge used was a Bond Elut Certify™ material which contained both 
hydrophobic and cation-exchange functional groups. By adjustment of the
52
extraction system pH, two different eluate fractions could be collected; the first 
being acidic, neutral and weakly basic drugs with lower pKa values, the second 
been the other basic drugs, with recoveries of > 81 % being obtained.
Mills et a ln compared silica- and styrene-divinylbenzene-based sorbents 
which contained a mixture of Cg, Ci8 and sulphonated cation-exchange groups for 
their efficiency in the isolation of neutral triazine compounds from water samples. 
Their efficiencies for the isolation of benzoylecgonine from urine was also 
examined. Larger recoveries (95 %) were obtained on copolymerized mixed­
mode resins in which Qg and sulfonic acid are in closer proximity than on 
blended mixed-mode resins, where recoveries of 60 - 70 % were obtained.
Collins et al.12 described a method using a mixed-phase (XtrackT) for the 
determination of clenbuterol, malbuterol and terbutaline from bovine urine and 
liver samples. The columns exhibit two retention mechanisms based on octyl and 
benzosulfonic acid groups bound to silica particles, and recoveries obtained were 
>75 % and 85 %, for urine and liver, respectively.
Dixit et al.13 described the extraction of a number of catecholamines and 
their metabolites from urine using a bonded silica gel solid-phase extraction 
column. The AccuCAT material is a chemically modified silica gel which 
exhibits multiple interactions including polar, nonpolar, anion-exchange and 
cation-exchange properties. These properties enabled the extraction of free 
catecholamines and their acidic and basic metabolites on a single column, by 
following a specific procedure for each class yielding clean extracts with high 
recoveries. A number of acidic, neutral and basic compounds were isolated using 
a Bond Elut Certify™ mixed-mode extraction column.14 Elution of the acidic and 
neutral components was achieved using methylene chloride and the basic 
components were eluted using a 2 % ammonium hydroxide solution in ethyl 
acetate. Recoveries obtained by this method varied in the range 60 - 100 %, the 
lower values being obtained for the recoveiy of the acidic/neutral fraction. A
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number of other drug components were determined by mixed-mode solid-phase 
extraction and these include iloperidone15 and codeine.16
Brown et al}1 described a mixed-bed ion-exchange (MBIE) column 
containing alumina and silica. The MBIE column was evaluated for the 
simultaneous separation of anionic and cationic analytes. Adjustment of the 
mobile phase pH allowed the alumina to provide anion-exchange sites while 
simultaneously providing cation-exchange sites on the silica. The elution order 
was effected by pH and type and concentration of counter-anions and counter­
cations. The weight ratio of the two sorbents could be altered to alter resolution 
and elution order. The column was found suitable for the simultaneous 
determination of inorganic mono- and divalent anions and cations.
A method was described by Saari-Nordhaus et al.n whereby inorganic 
anions and carboxylic acids were separated using a mixed-mode stationary phase. 
This phase contained reversed-phase (C]8) and ion-exchange (anion) ligands 
mixed in a 1:1 ratio and attached to a silica base. The compounds analysed on 
this phase included bromide, nitrate, phosphate and carboxylic acids such as 
acetic, lactic, formic and propionic acids. The separation of these analytes was 
effected by several factors such as type of the alkyl group in the support, ionic 
strength, eluent pH and percent organic modifier in the eluent. By careful 
manipulation of these parameters, the simultaneous determination of inorganic 
anions and carboxylic acids could be achieved.
A polymeric fluorocarbon-diamine silica (weak anion-exchanger/reversed- 
phase) column packing was prepared by Danielson et al}9 and the separation of a 
number of aromatic compounds were examined on this column and on a 
hydrocarbon (Cg) column. The fluorocarbon column was generally less retentive 
than the hydrocarbon one, with good resolution and fast analysis of the sample 
mixtures. It also had the advantage of being stable under alkaline conditions.
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Weatherall20 also used a mixed-mode column (anion-exchange/ reversed- 
phase), for the determination of sulphonated azo dyes. Previous reverse-phase 
methods required the use of aggressive acidic solvents or the use of ion-pair 
reagents. Separation of the structural isomers was obtained using isocratic elution 
with acetonitrile and near neutral phosphate buffers.
A mixed-mode column has been used by Me Laughlin21 to analyze nucleic 
acids. He found that the mixed-mode materials relied upon both the hydrophobic 
interaction with the nucleobases and ionic interactions with the phosphodiesters 
for determination of these compounds. The resolution in some cases surpassed 
that observed with either ion-exchange or reversed-phase chromatography. Other
* * * • 22 23 24work includes the determination of oligonucleotides ’ and tRNAs.
Haginaka et a l25 synthesized a mixed-functional silica support which was 
found suitable for the direct injection of drugs in serum. The phase is prepared 
from porous silica; 3-glycidoxypropyl groups are introduced, then phenyl groups 
are introduced and finally the oxirane is hydrolysed to diol groups. This phase 
was found suitable for the direct injection analysis of hydrophobic and 
hydrophilic drugs in serum, with recoveries in the region of 100 % being 
obtained.
Mixed-bed HPLC columns packed with equal proportions (w/w) of Cig- 
and SAX- bonded silica have been used for the chromatography of a range of 
substances, including phenols, substituted aromatic acids and sulphates, glycine 
and glucuronide conjugates.26 It was found that columns prepared in this way 
showed chromatographic properties which were intermediate between those of the 
individual phases. The dual nature of the retention mechanism allowed the 
retention of ionizable molecules to be adjusted by varying the pH. This did not 
affect the retention of the uncharged compounds. The simultaneous 
chr omatography of model compounds and their glucuronide, sulphate and glycine 
conjugates was demonstrated under a variety of conditions.
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Other mixed-phases included C4 alkyl/phenyl sulfonate27 bound to a silica 
support, a Poly-RP28 and its cyano and diol derivatives which could be used with 
polar and non-polar solvent systems.
The work described in this chapter relates to the retention properties of a 
column containing equal proportions (w/w) of ion-exchange and reversed-phase 
materials, since the combined separation modes would increase the number of 
parameters that could be varied to optimize retention and resolution and permit 
the separation of both non-ionic and ionic compounds simultaneously. It 
describes experiments with a mixed-mode column containing both reversed-phase 
(C]8) and a strong cation exchange material (SCX). The chromatographic 
characteristics of a range of drug compounds, including benzodiazepines, tricylic 
antidepressants and barbiturates was investigated utilizing typical “reversed- 
phase” mobile phases at various pH’s, with different buffer ions, buffer ion 
concentrations and various percentages of organic component. The 
chromatographic characteristics of these compounds were also determined on a 
Ci8 column for a comparison study.
2.2 EXPERIMENTAL
2.2.1 Reagents and solvents
HPLC grade methanol and acetonitrile were obtained from Labscan 
Analytical Sciences (Dublin, Ireland). Analar grade disodium hydrogen 
phosphate, sodium acetate, ammonium acetate, and dipotassium hydrogen 
phosphate, which were used as buffer salts, were obtained from Merck 
(Darmstadt, Germany). Deionized water was obtained from an Elgastat spectrum 
water purification unit.
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2.2.2 Test solutions
Phenolphthalein and phenol were obtained from Sigma Chemical Co. 
(Poole, UK). The remaining compounds were obtained from commercial 
suppliers and were of pharmaceutical quality. Stock solutions were prepared by 
dissolving the appropriate amount of drug in methanol (100 %) to give a 
concentration equivalent to 1 mg/ml. The solutions were diluted to 100 (ig/ml 
with deionized water and were stored at 4 °C. These stock solutions were freshly 
prepared on a weekly basis.
2.2.3 HPLC Eluents
A number of eluents were required for evaluation of this column; the 
organic component included acetonitrile or methanol. The buffer salts included 
sodium acetate, ammonium acetate, disodium hydrogen phosphate, dipotassium 
hydrogen phosphate. The pH was adjusted with 10 % phosphoric acid, 10 % 
acetic acid or 0.1 M sodium hydroxide.
2.2.4 HPLC separations
The HPLC system consisted of a Waters Associates (Milford, MA, USA) 
dual piston chromatography pump (Model 510) fitted with a Rheodyne (Cotati, 
CA, USA) injection port with a 20 jo.1 injection loop. Detection was achieved 
with a Waters Model 486 spectrophotometric detector set at 254 nm. The 
sensitivity was 0.5 AUFS and retention times were determined using an integrator 
(Waters 746 Data Module ). The column under evaluation was a Hypersil (250 
mm x 4.6 mm I.D.) SCX/Cig column (Shandon Scientific Ltd., Cheshire, UK).
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The column contained equal quantities of 5 i^m Ci8 and 5 (am sulphonate 
modified silica. The column used for the comparison study was a Hypersil (250 x 
4.6 mm i.d., 5 ^m) single-mode column containing the same batch of Qg silica 
(Shandon Scientific Ltd., Cheshire, UK). All separations were carried out at 
ambient temperature.
2.2.5 Calculations
The capacity factors (k') of components were calculated from the equation:
k' = (tr-t0)/t0
where tr is the retention time of the analyte and t0 is the retention time of the first 
deviation of the baseline following injection of the organic component of the 
mobile phase.
2.3 RESULTS AND DISCUSSION
Table 2.1 lists the compounds used in the study, with their pKa values to 
aid the rationalization of their retention properties, while Figure 2.2 shows some 
typical structures of the different classes of compounds studied.
The compounds investigated were mostly of pharmaceutical or medical 
interest, and included strongly basic compounds such as tricyclic antidepressants 
(TCAs) and (3-blockers, weakly basic compounds such as the benzodiazepines 
and compounds that are essentially acidic in character, such as the barbiturates.
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TABLE 2.1
Compounds used in the study and their pKa values
Compound pKa
Nitrazepam 3.2/10.8
Clonazepam 1.5/10.5
Diazepam 3.3
Flurazepam 1.9/8.2
Clomipramine ND
Desmethyl-clomipramine ND
Amitriptyline 9.4
Desipramine 10.2
Imipramine 9.5
Pindolol 8.8
Propranolol 9.5
Xylazine ND
Terbutaline 8.7/10.0/11.0
Norephedrine ND
N-Methyl-ephedrine 9.6
Barbitone 8.0
Phenobarbitone 7.3/11.8
Quinalbarbitone 7.9
Butobaibitone 8.0
Benzoic acid 4.2
Salicylic acid 3.0
Resorcinol 9.5/10.1
Furosemide 3.9
PhenoSphthalein 9.7
Phenol 10.0
ND = not determined
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Figure 2,2: Structures of some compounds used in study : nitrazepam (weakly 
basic), imipramine (strongly basic), quinalbarbitone (weakly acidic) and 
benzoic acid (strongly acidic).
2.3.1 Chromatographic Elution Parameters
2.3.1.1 Effect o f Eluent pH
The aqueous component of the mobile phase used in this part of the study 
consisted of a 0.025 M sodium phosphate buffer adjusted to pH 3.0, 4.0, 5.0, 6.0 
or 7.0 and mixed in a 50:50 (v/v) ratio with acetonitrile. The filtered degassed 
eluents were allowed to equilibrate on the column overnight to ensure that the 
desired on-column pH conditions were obtained.
Variation of the eluent pH alters the degree of ionization of ionizable 
compounds, resulting in different proportions of neutral and ionized forms. As 
only the unionized form of the compound will partition into the hydrophobic 
portion of the stationary phase, and the ionized form of the bases will interact 
with the sulphonate and the residual silanol groups, it is then to be expected that 
small changes in the pH of the eluent can elicit major changes in retention.
The benzodiazepines (nitrazepam, clonazepam, diazepam, flurazepam) are 
all weakly basic with pKa values of less than 3.5. Hence, the retention times of 
these compounds are determined principally by their interaction with the Ci8 
material over most of the pH range investigated. The data in Table 2.2 confirms 
that small increases in retention factors of these compounds occurred at lower pH 
values (3 - 4), while their retention indices were hardly affected by pH variation 
within the more alkaline eluents.
Phenobarbitone, barbitone, quinalbarbitone, butobarbitone, phenol and 
phenolphthalein are all weakly acidic with pKa values varying between 7.2 and
11.8. These compounds only interact with the hydrophobic component in the 
column, and then only when unionized. Since they are largely unionized over the 
pH range investigated, it was found, as was expected, that their retention times
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would remain unchanged over the pH range examined. Little variation in the 
retention times was indeed observed, as exhibited by the data shown in Table 2.2.
The tricylic antidepressants (clomipramine, desmethyl-clomipramine, 
amitriptyline, imipramine and desipramine) are all basic drugs with pKa values 
greater than 8 and are thus mainly ionized over the pH range examined. The 
retention of these compounds decreased between pH 3 and pH 5 and then rose 
again sharply between pH 6 and pH 7 (Figure 2.3). In reversed-phase 
chromatography (RPC), the retention of basic compounds is strongly influenced 
by secondary equilibria between the oppositely charged amines and residual 
silanol groups on the stationary phase. These secondaiy equilibria will also 
contribute to the observed retention patterns on the mixed-mode phase, though the 
significance of these equilibra cannot be evaluated in terms of the primaiy ion 
exchange interactions with the SCX component in the column. It is possible that 
the decrease in retention observed between pH 3 and pH 5 is due to the 
decreasing percent ionization as the pH approaches the pKa of the drugs.
However, as even the most weakly basic amine is still 99 % ionized at pH
7.0, the contribution from this source is probably not significant. It is more likely 
that since the fixed charge moiety is ionized over the entire pH range, the slight 
decrease in retention results from the increased molar concentration of competing 
cation (sodium) with increasing pH. Between pH 6 and pH 7, ionization of the 
silanol moieties becomes significant and the secondaiy silanophilic interaction 
could account for the dramatic increase in retention observed at this point.
Acidic compounds (benzoic acid, salicylic acid, resorcinol and 
furoscmide) were found to be largely unaffected by eluent pH. In fact, they all 
had veiy low capacity factors at all pH’s, which may be explained in terms of a 
low affinity for the hydrophobic component of the more acidic compounds (even 
when unionized) at low pH or, at high pH, in terms of electrostatic repulsion 
between the analytes and the similarly charged sulphonate sites.
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TABLE 2.2
EFFECT OF ELUENT pH ON THE CAPACITY FACTORS 
Eluentr-Acetonitrile :Disodium hydrogen phosphate 0.025 M (50:50) 
Compound Capacity Factor
pH
3 4 5 6 7
Nitrazepam 1.28 1.06 0.94 1.05 1.11
Clonazepam 1.35 1.13 1.03 1.24 1.20
Diazepam 2.32 2.19 1.98 2.32 2.37
Flurazepam 4.59 4.15 4.23 4.66 4.83
Clomipramine 3.99 3.75 3.59 4.61 8.59
Desmethyl-clomipramine 3.45 3.26 3.02 3.77 4.69
Amitriptyline 3.79 3.61 2.83 4.46 7.47
Desipramine 3.28 2.95 3.03 3.59 4.34
Imipramine 3.37 3.36 3.21 4.31 6.31
Pindolol 2.35 2.18 2.13 2.74 2.88
Propranolol 2.81 2.56 2.54 3.14 3.40
Xylazine 4.53 4,25 4.17 5.56 4.67
Terbutaline 2.72 2.47 2.35 2.92 2.89
Norephedrine 3.39 3.01 3.50 3.62 3.65
N-Methyl ephedrine 4.11 3.93 4.33 5.21 5.86
Barbitone 0.44 0,48 0.39 0.41 0.46
Phenobarbitone 0.77 0.73 0.67 0.96 0.79
Quinalbarbitone 1.17 1.08 0.90 1.07 1.20
Butobarbitone 0.85 0.80 0.72 0.82 0.78
Phenolphthalein 0.96 0.96 0.87 1.08 1.03
Phenol 0.79 0.83 0.78 0.85 0.86
Benzoic acid 0.69 0.62 0.45 0.52 0.37
Salicylic acid 0.50 0.36 0.39 0.61 0.36
Resorcinol 0.38 0,45 0.48 0.59 0.47
Furosemide 0.42 0.52 0.34 0.49 0.52
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Figure 2.3: Effect of pH  on the k ' values of nitraz.epam( +), imipramine (tK), 
quinalbarbitone (A) and benzoic acid (X) on a Hypersil Cis/SCX column. 
Mobile phase: acetonitrile-disodium hydrogen phosphate 25 mM (50:50 v/v). 
Flow rate 1.0 ml/min.
The remaining basic compounds (pindolol, propranolol, terbutaline, 
xylazine and the catecholamines) were affected by pH in a manner similar to the 
TCA's: high retention values at low pH which decreased until pH 5, after which 
retention increased again.
The weakly basic and acidic analytes all have very low k' values over the 
pH range, suggesting either that there is insufficient Ci8 material present to give 
them reasonable capacity factors, or that these compounds, even when unionized, 
have low affinities for the very hydrophobic C18 material.
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2.3.1.2 Effect o f Ionic Strength
The mobile phase used for this part of the study consisted of either 0.01, 
0.025 or 0.05 M disodium hydrogen phosphate (pH 5.0) mixed in equal 
proportions with acetonitrile. The filtered degassed mobile phase was allowed to 
equilibrate on-column for at least 2 h.
It was expected that ionic strength would exert a considerable influence on 
the retention times of the cationic analytes since there are both primary 
(sulphonate) and secondary (silanophilic) cationic exchange mechanisms 
occurring. As indicated by the data in Table 2.3, the relative dominance of these 
two mechanisms was determined by the pH of the eluent. Either way, the 
concentration of competing cation in the mobile phase will influence retention in 
a characteristic ion exchange manner: as the concentration of competing ions in 
the mobile phase is increased, the number of ions with which the solute must 
compete for sites on the stationary phase is increased, resulting in lower retention 
times. Furthermore, compounds with different pKa values (showing different 
degrees of ionization) are susceptible to different extents. The TCA’s, 
catecholamines and a number of other basic compounds showed similar results: 
the retention values decreased as the ionic strength increased (Figures 2.4.a. and 
2.4.b.)
The weakly basic benzodiazepines, unionized over the pH range 
examined, were largely unaffected by changes in the ionic strength (Figures 2.5.a. 
and 2.5.b.). There was a small decrease in retention with increasing ionic 
strength observed for the acidic compounds, though the origin of this observation 
has not been identified. Figure 2.6 indicates the effect the ionic strength has on 
the capacity factors of the components examined.
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TABLE 2.3
EFFECT OF IONIC STRENGTH ON THE CAPACITY FACTORS 
Eluent:-Acetonitrile:Disodiuin hydrogen phosphate pH 5.0 (50:50)
Compound
0.01 M
Capacity Factor 
Relative Ionic Strength 
0.025 M 0.05
Nitrazepam 0.99 0.94 0.91
Clonazepam 1.18 1,03 0.99
Diazepam 2.51 1.98 1.88
Flurazepam >20 4.23 2.64
Clomipramine 8.02 3.59 2.26
Desmethyl-clomipramine 7.11 3.02 1.93
Amitriptyline 8.25 2.83 2.28
Desipramine 6.89 3.03 1.80
Imipramine 7.86 3.21 2.15
Pindolol 5.58 2.13 1.42
Propranolol 6.35 2.54 1.59
Xylazine >20 4.17 2.76
Terbutaline 6.08 2.35 1.44
Norephedrine 8.25 3.50 1.86
N-Methyl ephedrine >20 4.33 2.44
Phenobarbitone 0.78 0.67 0.62
Barbitone 0.61 0.39 0.35
Quinalbarbitone 1.30 0.90 0.84
Butobarbitone 0.92 0.72 0.62
Phenolphthalein 1.02 0.87 0.85
Phenol 0.91 0.78 0.74
Benzoic Acid 0,89 0.45 0.39
Salicylic Acid 0,55 0.32 0.39
Resorcinol 0.55 0.48 0.39
Furosemide 0.94 0.34 0.34
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Figure 2.4.a: Effect of eluent ionic strength on the capacity factor of the 
strongly basic compound clomipramine on a Hypcrsil Cu/SCXcolumn. Mobile 
phase: acetonitrile-disodium hydrogen phosphate 10 mM pH 5. (50:50 v/v). 
Flow rate 1.0 ml/min.
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Figure 2.4.h: Effect of eluent ionic strength on the capacity factor of the
strongly basic compound clomipramine on a Hypcrsil Clf/SCX column. Mobile 
phase: acetonitrile-disodium hydrogen phosphate 50 mM pH 5. (50:50 v/v). 
Flow rate 1.0 ml/min.
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Figure 2.5.a: Effect of eluent ionic strength on the capacity factor of the 
weakly basic compound clonazepam on a Hypersil Cjg/SCX column. Mobile 
phase: acetonitrile-disodium hydrogen phosphate 10 mM pH  5. (50:50 v/v). 
Flow rate 1.0 ml/min.
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Figure 2.5.b: Effect of eluent ionic strength on the capacity factor of the 
weakly basic compound clonazepam on a Hypersil Cu/SCX column. Mobile 
phase: acetonitrile-disodium hydrogen phosphate 50 mM pH  5. (50:50 v/v). 
Flow rate 1.0 ml/min.
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Figure 2.6: Effect of ionic strength on the k ' values of nitrazepam( +),
imipramine (R), quinalbarbitone (A) and benzoic acid (X) on a Hypersil 
Ci/SCX column. Mobile phase: acetonitrile-disodium hydrogen phosphate 25 
mM (50:50 v/v). Flow rate 1.0 ml/min.
2.3.1.3 Effect o f Buffer Cation
To examine the effect of buffer cation, the mobile phase consisted of either 
sodium, potassium phosphate or sodium or ammonium acetate. Each of these was 
prepared at two concentrations; 0.025 M and 0.05 M (pH 5.0) and mixed in equal 
proportions with acetonitrile. Changing the cation in the mobile phase will 
change retention values of ionized compounds. Increasing the ionic strength of 
the buffer cation results in a decreased retention of the compounds which are 
ionized at pH 5, regardless of the buffer cation. Varying retention values were 
obtained depending on the affinity of the cations for the fixed anionic sites 
(Figure 2.7). As expected, doubling the ionic strength caused the retention times
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of the strongly basic TCA’s and catecholamines to decrease dramatically (Table 
2.4). The order of competing ion ability to displace the analytes from the charged 
sites was found to be:- Na+ « N H 4+ « K +.
Na+ K' N H /
Buffer Cation
Figure 2.7: Effect of buffer cation on the k' values of nitrazepam,
imipramine, quinalbarbitone and benzoic acid on a Hypersil C/g/SCXcolumn. 
Mobile phase: acetonitrile-buffer 25 mM (50:50 v/v). Flow rate 1.0 ml/min.
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TABLE 2.4
EFFECT OF CATION ON THE CAPACITY FACTORS 
Eluent:- Acetonitrile : Buffer pH 5.0 (50:50)
Compound Capacity Factor/ Ionic Strength
Na+
0.025 0.05
K+
0.025 0.05
Na+
0.025 0.05
n h 4+
0.025 0.05
Nitrazepam 0.94 0.91 0.95 0.94 1.16 0.91 0.93 0.95
Clonazepam 1.03 0.99 1.03 1.00 1.24 0.99 1.01 0.97
Diazepam 1.98 1.88 2.00 1.94 2.34 1.96 2.00 1.87
Flurazepam 4.23 2.64 3.32 2.16 6.70 3.97 6.09 4.26
Clomipramine 3.59 2.26 3.17 2.20 5.84 3.74 5.22 3.81
Desmethyl-clomipramine 3.02 1 93 2.76 1.95 4.62 3.17 4.48 3.31
Amitriptyline 2.83 2.28 2.99 2.01 5.68 3.55 5.09 3.52
Desipramine 3.03 1.80 2.49 1.66 4.62 2,85 4.25 2.85
Imipramine 3.21 2.15 2.79 1.89 5.14 3.33 5.08 3.35
Pindolol 2.13 1.42 1.89 1.25 3.56 2.07 3.35 2.36
Propranolol 2.54 1.59 2.17 1.40 4,07 2.44 3.85 2.56
Xylazine 4.17 2.76 3.50 2.14 7.22 4.23 6.57 4.43
Terbutalme 2.35 1.44 2,01 1.31 3.69 2.20 3.54 2.42
Norephedrine 3.50 1.86 2.53 1.57 5.01 2,97 4.69 3.09
N -Methylephedrine 4.33 2.44 3.15 1.95 5.41 3.90 6.03 4.00
Phenobarbitone 0.67 0.62 0.65 0.64 0.80 0.61 0.62 0.63
Barbitone 0.39 0.35 0.43 0.37 0.56 0.42 0.46 0.40
Quinalbarbitone 0.90 0.84 1.07 0.98 1.28 1.04 1.08 1.12
Butobarbitone 0.72 0.62 0.72 0.65 0.88 0.69 0.72 0.77
Phenolphthalein 0.87 0.85 0.87 0.83 1.05 0.82 0.84 0.83
Phenol 0.78 0.74 0.75 0.74 0.92 0.72 0.72 0.78
Benzoic acid 0.45 0.39 0.36 0.33 0.43 0.33 0.30 0.30
Salicylic acid 0.39 0.39 0.29 0.27 0.41 0.33 0.29 0.33
Resorcinol 0.48 0.39 0.40 0.33 0,54 0.40 0.44 0.40
Furosemide 0.34 0.34 0.31 0.24 0.42 0.32 0.31 0.26
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2.3.1.4 Effect o f Organic Component and Percent Organic 
Component
The effect of both type and percentage of organic modifier was then 
investigated. Methanol and acetonitrile were compared by mixing either solvent 
with an equal volume of 0.025 M phosphate buffer, pH 5.0. The effect of 
changing the percentage organic component was investigated by adding 
acetonitrile to 0.025 M phosphate buffer, pH 5, in proportions ranging from 20 % 
to 80 % acetonitrile. Retention times were, on average, much shorter using 
acetonitrile as opposed to methanol in the mobile phase (Table 2.5). Acetonitrile 
has virtually no effect on selectivity, probably indicating that it does not modify 
the type, but rather the intensity of interaction between solutes and stationary 
phase (it competes with the solutes for occupation of the Ci8 groups). As 
acetonitrile changes only k' values, a decrease in acetonitrile concentration does 
not produce improved resolution of any two closely eluting solutes, but results in 
a longer analysis time. High retention values were observed with low proportions 
of acetonitrile, and these values decreased as the amount of acetonitrile present 
increased. For some compounds, retention values increased again between 60 % 
and 70 % acetonitrile (Table 2.6). This is in agreement with other workers who 
attributed the U-shape of the curve to hydrophobic interactions at low solvent 
concentrations and changes in the counter-ion solvation at high solvent
29concentrations.
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TABLE 2.5
EFFECT OF ORGANIC MODIFIER ON THE CAPACITY FACTORS 
Eluent: Organic Modifier: Disodium hydrogen phosphate pH 5 (50:50) 
Compound Capacity Factor
Organic Component 
Acetonitrile Methanol
Nitrazepam 0.94 3.41
Clonazepam 1.03 3.45
Diazepam 1.98 >20
Flurazepam 4.23 >20
Clomipramine 3.59 >20
Desmethyl-clomipramine 3.02 >20
Amitriptyline 2.83 >20
Desipramine 3.03 >20
Imipramine 3.21 >20
Pindolol 2.13 4.62
Propranolol 2.54 >20
Xylazine 4.17 8.76
Terbutaline 2.35 3.01
Norephedrine 3.50 4.13
N-Methylephedrine 4.33 7.68
Phenobarbitone 0.67 1.39
Barbitone 0.39 0.85
Quinalbarbitone 0.90 4.89
Butobarbitone 0.72 2.11
Phenolphthalein 0.87 5.34
Phenol 0.78 1.17
Benzoic Acid 0.45 0.54
Salicylic Acid 0.39 0.67
Resorcinol 0.48 0.61
Furosemide 0.34 0.70
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TABLE 2.6
EFFECT OF THE PERCENT ACETONITRILE ON THE CAPACITY FACTORS 
Eluent:- Acetonitrile: Disodium hydrogen phosphate 0.025 M pH 5.0 
Compound Capacity Factor
% Organic Component
20 35 50 65 80
Nitrazepam 3.52 3.88 0.94 1.13 0.14
Clonazepam 4.07 4.46 1.03 1.24 0.23
Diazepam >20 10.46 1.98 1.13 0.36
Flurazepam >20 >20 4.23 2.67 1.48
Clomipramine >20 >20 3.59 2.02 0.90
Desmethyl- >20 >20 2.83 1.14 0.83
clomipramine
Amitriptyline >20 >20 3.62 1.74 0.94
Desipramine >20 11.13 3.03 1.74 0.89
Imipramine >20 >20 3.21 1.99 0.94
Pindolol >20 4.76 2.13 1.80 1.34
Propranolol >20 7.33 2.54 2.99 0.95
Xylazine >20 >20 4.17 2.69 1.54
Terbutaline 3.81 3.68 2.35 2.36 2.27
Norephedrine 5.52 4.93 3.50 3.00 2.90
N-Methyl ephedrine >20 3.68 4,33 3.47 2.55
Barbitone 1.76 0.94 0.39 0.57 0.18
Phenobarbitone 3.28 1.85 0.67 0.45 0.20
Qumalbarbitone 5.44 4.21 0.90 0.73 0.15
Butobarbitone 2.70 2.16 0,72 0.54 0.12
Benzoic acid 0.76 0.76 0.45 0.37 0.11
Salicylic acid 0.70 0.68 0.39 0.43 0.10
Resorcinol 1.18 1.08 0.48 0.52 0.20
Furosemide 1,39 0.93 0.34 0.43 0.05
Phenolphthalein >20 4.05 0.87 0.60 0.28
Phenol 3.60 1.88 0.78 0.56 0.16
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2.4 COMPARISON OF Cw WITH Ci8/SCX
2.4.1 Chromatographic Elution Parameters
2.4.1.1 Effect o f Eluent pH
The same experiments were carried out on a Ci8 column prepared from the 
same batch of silica base material. The column dimensions and particle size were 
the same as those previously described for the Cig/SCX column.
The benzodiazepines studied were found to interact strongly with the 
hydrophobic stationary phase above their pKa values (unionized state), while 
below these values very little interaction occurred with the stationary phase. The 
data in Table 2.7 demonstrates that a large increase in the capacity factors occurs 
between pH 3 and pH 4, with further minor increases occurring between pH 4 and 
pH 7. The change in capacity factors between pH 3 and pH 4 on the Cig material 
is much larger than the change observed on the Cig/SCX column for this pH 
range, hence indicating that the primary mode of interaction of the 
benzodiazepines is with the hydrophobic stationary phase (Figures 2.8.a. and
2.8.b.). The capacity factors of the barbitones and the weak acids show little 
variation over the entire pH range, with only a slight increase on moving from pH 
3 to pH 7 (Figure 2.9). The trend observed here is similar to that obtained on the 
Cig/SCX column.
The remaining acidic compounds (furosemide, benzoic acid) with low pKa 
values show a decrease in capacity factors from pH 3 - 5 and then an increase 
from pH 5 - 7. As their pKa values are low, these drugs are largely unionized at 
the lower pH values, and hence interact with the hydrophobic stationary phase. 
The trend observed here is similar to that obtained for these compounds on the 
Cig/SCX column.
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TABLE 2.7
EFFECT OF ELUENT pH ON THE CAPACITY FACTORS 
Eluent:-Acetonitrile :Disodium hydrogen phosphate 0.025 M (50:50) 
Compound Capacity Factor
pH
3 4 5 6 7
Nitrazepam 0.17 1.70 1.70 1.88 2.36
Clonazepam 0.67 1.85 1.86 2.07 2.54
Diazepam 0.52 3.81 3.80 4.26 5.07
Flurazepam 1.00 1.16 1.18 1.82 4.97
Clomipramine 2.71 2.91 3.08 3.96 8.87
Desmethyl-clomipramine 2.39 2.53 2.64 3.05 3.86
Amitriptyline 2.01 2.13 2.27 2.90 6.75
Desipramine 1.56 1.63 1.73 1.95 2.51
Imipramine 1.78 2.01 1.97 2.31 4.93
Pindolol 0.50 0.54 0.53 0.60 0.94
Propranolol 0.83 0.90 0.96 1.07 1.61
Xylazine 0.67 0.73 0.80 0.95 1.92
Terbutaline 0.46 0.51 0.56 0.70 0.71
Norephedrine 0.52 0.51 0.61 0.65 0.89
N-Methylephedrine 0.45 0.59 0.62 0.64 1.04
Barbitone 0.59 0.66 0.67 0.73 1.01
Phenobarbitone 0.94 1.08 1.08 1.14 1.44
Quinalbarbitone 1.67 1.99 2.00 2.13 2.71
Butobarbitone 1.17 1.26 1.26 1.15 1.75
Phenolphthalein 1.49 1.60 1.61 1.75 2.34
Phenol 1.59 1.76 1.68 1.72 1.87
Benzoic acid 0.83 0.48 0.40 0.48 0.79
Salicylic acid 0.83 0.55 0.43 0.51 0.87
Resorcinol 0.56 0.62 0.62 0.70 1.05
Furosemide 1.24 0.86 0.51 0.51 0.91
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Figure 2.8.a: Influence of column packing material on the capacity factor of 
a weakly basic compound, clonazepam, on a Hypersil Cjg/SCX column. Mobile 
phase: acetonitrile- disodium hydrogen phosphate 10 mM pH 5 (50:50 v/v). 
Flow rate 1.0 ml/min.
RETENTION TIME (min.)
Figure 2.8.b: Influence of column packing material on the capacity factor of 
a weakly basic compound, clonazepam, on a Hypersil C18 column. Mobile 
phase: acetonitrile- disodium hydrogen phosphate 10 mM pH 5 (50:50 v/v). 
Flow rate 1.0 ml/min.
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Figure 2.9: Comparsion between C18/SCX and Ci8 columns at pH  3.0 and pH
7.0. Mobile phase 0.025 M  disodium hydrogen phosphate (pH 3.0 or pH 7.0)- 
acetonitrile (50:50 v/v).
The TCA’s are ionized over this entire pH range and show increasing 
capacity values as pH increases. This is probably due to the secondaiy silanol 
interactions of the compounds with the stationaiy phase. The presence of 
dimethyl groups on the nitrogen (reduced steric hindrance around the nitrogen 
atom), and increased substitution on the nitrogen atom favour secondary 
interactions, the effects decreasing with decreasing pH.
The remaining basic compounds (pindolol, propranolol, terbutaline and the 
catecholamines) were affected in a manner similar to the TCA’s (Figure 2.10). 
However the capacity factors obtained on this column compared to the Cig/SCX 
column are much lower, and hence this would indicate that the ion-exchange 
interaction of the analytes with the SCX material is an important factor in the 
retention of these compounds. Therefore the Cis/SCX would find particular
C18/SCXpH3 C18/SCXpH7 C18pH3 C18pH7
Column pH
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application in the simultaneous determination of these compounds (Figures 2.1 l.a 
and 2.11 .b).
PH
Figure 2.10: Effect of pH  on the k'values of nitrazepam( +), imipramine (K), 
quinalbarbitone (A) and benzoic acid (X) on a Hypersil Ci% column. Mobile 
phase: acetonitrile-disodium hydrogen phosphate 25 mM (50:50 v/v). Flow rate
1.0 ml/min.
79
D
ET
EC
TO
R 
RE
SP
O
N
SE
 
D
ET
EC
TO
R 
RE
SP
O
N
SE
RETENTION TIME (min.)
Figure 2.11.a: Influence of column packing material on the capacity factor of 
a weakly basic compound, clonazepam, on a Hypersil Cjg/SCX column. Mobile 
phase: acetonitrile- disodium hydrogen phosphate 10 mM pH 5 (50:50 v/v). 
Flow rate 1.0 ml/min.
A 8 (1 2
■ RETENTION TIME (min.)
Figure 2.1 l.b: Influence of column packing material on the capacity factor of 
a strongly basic compound, norephedrine, on a Hypersil Cm column. Mobile 
phase: acetonitrile- disodium hydrogen phosphate 10 mM pH 5 (50:50 v/v). 
Flow rate 1.0 ml/min.
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2.4.1.2 Effect o f  Ionic Strength
It is expected that the ionic strength will affect the capacity factors of the 
cationic analytes due to the secondary (silanophilic) interactions. The largest 
variations in capacity factors with increasing ionic strength were observed for the 
TCA’s (Table 2.8). The benzodiazepines were largely unaffected by changes in 
ionic strength and similar results were obtained on the Ci8/SCX column. The 
catecholamines showed a reduction in capacity factors, although these changes 
were not as large as those observed for the TCA’s or indeed the same compounds 
on the SCX/Cig column (Figure 2.12). The remaining compounds examined 
showed decreasing capacity factors with increasing ionic strength.
3 
2.5 
2
k' 1.5 
I
0.5 
0
Figure 2.12: Effect of ionic strength on the k ' on nitrazepam, imipramine, 
quinalbarbitone and benzoic acid on a Hypersil Cu column. Mobile phase: 
acetonitrile-disodium hydrogenphosphate pH  5.0 (50:50 v/v). Flow rate 1.0 
ml/min.
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TABLE 2.8
EFFECT OF IONIC STRENGTH ON THE CAPACITY FACTORS 
Eluent:-Acetonitrile:Disodium hydrogen phosphate pH 5 (50:50)
Compound Capacity Factor
Relative Ionic Strength
0.01M 0.025M 0.05M
Nitrazepam 1.78 1.70 1.58
Clonazepam 1.93 1.86 1.74
Diazepam 4.06 3.80 3.58
Flurazepam 1.60 1.18 0.93
Clomipramine 4,37 3.08 2.50
Desmethyl-clomipramine 3.85 2.64 2.11
Amitriptyline 3.15 2.27 1.83
Desipramine 2.46 1.73 1.37
Imipramine 2.75 1.97 1.58
Pindolol 0.68 0.53 0.42
Propranolol 1.34 0.96 0.75
Xylazine 1.02 0.80 0.60
Terbutaline 0.59 0.56 0.42
Norephedrine 0.62 0.61 0.41
N-Methyl ephedrine 0.62 0.62 0.45
Phenobarbitone 1.09 1,08 0.98
Barbitone 0.69 0.67 0.57
Quinalbarbitone 2.08 2.00 1.87
Butobarbitone 1.28 1.26 1.15
Benzoic Acid 0.42 0.40 0.20
Salicylic Acid 0.49 0.43 0.40
Resorcinol 0.64 0.62 0.54
Furosemide 0.63 0.51 0.44
Phenolphthalein 1.65 1.61 1.51
Phenol 1.78 1.68 1.62
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TABLE 2.9
EFFECT OF THE PERCENT OF ACETONITRILE ON THE CAPACITY 
FACTORS Eluent:- Acetonitrile: Disodium hydrogen phosphate 0.025M  pH 5 
Compound Capacity Factor
% Organic Component
20 35 50 65 80
Nitrazepam 14.40 2.71 1.70 1.03 0.91
Clonazepam 11.20 2.11 1.86 0.52 0.51
Diazepam >20 8.64 3,80 2.02 1.10
Flurazepam >20 2.71 1.18 0.82 0.63
Clomipramine >20 >20 3.08 1.46 0.98
Desmethyl- >20 >20 2.64 1.28 0.88
clomipramine
Amitriptyline >20 >20 2.27 1.20 0.84
Desipramine >20 5.41 1.73 0.96 0.71
Imipramine >20 6.12 1.97 1.07 0.77
Pindolol >20 0.60 0.53 0.43 0.42
Propranolol >20 2.08 0.96 0.59 0.49
Xylazine >20 1.04 0.80 0.58 0.55
Terbutaline 5.18 0.67 0.56 0.42 0.39
Norephedrine 5.29 0.65 0.61 0.42 0.41
N-Methyl ephedrine 5.39 0.69 0.62 0.46 0.46
Barbitone 14.75 0.77 0.67 0.54 0.48
Phenobarbitone 31.65 1.84 1.08 0.66 0.49
Quinalbarbitone >20 3.56 2.00 1.08 0.62
Butobarbitone 10.20 2.00 1 26 0.76 0.49
Benzoic acid 6.88 0.61 0.40 0.36 0.15
Salicylic acid 5.14 0.53 0.43 0.32 0.12
Resorcinol 7.96 0.69 0.62 0.49 0.42
Furosemide 10.27 0.88 0.51 0.39 0.31
Phenolphthalein 9 35 2.27 1.61 0.77 0.52
Phenol 5.86 1.83 1 68 0 85 0.51
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2.4.1.3 Effect o f Organic Component
All compounds showed decreasing capacity values with increasing 
percentage acetonitrile (Table 2.9). These results are similar to those obtained 
with the SCX/Cis column.
2.5 CO NC LU SIO N
The data obtained indicates that the primary ion-exchange mechanism is a 
significant force in determining the retention indices of the more strongly basic 
cationic analytes. All the basic compounds showed varying retention times with 
changing eluent pH, the effect being more pronounced for more strongly basic 
analytes. Acidic compounds were little influenced by pH changes, so the 
retention of strongly basic compounds could be altered independently of the 
acidic compounds. The cation-exchange mechanism could be influenced by 
changing ionic strength, and in this respect, potassium was found to be the 
strongest competing cation. The Ci8/SCX column has particular application for 
the determination of the catecholamines, the capacity factors on this column were 
found to be substantially higher than those obtained on the Cig column. 
Therefore changes in pH are more pronounced on this column and hence 
separations may be carried out simply by varying pH alone. Changes in the ionic 
strength results in substantial changes in the capacity values compared with the 
values on a Ci8 column. Variation in the percent acetonitrile in the mobile phase 
effected both columns in a similar manner; increasing percentages of organic 
modifier resulting in decreases in capacity factors for all the test compounds. The 
C]8/SCX mixed-mode column is capable of separating both basic and neutral 
compounds simultaneously, and should therefore be particularly useful in
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screening for drugs of abuse. This phase could also find application where it is 
necessary to determine a pharmaceutical product along with its 
degradation/process impurities which collectively may not be suitable for analysis 
by either reversed-phase or ion-exchange chromatography alone.
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CHAPTER THREE
SIMULTANEOUS DETERMINATION 
OF PROPRANOLOL AND 
FUROSEMIDE IN HUMAN PLASMA 
BY MIXED-MODE 
CHROMATOGRAPHY
3.1 INTRODUCTION
Propranolol (Figure 3.1) is a competitive antagonist at (3i and (32 receptors. 
It antagonizes catecholamine action at both Pi and p2 receptors. It functions by 
blockade of cardiac Pi-receptors and reduces heart rate and contractility. p2 
receptor blockade increases airway resistance and decreases catecholamine- 
induced glycogenolysis and peripheral vasodilation. It has found wide 
application in the treatment of cardiac arrhythmia, sinus tachycardia1 and angina 
pectoris. It has also been suggested for use for a number of other conditions 
including dysfunctional labour2 and anxiety.3 It has been employed in the long­
term treatment of hypertension, often in combination with a diuretic or 
vasodilator.
To date there have been a number of techniques which have been used for 
the determination of propranolol including GC,4 GC-MS,5’6 ion-exchange HPLC7 
and HPLC.8’9 Singh-Rekhi et a/.10 determined propranolol from human 
plasma/serum using pronethalol hydrochloride as the internal standard. The 
plasma was first mixed with acetonitrile and centrifuged, the supernatant was 
evaporated to dryness under nitrogen, and the residue was reconstituted in 
methanol. The analysis was carried out using a Hypersil CN column (25 cm x 4.6 
mm) with a mobile phase of acetonitrile/1 % acetic acid, pH 3 .6 with 0.2 % TEA 
(36:65). The calibration graphs were linear in the range 5 - 200 ng/ml and the 
recoveries from serum and plasma were 60.98 % and 81.35 %, respectively.
Cosbey et a lu extracted propranolol and a number of basic components 
from whole blood by solid-phase extraction. This method involved the use of two 
cartridges in series; namely superclean ENVIcarb and Bondelut PRS. The blood 
was first applied to the ENVIcarb, and any interferents present were removed by 
washing with water. The analytes of interest were then eluted with methanolic 
TFA and xylene/methanol (4:1). The eluates were then applied to the Bondelut
89
PRS cartridge and washed further with methanol and ethyl acetate. Elution was 
achieved with ethyl acetate/methanol/NH3 (48:1:1) and recovery values for 
propranolol were in the region of 100 %. This method was found suitable for 
automated sample preparations.
Hubert et a ln  isolated a number of P-blockers, including propranolol, 
from plasma using Bond Elut extraction cartridges. After pre-conditioning and 
washing, the analytes were desorbed with methanol or acetonitrile. The eluate 
was diluted with 0.05 M phosphate buffer, pH 3, and analyzed on a LiChrospher 
100 RP-18 column with a mobile phase of 0.05 M phosphate buffer, pH 
3.0/methanol or acetonitrile containing 0.5 % 2-aminoheptane. Calibration 
graphs were found to be linear in the region 5 - 500 ng/ml with a detection limit 
of 1.3 ng/ml; the recovery was found to be 93 %.
Furosemide (Figure 3.1) is considered to be a short-acting loop diuretic. It 
exerts its major effect by inhibiting sodium readsorption in the proximal 
convoluted tubule and the loop of Henle. It has a high capacity for NaCl 
readsorption in this segment and agents active at this site markedly increase water 
and electrolyte excretion and are referred to as “high ceiling” diuretics. Its major 
uses are in acute or chronic renal failure, congestive heart failure and liver 
cirrhosis.13,14 It has also found use for treatment of hypertension, in particular in 
individuals with diminished renal function.
The principal methods for the determination of furosemide have been 
based mainly on HPLC15,16 and GC-MS. Vree et a l xl determined furosemide and 
its acyl glucuronide fiom human plasma and urine by HPLC with fluorescence 
detection. The components were analyzed on a Spherisorb ODS column using 
gradient elution. The initial mobile phase was acetonitrile: 0.05 %
orthophosphoric acid, pH 2.1 (1:19) and these varied to a final mobile phase with 
a ratio of 41:59. Detection limits of 5 ng/ml were achieved for furosemide with a 
recovery value of 91.5 %.
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Bonet-Domingo et a/.18 determined a number of diuretics from urine 
samples using a SDS/propanol micellar eluent. This HPLC method used a Ci8 (12 
cm x 4.6 mm) column and employed a phosphate buffer (10 mM), pH 4.5, 42 mM 
SDS with 4 % propanol. It was found suitable for resolution of a number of 
compounds including furosemide.
Farthing et al,19 determined furosemide by a solid-phase extraction method 
using a Varian AASP advanced automatic sample processor. The column packing 
material used was a C2 ethyl sorbent. This was activated with acetonitrile and 
KH2P04. Analysis was carried out using a Nucleosil Ci8 column with a 
phosphate buffer (pH 3): acetonitrile (70:30) mobile phase. Calibration curves 
were found to be linear in the range 25 - 1000 ng/ml with recoveries in the region 
80 - 85 %. Cline-Love et al.20 developed a micellar liquid chromatographic 
technique which allowed determination of propranolol and furosemide in urine by 
micellar chromatography using a Hypersil Cig column and Brij 35 as the 
surfactant. The micellar mobile phase was optimized by varying the pH and 
concentration of Brij 35; depending on these conditions, either propranolol or 
furosemide could be determined; lower pH and lower surfactant levels allowed 
the determination of furosemide, while the addition of TEA in small amounts, as 
well as higher pH and higher surfactant concentration, were necessary for the 
determination of propranolol. To date no other method has been reported that 
allows the simultaneous determination of furosemide and propranolol.
The aim of this work was to investigate the use of a mixed-mode stationary 
phase for the simultaneous determination of propranolol and furosemide in 
biological fluids. The development of the chromatography and the extraction 
procedures from first principles is also described. Two sample clean-up 
procedures were examined: liquid/liquid extraction and column-switching. Each 
of these methods was validated and a comparison of the two methods was carried 
out.
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9CH2CH(OH)CH2NHCH(CH3)2
Propranolol
OCH CH(OH)CH NHCH(CH )2
Pindolol
NH CH ^ , 0 .
2
T
Furosemide
Figure 3.1: Chemical structures of propranolol, furosemide and pindolol (the 
internal standard).
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3.2 EXPERIMENTAL
3.2.1 Reagents and solvents
Propranolol, pindolol and furosemide were obtained from Sigma Chemical 
Co. (Dorset, U.K.). HPLC grade acetonitrile, diethyl ether, hexane and water 
were obtained from Labscan Analytical Sciences, (Dublin, Ireland). Analar grade 
sodium acetate, acetic acid and sodium hydroxide were obtained from Merck, 
(Darmstadt, Germany). Deionized water was obtained using an Elgastat spectrum 
water purification unit. A small pooled human plasma sample was obtained by 
drawing blood into evacuated tubes containing heparin as anticoagulant. These 
were then centrifuged at 3000 g for 5 min and the upper plasma layer was gently 
removed and stored at -18 °C until required for assay purpose.
3.2.2 Standards
Stock solutions were prepared by dissolving the appropriate amount of 
analyte in methanol (100 %) to yield a solution of concentration 1 mg/ml. A set 
of calibration standards were prepared by dilution of the stock solution with 
deionized water. The furosemide and propranolol standards covered the range 25 
- 200 ng/ml and 50 - 400 ng/ml, respectively. A stock solution of pindolol (the 
internal standard) was made up to a concentration of 100 ng/ml in methanol. A 
working solution of 20 n.g/ml was prepared by dilution of the stock solution with 
deionized water.
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3.2.3 Plasma Standards
Aliquots of blank plasma were spiked with stock solutions to produce the 
required concentration of the two drug components and the internal standard.
3.2.4 Instrumentation and Operating Conditions
Furosemide, propranolol and pindolol were separated on a Cig/SCX (5 jam) 
reversed-phase/cation exchange column (250 mm x 4.6 mm i.d.) supplied by 
Shandon Scientific Ltd. (Cheshire, U.K.). The mobile phase was 100 mM sodium 
acetate (pH 4.0) -acetonitrile (67:33) delivered at a flow rate of 1.0 ml/min by a 
Waters 510 HPLC pump (Waters Associates, Milford, MA, USA). Injections 
were made using a Rheodyne (Cotati, CA, USA) injection valve fitted with a 20 
|il loop. The analytes were detected by ultraviolet absorption at 230 nm using a 
Waters Model 486 spectrophotometric UV detector (Waters, Milford, MA, USA). 
The resulting chromatograms were recorded on an integrator (Waters 746 Data 
Module). For the purpose of column-switching a Waters 501 pump and an 
extraction column were connected to the analytical assembly via a ten-port 
switching-valve (Figure 3.2). The extraction column (10 mm x 1.5 mm i.d.) was 
packed with Hypersil Ci8 (30 jim) material. For column-switching purposes 100 
1^ of each standard was centrifuged for 30 s and 50 pil was introduced into the 
chromatographic system via a loop. Under the described chromatographic 
conditions the mean retention times for the elution of furosemide, pindolol and 
propranolol were 5.70, 7.30 and 12.50 min, respectively.
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3.2.5 Procedures
3.2.5.1 Extraction method 1 (liquid/ liquid extraction)
As furosemide is acidic and propranolol is basic, a single extraction step 
will not permit the simultaneous recovery of the two compounds. Therefore it is 
neccessary to carry out a double extraction; this involves first extracting the 
furosemide from acidified plasma and then extracting the propranolol and 
pindolol from alkaline plasma. The extraction procedure was based on a method 
by Kerremans et al.2] Furosemide was extracted by adding 25 jil of 2.0 M acetic 
acid to 125 fil of spiked plasma, and vortex-mixing each tube for 30 seconds. 
After the addition of 1 ml diethyl ether:hexane (65:35), the drug was extracted by 
vortex mixing for 150 seconds. Following centrifugation at 1000 g for 15 min at 
4 °C, the upper organic layer (800 |il) was transferred into a clean polypropylene 
Eppendorf tube (Figure 3.2). The plasma was then subjected to further extraction 
to remove basic components following a procedure based on a method by 
Pritchard et a l22 In this procedure, the basic components were extracted by 
adding 50 jil 1 M NaOH to the plasma and vortex mixing for 60 s. After addition 
of 1 ml of diethyl ether to all tubes, they were then centrifuged at 1000 g for 15 
min at 4 °C. The upper organic layer (800 fil) was removed and added to the 
previously extracted acidic layer. The combined layers were evaporated to 
dryness under a gentle stream of nitrogen. The residue was reconstituted in 100 
jil of mobile phase and a 20 (il aliquot was injected for chromatography.
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EXTRACTION TECHNIQUES 
ACIDIC LIQUID/LIQUID EXTRACTION
Plasma standards (125 jal) + 2.0 M acetic acid (25 fil) 
+ 1 ml diethyl ether:hexane (65:35) + vortex for 150 s 
Centrifugation for 15 min, 1000 g at 4 °C 
800 |ol organic layer removed to an Eppendorf tube
BASIC LIQUID/LIQUID EXTRACTION
125 nl of resubmitted plasma + 50 jj.1 of 1 M NaOH 
+ 1 ml diethyl ether + vortex for 150 s 
Centrifugation for 15 min, 1000 g at 4 °C 
800 jil organic layer added to previous layer
Combined layers evaporated to dryness under a gentle 
stream of nitrogen. Reconstituted in 100 |il of mobile phase 
20 jjlI injected onto chromatographic system
Figure 3.2: Flow chart for liquid/liquid extraction.
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3.2.5.2 Extraction method 2 (Column-switching)
The spiked plasma sample was introduced via the injector port and swept 
onto the extraction column by water. The drug components were selectively 
retained by the packing material in the extraction column, while the endogenous 
plasma components were eluted to waste. Upon switching the valve, the mobile 
phase was diverted in a backflush mode via the extraction column, where it 
desorbed the drugs and swept them onto the analytical column for separation. 
The ten port valve used in this part of the study is shown in Figure 3.3 while
Pump 2 
Waste
POSITION A 
Detector Somple In
Waste
POSITION B 
Delector Sample In
Waste
Anolyticol
Column
Anolytical
Column
Irace
Enrichment
Column Pump I
Pump 2
Waste
Trace
Enrichment
Column
Figure 3.3: Ten port injection valve: Position A, the sample is loaded into the 
injection loop while the precolumn is been washed with mobile phase. On 
switching the valve to position If, the loop is flushed with the eluent from pump 
2, allowing endogenous components to be eluted to waste. On returning to 
position A, the sample is eluted o f the pre-column and onto the analytical 
column.
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3.2.6 Calibration and calculation
Evaluation of the assay was carried out by the construction of a five-point 
calibration graph covering the concentration range 50 - 300 ng/ml (furosemide) 
and 50 - 500 ng/ml (propranolol) in plasma for the liquid/liquid extraction 
method. The concentration ranges for the column-switching method for 
furosemide and propranolol were 25 - 200 ng/ml and 50 - 400 ng/ml, respectively. 
The slope and the intercept of the calibration graphs were determined through 
linear regression of the drug to the internal standard peak-height ratio versus drug 
concentration. Individual peak-height ratios were then interpolated on the 
calibration graphs to determine values of concentration found as compared to 
concentration added.
3.3 RESULTS AND DISCUSSION
3.3.1 Development o f  chromatography
It is often necessary in drug management programmes to co-administer a 
number of components together, in order to overcome the side effects of the 
individual components. Since propranolol and furosemide are occasionally co­
administered, the aim of this work was to develop a suitable method for the 
simultaneous determination of furosemide and propranolol in plasma. The initial 
step was to select the mobile phase conditions and selection was guided by 
previous work earned out in Chapter 2.
The development of a chromatographic method for the simultaneous 
determination of furosemide and propranolol began with selection of a suitable 
mobile phase. It is necessary for the mobile phase to elute both the acidic and 
basic components in a short period of time from a SCX/C]8 stationary phase and
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the mobile phase selected initially contained sodium acetate and acetonitrile. 
Sodium acetate was selected as it allowed furosemide to elute separately from the 
void volume, this fact being important in the analysis of plasma samples whose 
endogenous components elute with or close to the void volume. On increasing the 
concentration of sodium acetate from 0.01 M to 0.1 M, the retention time of 
propranolol decreased. The next parameter examined was the percentage of 
buffer, this value being increased up to a maximum of 65 - 70%. Above this 
value, the retention time of propranolol increased considerably, therefore, a value 
of 67.0 % was selected. A number of pH values were examined, but lower values 
gave longer retention for furosemide. Acetonitrile was chosen over methanol 
since it gave shorter retention times for the basic compounds, as it is important to 
keep the analysis time as short as possible and prevent peak tailing of the later 
eluting peaks. The final mobile phase selected was 0.1 M sodium acetate (pH 
4.0): acetonitrile (67:33).
The wavelength of the detector was determined by scanning solutions of 
each of the drug components in the buffer selected over the range 200 - 400 run. 
The maximum absorbance for furosemide, propranolol and pindolol was 230.5 
nm, 232.5 nm and 223.3 nm, respectively. The value selected was 230 nm.
The final step was to select a suitable internal standard. A number of 
compounds were investigated, including pindolol and terbutaline; the later 
however eluted too closely to furosemide to be suitable as an internal standard. 
The remaining compounds interfered with either furosemide or propranolol and 
hence pindolol was selected as its retention was intermediate between those of 
furosemide and propranolol.
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3.3.2 Development o f  an extraction procedure
A method was set up which enabled the simultaneous extraction of 
furosemide, propranolol and pindolol. The extraction was carried out on spiked 
plasma samples. As it is not possible to extract acidic and basic components in a 
single extraction, it was necessary to implement a double extraction. First, 
furosemide was extracted from acidified plasma, and then propranolol was 
extracted from alkaline plasma; the two extracts were then combined. A 
technique was developed based on a method by Lindstrom et al. in which 
furosemide was extracted from acidified plasma with diethyl ether. The pH of 
spiked plasma was adjusted by the addition of hydrochloric acid, and the 
furosemide was then extracted with diethyl ether by vortex mixing. Following 
centrifugation the organic layer was removed and dried under a stream of 
nitrogen. The extraction solvent was modified by the addition of hexane which 
improved the recoveries obtained. Also the replacement of hydrochloric acid by 
acetic acid21 resulted in increased recoveries. The extraction of propranolol was 
based on a method by Pritchard el a l22 which allowed determination of 
propranolol from alkaline plasma. The solvent used for extraction was diethyl 
ether. Following centrifugation, the organic layer was removed, added to the 
previous extract, and dried under a stream of nitrogen. Figure 3.4 indicates 
chromatograms of samples following extraction by this method.
It was necessary to determine which type of packing material in the pre­
column would prove most suitable in terms of recovery of drug components and 
sample clean-up. This selection was determined by injection of an aqueous 
standard on all materials and determining the recovery compared to aqueous 
standards injected directly onto the analytical column. The concentration column 
used was packed with either Qg, CN or phenyl packing materials. This column 
was fitted between the pump and the detector. Of the three columns evaluated in
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Figure 3.4: Chromatograms showing (a) blank plasma, (b) the lowest
concentration and (c) the highest concentration following extraction by 
liquid/liquid extraction. Compounds were separated on a Hypersil Cn/SCX 
column using a mobile phase o f 100 mM sodium acetate (pH 4)-acetonitrile 
(67:33 v/v) delivered at a flow  rate o f 1.0 ml/min.
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terms of drug recovery, Ci8 was the one which gave the best results, as both the 
CN and phenyl materials showed recoveries only in the region of 30 - 50 % for 
the basic compounds. Due to the build up of plasma on the pre-column it needed 
to be replaced on a regular basis. The rinse time was also varied: a range of 
values were examined and these included 1.0 - 5.0 min. It was found that times 
above 2 min, the recovery of furosemide decreased to a large extent; to values of
below 50 % at 5 min. A rinse time of 1 min was selected as this allowed the
greatest recovery while allowing the removal of endogenous components. Figure
3.5 shows chromatograms following extraction by this method of a) blank plasma, 
b) the lowest concentration and c) the highest concentration of furosemide and 
propranolol.
3.3.3 Assay Validation
Each of the methods developed for the simultaneous determination of 
propranolol and furosemide was validated over the concentration ranges shown in 
Tables 3.1 - 3.4 and 3.7 - 3.10.
3.3.3.1 Limit o f Detection
The limit of detection was found to be 15 ng/ml for furosemide and 30 
ng/ml for propranolol.
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Figure 3.5: Chromatograms showing (a) blank plasma, (b) the lowest
concentration and (c) the highest concentration following extraction by column 
switching. Compounds were separated on a Hypersil Cn/SCX column using a 
mobile phase o f 100 mM sodium acetate (pH 4)-acetonitrile (67:33 v/v) 
delivered at a flow rate o f 1.0 ml/min.
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3.3.3.2 Precision
The data presented in Tables 3.1 - 3.4 demonstrate the inter- and intra­
assay variation in the liquid/liquid extraction method. The data presented in 
Tables 3.7-3.10 demonstrate the inter- and intra- assay variation in the column- 
switching method. Inter-assay variation was assessed singly in four replicate 
runs. Intra-assay variability was determined in quadruplicate over the same 
concentration range. The precision of the method (as expressed by mean 
coefficient of variation) was determined for analyte to internal standard peak- 
height ratios when interpolated as unknowns on the regression lines. For inter­
assay variation, peak-height ratios were interpolated on the four regression lines 
generated from the four replicate runs. For intra-assay variation, peak-height 
ratios were interpolated on a single regression line generated from the 
quadruplicate run. The mean coefficients of variation for each method are given 
in Tables 3.1 - 3.4 and 3.7 - 3.10.
3.3.3.4 Linearity and Accuracy
Linearity is defined by the correlation coefficient of the regression line, 
and accuracy is defined by the percentage difference between “added” and 
“found” concentrations for inter-assay values. These are presented in Tables 3 .5 - 
3.6 and 3.11 - 3.12. The correlation coefficient of the regression line for the
mean intra-assay value was better than 0.995 or better in all cases.
3.3.3.5 Recovery
Recovery of furosemide/propranolol from plasma was measured by 
calculating the percentage difference between the peak heights of extracted
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standards and those of the authentic (unextracted) standards in the relevant 
concentration range. Using this method, the mean recovery by the liquid/liquid 
extraction method for furosemide from plasma was found to be 90.75 % and for 
propranolol to be 90.08 % (Table 3.5 and 3.6). The mean recovery by the 
column-switching extraction method for furosemide from plasma was found to be 
76.32 % and for propranolol to be 90.80 % (Table 3.11 and 3.12). Figure 3.6 is a 
graphical representation of a comparison for the recoveries of the drug 
components by the two methods.
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Figure 3.6: Bar chart showing the recovery of furosemide and propranolol 
from plasma by both liquid/liquid extraction and column-switching.
3.3.3.6 Selectivity
A number of drugs were investigated as potential interferants in the 
method. These included nitrazepam, clonazepam and quinalbarbitone. None of 
these compounds were found to interfere.
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TABLE 3.1
Precision and Linearity-INTRA-ASSAY from liquid/liquid extraction
Amount Propranolol Peak height Amount found
added ng/ml Ratio ng/ml
50 0.15 53.65
100 0.26 106.03
150 0.31 129.84
300 0.73 329.84
500 1.09 501.27
50 0.15 53.65
100 0.22 86.99
150 0.31 129.84
300 0.72 325.08
500 1.07 491.75
50 0.16 58,41
100 0.24 96.51
150 0.33 139.37
300 0.68 306.03
500 1.05 482.22
50 0.14 48.89
100 0.27 110.80
150 0.33 139.37
300 0.69 310.80
500 1.08 496.51
50.00 100.00
Concentration ng/ml 
150.00 300.00 500.00
Mean Amount 
Found ng/ml 53.65 100.08 134.61 317.94 492.94
Standard 3.89 
Deviation
10.56 5.50 11.33 8.13
Coefficient 7.25 
of variation %
10.56 4.09 3.56 1.65
Difference +3.65 
between added 
and found
+0.08 -15.40 +17.94 -7.06
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TABLE 3.2
Precision and Linearity-INTER-AS SAY from liquid/liquid extraction
Amount Propranolol Peak height Amount found
added ng/ml Ratio ng/ml
50 0.15 53.75
100 0.26 106.63
150 0.34 145.09
300 0.69 313.36
500 1.08 500.86
50 0.14 48.94
100 0.24 97.01
150 0.31 130.67
300 0.73 332.59
500 1.09 491.25
50 0.17 63.36
100 0.24 97.01
150 0.30 125.86
300 0.65 294.13
500 1.06 486.44
50 0.16 58.55
100 0.24 97.01
150 0,33 140.28
300 0.68 308.55
500 1.05 496.05
50.00 100.00
Concentration ng/ml 
150 00 300.00 500.00
Mean Amount 
Found ng/ml 56.15 99.42 135.48 312.16 493.65
Standard 6.20 
Deviation
4.81 8 78 15.88 6.20
Coefficient 11.04 
of variation %
4.84 6.48 5.09 1.26
Difference +6.15 
between added 
and found
-0.58 -14 52 +12.16 -6.35
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TABLE 3.3
Precision and Linearity-INTRA-ASSAY from liquid/liquid extraction
Amount Furosemide Peak height Amount found
added ng/ml Ratio ng/ml
50 0.18 62.84
100 0.20 78.47
150 0.29 148.78
250 0.43 258.16
300 0.52 328.47
50 0.16 47.22
100 0.19 70.66
150 0.28 140.97
250 0.41 245.63
300 0.46 281.59
50 0.17 55.03
100 0.23 101.91
150 0.32 172.22
250 0.41 245.63
300 0,46 281.59
50 0.16 47.22
100 0.24 109.72
150 0.33 180.03
250 0.40 234.72
300 0.51 320.66
50.00 100.00
Concentration ng/ml
150.00 250.00 300.00
Mean Amount 
Found ng/ml 53.08 90.19 160.50 246.04 303.08
Standard 7.48 
Deviation
18 60 18.60 3.89 8.25
Coefficient 14.09 
of variation %
20.62 11.59 3.89 8.25
Difference +3.08 
between added 
and found
-9.81 +10.52 -3.96 +3.08
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TABLE 3.4
Precision and Linearity-INTER-ASSAY from liquid/liquid extraction
Amount Furosemide Peak height Amount found
added ng/ml Ratio ng/ml
50 0.19 62.05
100 0.23 94.57
150 0.31 159.61
250 0.41 240.91
300 0.47 289.69
50 0.19 62.05
100 0.22 86.44
150 0.25 110.83
250 0.43 257.17
300 0.51 322.21
50 0.17 45.79
100 0.22 86.44
150 0,29 143.35
250 0.38 216.52
300 0.46 281.56
50 0.19 62.05
100 0.23 94.57
150 0.33 175.87
250 0.41 240.91
300 0.46 281.56
50.00 100.00
Concentration ng/ml 
150.00 250.00 300.00
Mean amount 
Found ng/ml 57 .99 90.51 147.42 238.88 293.76
Standard 8 13 
Deviation
4.69 27.76 16.76 19.35
Coefficient 14.02 
of variation %
5.18 18.84 7.02 6.59
Difference +7.99 
between added 
| and found
+9.50 -2.59 -7.87 -6.25
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TABLE 3.5
Results for recovery of propranolol by liquid/liquid extraction
Propranolol peak height (mm)
Concentration Authentic Extracted Recovery
ng/ml standards standards %
50 17 15 88.24
100 21 18 85.71
150 33 31 93.94
300 60 55 91.67
500 98 89 90.82
Mean recovery (+ standard deviation) = 90.08 + 3.18%
TABLE 3.6
Results for recovery of furosemide by liquid/liquid extraction
Furosemide peak height (mm)
Concentration Authentic Extracted Recovery
ng/ml standards standards %
50 12 11 91.67
100 14 13 92.86
150 17 15 88.24
250 24 22 91.67
300 28 25 89.29
Mean recovery (+ standard deviation) = 90.75+ 1.91 %
no
TABLE 3.7
Precision and Linearity-INTRA-ASSAY from column-switching
Amount Propranolol Peak height Amount found
added ng/ml Ratio ng/ml
50 0.26 58.56
100 0.32 106.17
200 0.46 217.29
300 0.59 320.46
400 0.69 399,83
50 0.25 50.62
100 0.29 82.37
200 0.47 225.22
300 0.54 280.78
400 0.73 431.57
50 0.25 50.02
100 0.33 114 .11
200 0.42 185.54
300 0.53 272.84
400 0.72 423.63
50 0.23 34.75
100 0.31 98.24
200 0.41 177.60
300 0.57 304.59
400 0.70 407.76
50 00 100 00
Concentration ng/ml 
200.00 300 00 400 00
Mean Amount 
Found ng/ml 48.64 100.22 201.41 294.67 415.70
Standard 9.99 
Deviation
13.55 23.37 21.86 14.49
Coefficient 20.54 
of variation %
13.52 11.60 7.42 3.49
Difference -1 36 
between added 
and found
+0.22 +1.41 +5.33 +15 70
i l l
TABLE 3.8
Precision and Linearity-INTER-AS SAY from column-switching
Amount Propranolol Peak height Amount found
added ng/ml Ratio ng/ml
50 0.23 35.68
100 0.30 90.36
200 0.45 207.55
300 0.58 309.12
400 0.70 402.87
50 0.25 51.30
100 0.29 82.55
200 0.44 199.74
300 0.54 277.87
400 0.69 395.05
50 0.25 51.30
100 0.33 113.80
200 0.48 231.00
300 0.55 285.68
400 0.67 379.43
50 0.24 43.49
100 0.34 121.62
200 0.44 199.74
300 0.57 301.30
400 0.73 426.30
50.00 100.00
Concentration ng/ml
200.00 300.00 400.00
Mean Amount 
Found ng/ml 45.44 102.08 209.51 293.49 400.91
Standard 7.48 
Deviation
18.60 14.79 14.26 19.53
Coefficient 16.46 
of variation %
18.22 7.06 4.86 4 87
Difference -4.56 
between added 
and found
+2.08 +9.51 -6.51 +0.91
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TABLE 3.9
Precision and Linearity-INTRA- AS SAY from column-switching
Amount Furosemide Peak height Amount found
added ng/ml Ratio ng/ml
25 0.13 32.40
50 0.16 61.81
100 0.19 91.23
150 0.26 159.85
200 0.30 199.07
25 0.13 32.40
50 0.14 42.21
100 0.20 101.03
150 0.27 169.66
200 0.30 199.07
25 0.12 22.60
50 0.16 61.81
100 0.23 130.44
150 0.26 159.85
200 0.31 208,60
25 0.12 22.60
50 0.14 42.21
100 0.19 91.23
150 0.24 140.25
200 0.30 199.07
25.00 50.00
Concentration ng/ml 
100.00 150.00 200.00
Mean Amount 
Found ng/ml 27.50 52.01 103.48 157.40 201.52
Standard 5.66 
Deviation
11.32 18.55 12.33 4 90
Coefficient 20.58 
of variation %
21.77 17.93 7.83 2.43
Difference +2.50 
between added 
and found
+2.01 +3.48 +7.40 + 1.52
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TABLE 3.10
Precision and Linearity-INTER-ASSAY from column-switching
Amount Furosemide Peak height Amount found
added ng/ml Ratio ng/ml
25 0.13 31.45
50 0.14 41.98
100 0.19 94.61
150 0.23 136.72
200 0.30 210.40
25 0.12 20.93
50 0.17 73.56
100 0.20 105.14
150 0.21 168.24
200 0.29 199.87
25 0.12 20.93
50 0.15 52.51
100 0.18 84.08
150 0.23 136.72
200 0.27 178.82
25 0.12 20.93
50 0.16 63.03
100 0.19 94.61
150 0.25 157,77
200 0.29 199.87
25.00 50.00
Concentration ng/ml 
100.00 150.00 200.00
Mean amount 
Found ng/ml 23.56 57.77 94.61 149.88 197.24
Standard 5.26 
Deviation
13.59 8.60 15 79 13.25
Coefficient 22.33 
of variation %
23.52 9.08 10.54 6.72
Difference -1.44 
between added 
and found
+7.77 -5.39 -0.12 -2.76
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TABLE 3.11
Results for recovery of propranolol by column-switching
Propranolol peak height (mm)
Concentration Authentic Extracted Recovery
ng/ml standards standards %
50 22 19 86.36
100 28 23 82.14
200 38 36 94.74
300 55 52 94.55
400 79 76 96.20
Mean recovery (+ standard deviation) = 90.80 + 6.19
TABLE 3.12
Results for recovery of furosemide by column-switching
Furosemide peak height (mm)
Concentration Authentic Extracted Recovery
ng/ml standards standards %
25 21 16 76.19
50 29 22 75.86
100 33 25 75.76
150 42 30 73.81
200 45 36 80.00
Mean recovery (+ standard deviation) = 76.32 + 2.26
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3.4 CONCLUSION
This study shows that a mixed-mode Ci8/SCX column can find application 
in the simultaneous determination of strongly basic and acidic compounds. The 
HPLC method described is capable of simultaneously determining propranolol 
and furosemide following extraction from human plasma. It was found that they 
could be adequately separated on a mixed-mode column in less than 15 minutes. 
Pindolol was the internal standard used. Liquid/liquid extraction and column- 
switching techniques were developed for the determination of propranolol and 
furosemide from plasma samples. Each of the methods was validated in terms of 
coefficient of variation and recovery, linearity and accuracy. The column- 
switching method has the advantage of being less tedious and time consuming 
than the liquid/liquid extraction method, though the recoveries obtained were 
much lower than those obtained for the liquid/liquid extraction method. The low 
recovery values obtained for furosemide by the column-switching method than 
liquid/liquid extraction may be due to the fact that furosemide has little affinity 
for the Cig material. If a different material in the pre-column, e.g. mixed-mode or 
a material more suitable for the determination of furosemide were used, higher 
recoveries could be obtained.
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CHAPTER FOUR
4.1 INTRODUCTION
The area of molecular imprinting is an emerging technique for the 
preparation of polymers with highly selective recognition properties, and is 
only a recently developed concept, having been first developed by Wulff1 in 
1972. The basic idea involves the preparation of synthetic polymers with a 
predetermined selectivity; that is, polymers are prepared which attempt to 
mimic antibody combining sites. During the polymerization step the 
monomers link together around the target molecule; the “imprint” molecule 
being held in place by interactions with the monomers. The copolymerization 
of these monomers with cross-linkers in the presence of the imprint molecule 
results in a rigid structure with sites selective for the imprint molecule.
Two different types of approach to this technique have been developed: 
covalent and non-covalent molecular imprinting. Both techniques are similar, 
as in both cases the functional monomers are chosen to allow interactions with 
the functional groups of the imprint molecule. In both cases, the 
polymerization occurs in the presence of the print molecule while interacting 
with the complementary functionality found in the monomer. The resulting 
polymers have been found to have a good affinity for the original print 
molecule.
The first approach is the “covalent method” which has been used by 
both Wulff and Shea. With this method the imprint molecule is covalently 
coupled to a polymerizable molecule; i.e. an adduct composed of the print 
molecule and the monomer is synthesized and added to the polymerization 
mixture. This is then copolymerized with a cross-linker after which the 
imprint molecule is chemically cleaved from the highly cross-linked polymer. 
This method relies on a reversible reaction as shown in Figure 4.1. There are 
quite a number of applications of this method involving amino acids and
* * • 2 3amino acid derivatives, aromatic ketones, and natural and derivatised 
sugars.1
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Figure 4.1: Schematic representation of (a) a cavity obtained by
polymerization with the covalently bound template. The template (phenyl-a- 
D-mannopyranoside [x]) can be removed with water or methanol to give (b). 
Addition of the original template causes the cavity to be reoccupied, giving 
(a) again. The binding of the template is by covalent bonds.
The second approach, i.e. the “non-covalent method” has been 
pioneered by Mosbach et al.A Using this method, the imprint molecules are 
mixed with functional monomers and these are then capable of interacting 
non-covalently with the imprint molecules. The preparation of these polymers 
is discussed further in Section 4.2. The recognition sites are capable of 
selectively recognizing the imprint species, therefore the imprint species that 
interacts during the imprinting procedure is capable of interacting again during 
the rebinding with the polymer by non-covalent interactions. These 
interactions can be ionic or hydrophobic in nature, or involve hydrogen 
bonding. This method of molecular imprinting has allowed a number of 
molecularly imprinted polymers (MIPs) to be prepared against a large number 
of components including amino acid derivatives,5’6 peptides,7 diazepam and 
theophylline,8 as well as a number of other drug compounds. This method has 
an advantage over the “covalent method” in that no covalent modification of
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the print molecule is required. A variety of different binding interactions may 
exist, and hence this procedure would be regarded as a simple and general 
method for preparation of a molecularly imprinted polymer.
It is also possible to use a combination of both approaches, where the 
monomers and the imprint molecules are covalently coupled9 during the 
polymerization, and the subsequent rebinding takes place by non-covalent 
interactions. The area of molecular imprinting is expanding rapidly and has 
found application in a number of areas including the preparation of tailor- 
made separation materials for use in HPLC, as enzyme mimics or catalytically 
active polymers in enzyme technology, and finally as sensors in biosenor-like 
configurations (where the polymers are used as substitutes for the biological 
materials that are normally employed).
4.1.1 Preparation o f  molecularly imprinted polymers
(non-covalent method)
In the non-covalent approach, the functional monomers are mixed with 
the template molecules; the monomers are then capable of interacting with the 
imprint molecule. These functionalized monomers are allowed to “pre­
arrange” around the print molecule by non-covalent interactions (i.e. 
electostatic, hydrophobic and hydrogen bonding). The monomers are 
polymerized with cross-linking monomers and the result is a highly cross- 
linked, rigid polymer. The imprint molecules are then extracted (using a 
Soxhlet extraction apparatus) and the polymer now has recognition sites which 
are complementary to the target molecule. The particles are ground to a size 
in the range of 25 - 45 ^m (Figure 4.2).
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Figure 4.2: 7Yie preparation of molecular imprinted polymers, a) the
functional monomer methacrylic acid is mixed with the print molecule 
propranolol and ethylene glycol dimethacrylate the cross-linking agent is 
added; the solvent used is chloroform, b) the polymerization reaction is 
started by addition of the initator [2,2>-azobis(2-methylpropionitrile), AIBN] 
and c) the extraction of the template.
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4.1.2 Materials fo r  molecular imprinting
To date, a number of monomers have been used which include 
methacrylic acid l ,10 acrylic acid 2,10 methyl methacrylate 3,6 4-vinylpyridine
11 1 0  7  n
4, 2-vinylpyridine 5, itaconic acid 6, and /7-vinylbenzoic acid 7. Figure 
4.3.a shows the functional monomers most commonly used in molecular 
imprinting. A number of cross-linking agents have also been used which 
include TV, A^-methylenediacrylamide 8,6 ethylene glycol dimethacrylate 9,10 
pentaerythritoltriacrylate (PETRA) 1014 and trimethylolpropane trimethyl 
acrylate (TRIM) 11 (Figure 4.3.b).
The functional monomers were chosen so as to facilitate specific 
interactions with the functional groups of the imprint molecules. Methacrylic 
acid (MAA) 1 is the most widely used functional monomer, whereas ethylene 
glycol dimethacrylate (EDMA) 6 is the the most commonly used cross-linker. 
The carboxylic acid of 1 forms ionic interactions with amino groups and 
hydrogen bonds with polar functions. The ionic interaction is stronger than 
the hydrogen bonding interaction, a fact which is reflected in better 
selectivities of polymers interacting with the imprint molecules via ionic bonds 
than of polymers interacting via hydrogen bonds. Other interactions found to 
contribute to the molecular imprinting process include dipole-dipole and 
hydrophobic interactions. However, the pentaerythritol derivative15 polymers 
10 and 11 have been found to show better load capacities, selectivities and 
resolving capabilities when used as stationary phases in LC. A variety of 
polymers have been prepared, encompassing styrene, silica and acrylic-based 
polymers. These are assumed to interact via ionic interactions with amines 
and via hydrogen bonds with amides, carbamates and carboxyls. The 
introduction of 4-vinylpyridine 412,15 as a monomer in non-covalent molecular 
imprinting (MI) made the ionic interactions possible between the recognition
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7
FIGURE 4.3.a: Monomers used in non-covalent molecular imprinting.
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FIGURE 4.3.b: Cross-linking monomers used in non-covalent molecular 
imprinting.
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sites of the polymers and the imprint species containing the carboxyl 
functionality. This had an advantage over other monomers in that it resulted in 
better selectivities for such imprint species compared to the selectivities that 
have been achieved with polymers prepared with methacrylic acid. A similar 
monomer, 2-vinylpyridine 5 was also found to achieve better selectivities 
compared to methacrylic acid.12
4.1.3 Molecular imprints and their use in chiral separations
One of the most common uses for molecularly imprinted polymers is 
for the determination of racemates.16 There is a need for optically pure 
enantiomers, since stereoisomers can express varying pharmacological 
activity, and in some cases can even be used against different symptoms. 
However, it is possible for the two enantiomers to interact differently with the 
biological system and only one of these to have the desired effect.
The increasing demand for optically pure compounds has resulted in an 
interest in asymmetric synthesis and development of supports for efficient 
chiral separations. There is a need for analytical methods to be able to 
perform pharmacokinetic studies and examine final products of asymmetric 
synthesis. Chiral separation by LC is a widely studied area with three main 
approaches: 1) addition of chiral additive to the mobile phase, 2) derivatization 
with an optically active reagent; and 3) separation on a chiral stationary phase 
(all previously discussed in Chapter 1).
The field of chiral stationary phases (CSPs) is still growing and MIPs 
have found use in this area,17 as an optically active compound (one enantiomer 
of a pair) can be imprinted and the resulting polymer can discriminate between 
the imprint and its antipode. The advantage of this method is that it allows the 
manufacture of specific tailor-made polymers for a given separation process.
1 o . . .
Andersson et al. prepared molecular imprints against TV-protected 
amino acids to evaluate their ability to resolve the enantiomers of print
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molecules in the chromatographic mode. Mixtures of two racemates, Cbz- 
aspartic acid and Cbz-glutamic acid were examined on polymers prepared 
against the L- form of both of these compounds. The print molecule was the 
most retained compound on the respective polymer preparation indicating that 
efficient substrate selectivity between compounds with very similar structures 
was possible.
Kempe et al.12 examined the use of 4-vinylpyridine and 1- 
vinylimidazole as functional monomers for the preparation of novel 
molecularly imprinted polymer systems. They found that the polymer 
prepared with 4-vinylpyridine was found to be more efficient in racemic 
resolution than those prepared with 1-vinylimidazole. The ratio of monomer 
to template was optimized and found to be 12:1, as below this value it was not 
possible to satisfy all possible interaction points of the target molecule because 
of competition from the other species present in the mixture. A ratio of > 12:1 
results in increased non-specific binding sites within the rigid polymer, 
thereby reducing the selectivity of the polymer. The introduction of a 
nitrogen-containing aromatic monomer into the field of molecular imprinting 
increases the number of compounds that can be used as template molecules, 
and this in turn enhances the general versatility of molecular imprinting.
O’Shannessy et al}1 examined a number of polymerization parameters 
in order to determine the influence of these factors on the ability of the 
polymer to separate a racemic mixture of the print molecule. These 
parameters included variation of the solvent employed during polymerization, 
the reagents used for initiation of the polymerization, and the effect of molar 
ratio of functional monomer to print molecule. Polymers prepared in a less 
polar solvent, e.g. chloroform, were found to be superior to those prepared in 
more polar solvents, e.g. acetonitrile. Furthermore, polymers prepared at 0 °C 
using light-induced initiation were superior to those prepared at 60 °C using 
heat-induced initiation.19 An increase in the molar ratio of functional 
monomer to print molecule improved separation, however, the second
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component was found to tail considerably. They found the optimal ratio of 
functional monomer to print molecule to be 4:1.
4.1.4 Preparation o f  monomers
There are two main types of classification of optically active polymers; 
main chain and side chain chirality. Main chain chirality possess chiral 
centres in the polymer backbone while side chain possess chiral pendant 
groups. The use of polymers (MI) which are optically active might further 
enhance the enantioselectivity of these materials when used as chiral stationary
phases by creating a chiral cavity for the imprint molecule to interact with.
■ 20Tamai et al. synthesized optically active polymethacrylate derivatives 
possessing pendent chiral 1,1-binaphthalene moieties. Their ability to resolve 
racemates was measured by coating the polymers onto spherical macroporous 
silica gel and preparing HPLC columns. It was found that a polymer with the 
1,1-binapthalene moiety farthest from the polymer backbone gave rise to 
substantially better enantiomeric separation.
Andersson et a l21 have synthesized a new amino acid based cross­
linker for the preparation of substrate-selective acrylic polymers. The idea 
was to prepare monomers possessing different functional groups which were 
found suitable for the preparation of highly cross linked macroporous 
polymers. This was achieved by modifying an amino acid (L-phenylalanine) 
by the introduction of acrylic groups. The polymers imprinted with L- 
phenylalanine ethyl ester were found to be chiral and these were found to 
show preference for L- specificity.
Molecular imprinting is dependant on various interactions. Therefore 
to exploit it to its full potential it is necessary to prepare new monomers 
possessing different functional groups to enable maximum interaction between 
the imprint molecules and the monomers during polymerization.
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The work described here involves the preparation of molecularly 
imprinted polymers to 7-hydroxycoumarin (7-OHC). The amount of solvent 
used in the polymerization step was examined by spectroscopic studies to 
determine if it affected the selectivity of the MIP for 7-OHC. Further 
spectroscopic studies included examination of the load capacity of the MIP, 
the equilibration time and the selectivity of the MIP for 7-OHC over other 
members of the coumarin family. The polymer which showed the greatest 
selectivity for 7-OHC was further used as a solid-phase extraction material for 
the determination of 7-OHC from urine (Chapter 5).
The next step was to prepare a monomer which incorporated a chiral 
centre in its side chain. This work was based on modification of a commonly 
used monomer, methacrylic acid, with a number of compounds which already 
contained a chiral centre. These compounds included menthol and the amino 
acids alanine, phenylalanine, leucine and valine. A monomer was prepared 
from a reaction involving alanine and acryloyl chloride. This was 
copolymerized with EDMA using ^-propranolol as the imprint molecule. A 
second MIP was prepared from MAA and EDMA again using propranolol as 
the imprint molecule. Both these polymer were examined further by capillary 
electrophoresis (Chapter 6).
4.2 RESULTS AND DISCUSSION
4.2.1 Polymerization o f  monomers, target compound 7-OHC
The aim of the work was to prepare a molecularly imprinted polymer to 
7-OHC by the “non-covalent” method. This was carried out based on the 
method of Vlatakis et a l9 A solution of methacrylic acid 1 was added to 
ethylene glycol dimethacrylate 9, chloroform and the target molecule 7- 
hydroxycoumarin. Polymerization was initiated using AIBN [2,2’-azo-bis (2 
methylpropionitrile)], and as the polymer formed it was precipitated out of
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solution. Both methacrylic acid and EDMA have vinyl protons in the region 
5.0 - 6.0 ppm; therefore on polymerization it was expected that there would be 
no protons observed in this region. This was indeed found: the ‘H-NMR 
spectrum showed a singlet at 1.60 ppm for the three protons of the methyl 
group from the methacrylic acid. The singlet at 0.97 ppm was due to the 
methyl group of the EDMA and the signal at 3.46 ppm was due to the 
methylene group on the EDMA. Also the signal at 3.2 ppm is due to the 
methylene group of the backbone of the polymer. The signal at 11.6 ppm is 
due to the hydroxyl group of the methacrylic acid.
+
OH OH
1 9  12
At this point it was decided to modify the polymerization process by 
varying the amounts of chloroform added; 15, 25 and 35 ml were added to the 
mix prior to polymerization while all other parameters remained unchanged.
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The selectivity of these polymers for 7-OHC was examined by 
spectroscopic studies. A number of other spectroscopic studies were carried 
out on the polymer selected from the previous section: a) the 7-OHC MIP was 
examined for selectivity of 7-OHC over other drug components including a 
number of coumarins; b) the amount of time necessary for equilibration of the 
polymer with the test solution was investigated; and c) the capacity (uptake of 
7-OHC) of the material was determined. The structures of the compounds 
used are shown in Figure 4.4.
l
Ri r 2 r 3
Coumarin H H H
7-hydroxy coumarin OH H H
7-hydroxy-4-methylcoumarin OH CH3 H
7-diethylamino-4-methylcoumarin N(Et)2 c h 3 H
Coumarin-3 -carboxylic acid H H c o 2h
Figure 4.4: Structure of coumarin compounds.
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Figure 4.5 shows a typical spectroscopic study of solutions of 7-OHC, 
7-OHC polymer after mixing with 7-OHC standard (10 (.tg/ml), and a solution 
of polymer after mixing with methanol (blank) for 60 min. It shows the 
uptake of 7-OHC by the 7-OHC polymer.
5 in
Wavelength (nm)
Figure 4.5: The uptake of 7-OHC polymer of 7-OHC solution after mixing 
for 60 min.
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4.2.2 Spectroscopic studies: Selection o f  amount o f  solvent for
polymerization
The amount of solvent (chloroform) used in the polymerization was 
varied, the amounts investigated were 15, 25 and 35 ml. The polymers were 
prepared in the usual manner (Section 4.2.1). Known amounts (0.1 g) of 
polymer were stirred in 10 fig/ml solutions of 7- hydroxycoumarin for 60 min. 
The polymers were filtered, rinsed with methanol and dried and solutions (1 
mg/ml of polymer) prepared in acetonitrile. These were then scanned in the 
region 200 - 450 nm. From the results obtained it would seem that the 
polymer prepared in 15 ml of chloroform was more selective for 7- OHC 
(Figure 4.6).
Wavelength (nm)
Figure 4.6: The selection of the amount of solvent for the polymerization 
reaction. UVscans carried out in the region 200 - 450 nm.
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4.2.3 Spectroscopic studies: Selectivity
The polymer was prepared in the usual maimer using 15 ml of 
chloroform and with 7-OHC as the template. To determine the selectivity of 
the polymer, known amounts (0.10 g) of polymer were stirred in solutions of 
7-OHC, coumarin, 7-diethylamino-4-methylcoumarin, amitriptyline and 
methanol (blank). The polymers were filtered, rinsed and dried (as in 4.2.2) 
and solutions prepared in acetonitrile (1 mg/ml polymer). These were then 
scanned in the region 200 - 450 nm. From the results obtained (Figure 4.7) it 
would seem that the polymer prepared against 7- hydroxycoumarin was 
relatively selective for this compound over the other drug compounds.
Wavelength (nm)
Figure 4.7: The selectivity of the polymer prepared to 7-hydroxycoumarin, 
using a number of other drug components. UV scans carried out in the 
region 200 - 450 nm.
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4.2.4 Spectroscopic studies: Effect o f  Stir Time
The next parameter for examination was the effect of stir time or 
equilibration time. This was the amount of time necessary for the polymer to 
interact (and as such allow the 7-OHC to be taken up by the polymer). Small 
amounts of the polymer were equilibrated with solutions of 7- 
hydroxycoumarin for 30, 60, 120 and 180 min. The polymers were filtered, 
rinsed and dried as before and were scanned in the region 200 - 450 nm. From 
the results obtained in Figure 4.8 variation was observed by varying the stir 
time between 30 and 180 min and hence it was decided to use equilibration 
times of 60 min for further studies.
W avelength (nm)
Figure 4.8: The effect of stir time required for the polymer prepared to 7- 
hydroxycoumarin to interact with the target compound. UV scans carried 
out in the region 200 - 450 nm.
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4.2.5 Spectroscopic studies: Determination o f  capacity o f
material
To determine the capacity of the selected polymer, solutions of various 
concentrations of 7-hydroxycoumarin (1 mg/ml, 100 pig/ml, 50 i^g/ml 10 
Hg/ml and 1 p.g/ml) were mixed with known amounts of the MI P. After 
mixing the polymer with the sample solutions for one hour, the polymer was 
filtered and rinsed and dried. Solutions were prepared from the dry polymers 
in acetonitrile and these were examined by UV spectroscopy. From the UV 
scans obtained, it would seem that the polymer was unable to absorb 7-OHC 
in large quantities from the highly concentrated solutions. It seems for the 
quantity of polymer examined it was more suitable for the lower 
concentrations. Hence, for the amount of material used (0.10 g polymer), the 
maximum solution permissible was a solution of 10 jig/ml.
■ 100 ug/ml
■ 50 ug/ml 
1 ug/ml
1 mg/ml
■ 10 ug/ml
W avelength (nm)
Figure 4.8: The capacity of the polymer prepared to 7-hydroxycoumarin 
using a range of concentrations. UV scans carried out in the region 200 - 
400 nm.
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4.2.6 Preparation o f  a chiral monomer
The aim of this work was to prepare a monomer containing a chiral 
centre. Inital work involved esterification of methacrylic acid 1 with /- 
menthol 11 by the reaction scheme below. However from the results obtained 
it was impossible to isolate the chiral monomer in sufficient quantities for 
further use.
The next scheme to be examined was the conversion of methacrylic acid to the 
corresponding methacryloyl chloride by reaction with thionyl chloride. The 
acyl chloride was then reacted with /-menthol. Unfortunately this product 
could not be isolated.
o o
1 11 13
+ SOCl2
o o
2 14
o o
14 11 13
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The next stage involved reacting the acryoyl chloride (commercially available) 
with menthol in an attempt to produce compound 15. Again it was unsuitable 
as the final product could not be obtained.
V  *
o
14 11 15
The next stage involved the attempted synthesis of TV-acyl amino acids by 
reacting either methacryoyl chloride or acyloyl chloride with the following 
amino acids; alanine, phenylalanine, leucine and valine by a method described 
by Iwakura et al. 22 However, only the reaction of alanine and acryloyl 
chloride yielded an analytically pure compound which could be used in further 
polymerization reactions.
4.2.7 Synthesis o f  N-acryloyl-alanine
A portion of L-alanine 16 (L-a-aminopropionic acid) was added to a 
solution of sodium hydroxide. Acryoyl chloride 14 was added dropwise to 
this solution at 4 °C. When the reaction was complete, the mixture was 
neutralized with concentrated HC1. A white precipitate was formed and this
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was filtered and dried. Repeated recrystallization from ethanol yielded an 
analytically pure sample which was submitted for 'H-NMR analysis. This 
data confirmed that the compound 17 had been prepared due to the presence of 
vinyl protons which were observed in the region 5.0 - 6.0 ppm.
4.2.8 Polymerization o f  N-acryloyl-alanine
A polymer was prepared using the prepared monomer yV-acryloyl 
alanine 17 (replacing methacrylic acid used in the previous polymerization). 
The target molecule was S-propranolol. The resulting polymer was submitted 
for 1 H-NMR analysis and the absence of the vinyl protons was again observed 
in the region 5.0 - 6.0 ppm. This polymer is used in further work in Chapter 6.
4.2.9 Polymerization o f monomers in the presence o f  
S-propranolol
As before (4.3.1) the polymerization was carried out using methacrylic 
acid 1 and ethylene glycol dimethacrylate, chloroform and the target molecule 
S-propranolol. The polymer formed was found to have no vinyl protons in the 
region 5.0 - 6.0 ppm (Used for further work in Chapter 6).
140
4.3 EXPERIMENTAL
'H-NMR spectra were measured at 400 MHz using a Bruker AM 400 
spectrometer. C -NMR spectra were measured at 100 MHz. Infrared spectra 
were recorded on a Perkin-Elmer, 2000FT-IR infrared spectrophotometer. 
Ultra-violet absorption spectra were recorded on a UV-3100, Shimadzu UV- 
VIS-NIR spectrophotometer. Thin layer chromatography (TLC) was carried 
out on a silica gel TLC plates (layer thickness 0.20 mm, Riedel-de-Haen). 
Flash chromatography columns was performed according to Still et a l23 with 
silica 32 - 63 (im, 230 - 400 mesh. Chloroform was purified by passing 
through an alumina column. A short path distillation (Kugelrohre) of 
methacrylic acid was carried out prior to its use. All polymerizations were 
carried out under nitrogen.
4.3.1 Polymerization o f  methacrylic acid in the presence o f  the
target molecule 7- hydroxycoumarin
The polymerization was carried out by mixing (0.45 g, 5.2 mmol) 
methacrylic acid, (0.21 g, 1.4 mmol), 7- hydroxycoumarin ethylene glycol 
dimethacrylate (EDMA) (4.68 g, 23.5 mmol) and azo-iso butyronitrile (AIBN) 
(0.06 g, 0.37 mmol). Chloroform (15 ml) was added and the mixture was 
degassed under vacuum and then sonicated for 5 min. It was then sparged 
with nitrogen for 5 min. The polymerization was carried out by heating the 
mixture to 60 °C for 12 hours under nitrogen. As the polymer was formed it 
precipitated out of solution. This was filtered and then ground in a pestle and 
mortal' to give particles in the range 45 - 65 |j.m. The material was then placed 
in a Soxhlet apparatus and the 7-hydroxycoumarin was extracted using 
methanol:acetic acid (9:1 % v/v). Repeated sedimentation of the polymer 
removed any fines present and the polymer was dried overnight under vacuum.
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IR (Nujol Mull): 3310, 2984, 1743, 1471, 1385, 1296, 1261, 955, 722 cm 1. 
JH-NMR (DMSO-d6):5 1.6 (1H, s), 2.33 (2H, d), 3.2 (1H, q).
4.3.2 Synthesis o f  N-acryoyl alanine
The synthesis was based on a method by Iwakura et a l22 L-alanine 
(11.24 g, 125 mmol) was added to a round bottom flask and 50 ml of water 
was added. Sodium hydroxide (10.0 g, 1000 mmol) was added to the solution. 
When the alanine had dissolved in the solution acryoyl chloride (11.31 g, 125 
mmol) was added dropwise with stirring at 0 - 10 °C. When the reaction was 
complete, the mixture was neutralized with concentrated HC1. The precipitate 
thus formed was washed with ethanol. The desired product was then obtained 
from the ethanol extracts and three recrystallizations from ethanol gave an 
analytically pure sample.
IR (Nujol Mull): 3307, 3079, 1733, 1600, 1295, 1222, 1172, 1067, 975, 816, 
681, 660 cm '1.
!H-NMR (DMSO-d^S 1.5 (3H,d), 4.2 (1H, q), 5.6 (1H, dd), 6.1 (1H, dd), 6.3 
(1H, dd), 8.4 (1H, d).
13C-NMR (DMSO-de): 5 17.5, 47.8, 125.6, 131.5, 164.2, 174.3.
4.3.3 Polymerization o f acryloyl alanine in the presence o f  the
target molecule S-propranolol
The polymerization was repeated using 5-propranolol as the target 
molecule (0.112 g, 1.4 mmol) and the monomer (0.22 g, 1.7 mmol) prepared 
in section 4.3.2. The weights of the remaining reactants were reduced, the 
weights used being ethylene glycol dimethacrylate (1.588 g, 7.8 mM) and 
AIBN (0.02 g, 1.2 mM). The amount of solvent was also reduced (5 ml) and
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the mixture was degassed under vacuum and then sonicated for 5 min. The 
polymerization and extraction was carried out as before (section 4.2.12).
IR (Nujol Mull): 2969, 2845, 1700, 1652, 1557, 1471, 1378, 1260, 1160, 961, 
723 cm'1.
*H-NMR (DMS(M;):8 1.2 (1H, d), 1.6 (6H, m), 2.3 (1H, d).
4.3.4 Polymerization o f  methacrylic acid in the presence o f  the 
target molecule S-propranolol
The polymerization was repeated using S-propranolol as the target 
molecule (0.112 g, 1.4 mmol). The weights of the remaining reactants were 
reduced, the weights used been (0.15 g, 1.7 mmol) methacrylic acid, ethylene 
glycol dimethacrylate (1.588 g, 7.8 mmol) and AIBN (0.02 g, 1.2 mmol). The 
amount of solvent was also reduced (5 ml) and the mixture was degassed 
under vacuum and then sonicated for 5 min. The polymerization and 
extraction was carried out as before (section 4.2.12).
4.4 CONCLUSIONS
The method of “non-covalent” imprinting was found to be a relatively 
simple straightforward procedure for the preparation of a MIP to 7-OHC. By 
modification of the amount of solvent used in the reaction the selectivity of the 
polymer could be altered. This was determined by spectroscopic studies 
which allowed the polymers to be examined by a quick and simple method, the 
lower amounts of solvent produced more selective MIPs. Further 
spectroscopic studies examined the stir time (60 min was found to be suitable), 
the selectivity (the polymer was found to be selective for 7-OHC over other 
coumarins) and the capacity of the material (10 fig/ml was found to be the 
maximum for the amount of polymer examined).
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Although the number of monomers is quite large, only a small number 
of these have found use/or indeed have been used in molecular imprinting. A 
number of groups have shown that by using monomers other than methacrylic 
acid and cross-linking monomers other than EDMA, better selectivities and 
load capacities are obtained from the polymers prepared from these materials. 
It has also been shown that the addition of further points of interaction 
increase selectivity. Therefore, by use of a monomer other than methacrylic 
acid, or indeed by incorporating further functional groups and chiral centres, 
the selectivity could be increased further. A monomer was prepared from 
alanine and acryloyl chloride and this was then polymerized using S- 
propranolol as the imprint molecule. The possibility of making stereospecific 
polymers by the technique of molecular imprinting will be extended further 
and will fmd increasing application in the determination of enantiomers. 
Therefore, there is a need for methods of preparation of monomers, in 
particular on a large scale, by simple methods.
It is also necessary to examine the methods of preparation of polymers 
from these monomers and determine whether there is indeed enhanced 
selectivity. A number of parameters to be varied include variation in the 
monomer to template ratio, and the use of photo-initiation instead of thermal 
initiation. There is great potential to prepare a large amount of material 
suitable for drug analysis, in particular enantiomeric analysis, and indeed 
provide a cheap alternative to speciality chiral stationary phases.
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CHAPTER FIVE
USE OF A MOLECULARLY 
IMPRINTED POLYMER AS A SOLID- 
PHASE EXTRACTION MATERIAL
5.1 INTRODUCTION
Molecularly imprinted polymers (as previously mentioned in Chapter four) 
are prepared by polymerization of the functional monomer and cross-linking 
monomer in the presence of the target molecule. These MIPs have found a 
number of applications, e.g. as stationary phase and solid-phase extraction 
materials, for the analysis of numerous drug components, in particular for 
enantioselective separations.
Sellergren et al} prepared a molecularly imprinted polymer using 
methacrylic acid as the functional monomer to a L-phenylalanine derivative by 
the “non-covalent method”. This material was packed into a column and a 
racemic mix gave a maximum separation factor (a) of 3.5. They found that the 
selectivity was governed by the number and nature of interactions between the 
substrate and the polymer stationary phase, as well as the shape and rigidity of the 
substituents of the print molecule. The capacity of the material was 1.5 mg of 
racemate to 1 g of polymer. Substrates other than the respective template 
molecule were found to be poorly resolved in most cases.
Sellergren2 prepared chiral stationary phases and examined the selectivity 
and sample load capacity. Using either the D- or L- form of a particular amino 
acid derivative, the MIP was found to show high enantioselectivity in the 
chromatographic mode. However, broad peaks were obtained and slow mass 
transfer was found; this was due to a higher number of interactions between the 
solute and the MIP stationary phase. However, a polymer prepared at low 
temperature showed a more rapid mass transfer and higher selectivity. It was also 
found to achieve more rapid mass transfer and higher selectivity by increasing the 
column temperature.
Moradian et al.3 prepared a MIP to L-p-aminophenylalanine anilide, and 
packed it into a column. This was then used for the chromatographic analysis of
148
a racemic mixture, with separation factors (a) of above 8 being obtained. This 
was due to the multiple points of attachment between the print molecule and the 
polymer. However, it was necesssary to thermostat the column to 85 °C to elute 
the enantiomers. A high degree of selectivity was obtained by the polymer for the 
template molecule.
A chiral stationary phase was prepared by Fischer et a l4 which allowed the 
direct enantioseparation of (3-adrenergic blockers. The print molecule used was 
(S)- (-) timolol. They also examined the use of a different monomer, itaconic acid 
(ITA). Both polymers achieved baseline separation of a racemic mix of timolol 
with Rs values between 1.9 and 2.0 being obtained for ITA and MAA, 
respectively. ITA was found to give sharper peaks and a higher degree of 
selectivity. The advantage of molecular imprinted stationary phases over many 
other stationary phases is the predictable elution order of the enantiomers, the 
print molecule being eluted last. The load capacity of a particular MIP prepared 
by this method from MAA was found to be about 500 jig of a racemic amino acid 
derivative per 1 g of dry polymer.
Imprints have been made against the bronchodilator theophylline and the 
tranquilizer diazepam.5 Cross-reactivity profiles of these MIPs were practically 
identical to those reported for monoclonal antibodies against these drugs. The 
anti-theophylline MIPs were used for the determination of theophylline 
concentration in patient serum samples, the results obtained were comparable to 
those obtained using an immunoassay technique.
In medical/environmental fields it is often necessary to analyze target 
molecules in the presence of complex mixtures, and in some cases carry out some 
pretreatment steps. In fact, preconcentration may be necessary to permit analysis 
using the “end method” of determination. It may also be necessary to remove the 
analyte from a complex mixture which may include a number of interferents. The
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most commonly used methods which allow such sample preparation (refer to 
chapter 1) include liquid/liquid extraction and solid-phase extraction (SPE).
SPE6 allows the analyte to be sorbed onto the solid-phase while any 
interfering components are eluted to waste. Solid-phase materials normally used 
are sorbents that are hydrophobic which allows uncharged analytes to be 
adsorbed. Hydrophilic analytes cause more problems as regards enrichment and 
clean-up as they cause disturbances in subsequent chromatographic analysis. 
Affinity chromatography, with immobilized biomolecules exhibiting high affinity 
and specificity toward their substrates, have also been used for this purpose. 
However, there are problems associated with this technique, in that poor stability 
exists and results obtained are often irreproducible.
Molecularly imprinted polymers have found application as solid-phase
n
extraction materials, and this has been demonstrated by Sellergren. He prepared 
a SPE material to a drug used in the treatment of AIDS-related pneumonia; i.e. 
pentamidine (PAM). This MIP was found suitable for removal of PAM from 
dilute solutions of urine. He found that at a physiological concentration (30 mM) 
this gave an enrichment factor of 54 using a PAM-selective polymer, whereas the 
enrichment factor on a benzamidine (BAM) imprinted reference polymer was 
only 14. The high selectivity of the polymer allowed the drug to be detected 
directly in the desorption step, thus eliminating the need for a subsequent 
chromatographic analysis. The preparation of the solid-phase extraction columns 
involved the polymerization of the monomers in a sealed glass tube heated to 60 
°C for 24 hr in an oven. The glass tubes were cut and fitted with column end 
fittings and connected to a HPLC system. This method allowed a selective 
enrichment while allowing the analysis of low concentrations. This technique 
may offer a solution for the determination of metabolites or adducts of close 
structural similarity.
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The aim of this work was to find an application for the MIP previously 
prepared in chapter 4. The MIP prepared to 7-hydroxycoumarin (7-OHC) was 
packed into a cartridge and used as a solid-phase extraction phase. The extraction 
procedure using the solid-phase extraction cartridge is described from first 
principles. The method was validated for the extraction of 7-OHC from urine 
samples in the range 10 - 50 fig/ml. The selectivity of this polymer prepared to 7- 
OHC over other members of the coumarin family was also examined (Figure 5.1).
To date, there have been a number of methods for the determination of 7- 
OHC by TLC, 8 HPLC9 and CZE. Coumarin is a naturally occurring compound in 
a number of plants and has found use in the treatment of a number of diseases 
including brucellosis, cancer, bums and rheumatic disease. 10 It has been shown 
that approximately 63 % of the total dose of coumarin administered to patients 
was recovered as the 7-OHC derivative11 within 24 hr. Tan et al}2 developed a 
method for the extraction of coumarin and 7-OHC from whole blood, using 
spectrofluorimetric detection, where the mean recovery was found to be 94.8 %. 
This method involved repeated extraction of coumarin and 7-OHC with diethyl 
ether and combination of the extracts. Although this method was found to be 
sensitive, it had a number of drawbacks including the need for two extractions, 
and the use of large sample volumes.
Egan et al.13 used a spectrofluorimetric method for the determination of 7- 
OHC from urine and plasma using extracted and unextracted samples. As 7-OHC 
is conjugated to glucuronide, it had to be treated with (3-glucuronidase for 30 min 
at 37 °C to release it as 7-OHC, allowing free, total and conjugated 7-OHC to be 
determined. Extraction was carried out using diethyl ether, the sample being then 
dried down and reconstituted in an aliquot of phosphate buffered saline (PBS), pH 
10.0, and transferred to a 96 well microtitre plate (20 jil aliquots). The 
fluorescence was determined at 370 nm (excitation) and 450 nm (emission) and
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couinaiin
HO
7-hydi oxycoumarin
CH
7-hydroxy-4-methylcoumarin
7-diethylamino-4-inethylcouinarin
Figure 5 1. Chemical structures of con mar in, 7-hydroxycou m arin, 7-hydroxy- 
4-methylcoumarin and 7-diethylamino-4-methylcoumarin.
was found to be linear in the range 0. 5 - 10 and 10 - 100 jig/ml. The percentage 
of the dose recovered as 7-OHC over a 24 hr period was 92 - 98 %.
Bogan et al. 4 developed a method for the determination of free and total 
7-OHC from urine and serum by capillary electrophoresis, utilizing UV detection 
at 210 nm. The assay was found to be linear in the range 0 - 5 0  fig/ml with a 
limit of quantitation of 1 ng/ml. Urine from two volunteers, who had been 
administered coumarin, was analyzed by CE and HPLC, and the methods were 
compared and contrasted. The CE method gave rise to shorter analysis times 1.5 
min. compared to 12 min. for HPLC. However, no statistical difference between 
results was obseived. Therefore, it was decided to use CE as the method of 
determination of 7-OHC based on the previously mentioned method.
Capillary zone electrophoresis (CZE) was first developed by Jorgenson et 
al. 15,16 in the early 1980’s and it is a rapidly developing separation technique with 
high resolving power and separation speed. However, only ionic or charged 
solutes can be separated by this method, as its separation occurs by differential 
migration of analytes in an electric field. The capillary used is a narrow-bore 
with an internal diameter in the region of 25 - 75 |im, which is usually filled only 
with buffer.
The sampling procedure occurs by initially placing both ends of the 
capillary in the buffer reservoirs. These reservoirs also contain the electrodes 
which make the electrical contact between the capillary and the high voltage 
power supply. The sample is loaded onto the capillary by either one of two 
methods: an electric field or by an external pressure. The capillary is then 
replaced in the buffer reservoir and the electric field is applied and the separation 
is carried out.
A fundamental part of any CE separation is the electroosmotic, or 
electroendosmotic flow (EOF). This constitutes the bulk flow of liquid in the 
capillary and is due to the surface charge on the interior capillary wall; resulting
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from the effect of the applied electric field on the solution double-layer at the 
wall. The fused silica has numerous silanol groups which exist in an anionic form 
(SiO ). Counter-ions build up near the surface to maintain charge balance and 
form a double-layer thus creating a potential (zeta potential) difference close to 
the capillary wall. When a voltage is applied across the capillary, the cations 
become attracted to the cathode. These cations are solvated and as they move 
towards the cathode they drag the bulk solution towards the cathode also. The 
zeta potential is dependent on the surface charge on the capillary, and since this 
charge is pH dependent, variations in the pH results in changes in the EOF. 
Under alkaline conditions the silanol groups are mainly deprotonated and the 
EOF is large, whereas at low pH it is quite small. The zeta potantial is also 
affected by the ionic strength of the buffer; increases in ionic strength result in 
decreases in zeta potential, and hence the EOF decreases.
Separation in electrophoresis is dependent on the differences in the analyte 
velocity in an electric field. The velocity of the ion15 is described by
where v = ion velocity, |ue = electrophoretic mobility, E = applied electric field,
V = applied voltage, L = total capillary length.
The time required for an analyte to migrate to the point of detection is called the 
migration time. The migration time and a number of other experimental 
parameters are used in the calculation of the apparent mobility of the analyte:
v = jaeE =(j.e(V/L) 5.1
^  = IL/(tV) 5.2
where na = jie + Heof 5.3
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where I = effective capillary length (length to the detector), t = the migration time 
of the analyte and (j.eof = the apparent electric osmotic flow.
In the presence of electric osmotic flow (EOF), the measured mobility is 
called the apparent mobility, \ia. The effective mobility, p,e, can be extracted from 
the apparent mobility by independently measuring the EOF using a neutral marker 
that moves at a velocity equal to the EOF, e.g. acetone, methanol, DMSO and 
mesityl oxide.
5.2 EXPERIMENTAL
5.2.1 Reagents and solvents
HPLC grade methanol and diethyl ether were obtained from Labscan 
Analytical Sciences, (Dublin, Ireland). Analar grade sodium hydroxide and 
phosphoric acid were supplied by BDH (Poole, UK). Analytical grade 
dipotassium hydrogen phosphate and potassium dihydrogen phosphate were used 
as buffer salts and were obtained from Merck (Darmstadt, Germany). The 
electrolyte solution used was 0.025 M phosphate buffer, pH 7.5, which was 
prepared daily by dissolving 0.02 M K2HP04  and 0.005 M KH2 PO4 in deionized 
water. A Britton-Robinson (BR) buffer solution was prepared containing 11,48 
ml acetic acid (99.7 %), 12.44 g boric acid and 13.5 ml phosphoric acid (85%) 
per litre. The pH was adjusted using 2.0 M sodium hydroxide. Extraction 
columns were prepared in prewashed syringe barrels ( 2  ml) and qualitative filter 
paper discs (No. 1, Whatman, Maidstone, UK) were used as frits. 7-OHC and the 
other coumarin compounds were obtained from Sigma (St. Louis, MO, USA).
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5.2.2 Standards
Stock solutions were prepared by dissolving the appropriate amount of 
analyte in methanol (100 %) to yield a solution of concentration 1 mg/ml. A set 
of calibration standards were prepared by dilution of the stock solution with 
deionized water, covering the range 10 - 50 i^g/ml.
5.2.3 Urine Standards
Blank urine was obtained from a volunteer who had not been administered 
coumarin or 7-hydroxycoumarin. Aliquots of this blank urine were spiked with 
standard solutions of 7-OHC and vortex mixed to give the required concentration 
in the range 10 - 50 |j,g/ml.
5.2.4 Instrumentation and Operating Conditions
The capillary used was a 27 cm x 50 p.m I.D. fused-silica column 
(Beckman Instruments), with a capillary-to-detector distance of 20.0 cm. The 
capillary was prepared by rinsing with 0.1 M sodium hydroxide for 1 min and 
then with buffer solution for 1.2 min. This was based on a method by Bogan et 
al.14 The sample was applied to the capillary by a 3-s pressurized injection (0.5 
p.s.i.) and separation was achieved with an applied voltage of 20 kV (rise time 0.2 
min) at 25 °C. Typical running current was 100 jxA. The resultant 
electropherogram was monitored at 2 1 0  nm with a photodiode array detector 
using Beckman System Gold software. The migration time for 7-
hydroxycoumarin was 0.92 min.
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5.2.5 Procedures
The columns were prepared by a method described by Boyd, which 
involved the use of syringe barrels. Two filter paper discs were placed in a 2 ml 
syringe barrel and 0.40 g of polymer was added to the barrel and two more filter 
discs were placed on top. The columns were preconditioned by flushing with 3 
ml of methanol, 2 ml of water and 1 ml of buffer solution. The column was 
compressed with a syringe plunger. Sample (250 jil) was applied to the top of the 
column. The column was washed with 2 ml of deionized water and allowed to 
dry for 30 min. The drug component was eluted with 3 ml of methanol. This 
eluate was evaporated to dryness under a stream of nitrogen at 60 °C, and 
reconstituted in 250 |il of phosphate buffer (0.025 M).
5.2.6 Calibration and Calculation
Evaluation of the assay was carried out by the construction of a five-point 
calibration graph covering the concentration range 10 - 50 i^g/ml. The slope and 
the intercept of the calibration graphs was determined through the linear 
regression of the drug height versus drug concentration graphs. Individual peak 
heights were interpolated on the calibration graphs to determine values of 
concentration found as compared to concentration added.
5.2.5.1 Column preparation and extraction procedure
11 ’
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5.3 RESULTS AND DISCUSSION
5.3.1 Development o f  extraction procedure
The aim of this work was to use the MIP prepared to 7-hydroxycoumarin 
as a solid-phase extraction material. MIP stationary phases function by 
interactions between the polymer and the target compound (hydrogen bonding 
and ionic interactions); therefore the MIP prepared to 7-OHC should show 
recognition for the original ‘template’ molecule and hopefully some selectivity 
for it over other similar structure compounds, i.e. members of the coumarin 
family.
A method was set up which allowed the extraction of 7-hydroxycoumarin 
from urine. The columns were prepared as described in section 5.2.1. To 
optimize the extraction a number of parameters were varied, and these included 
the pH of the buffer used prior to the application of the sample, the wash step and 
the elution step. Each of the parameters was examined in triplicate. The columns 
were pre-conditioned with methanol and then water.
The pH of the buffer was the first parameter varied; this was carried out by 
applying 1 ml of buffer of appropriate pH to the pre-conditioned cartridges. The 
pH was varied using Britton-Robinson buffer in the range 3 - 10 pH units. From 
the data obtained the recoveries were found to vary, at very low pH, (3 - 4) values 
of c.a. 40 % were obtained; while at high pH, values in the region 0 - 5 % were 
obtained. Values between these two ranges gave the best recoveries with pH 6  
giving values in the region 80 - 96 %.
The next parameter to be studied was the wash step. This is important at 
this stage to remove any endogenous components without eluting 7-OHC. A 
number of wash procedures were examined including 100 % H20  and 50:50 H20 /
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methanol. The washings were dried down to determine if any 7-OHC had been 
eluted at this stage. Based on the results obtained, it was decided to use water as 
it gave cleaner extracts at a later stage and allowed 7-OHC to remain on the 
column while the use of 50:50 methanol:water caused small amounts of 7-OHC to 
elute. The amount of wash was also varied in the region 1 - 5 ml, with 2 ml being 
found the most suitable.
The final step was to select a suitable elution solvent and a number of 
solvents were examined, including methanol, diethyl ether, hexane:diethyl ether 
(50:50) and ethyl acetate. Methanol gave rise to the best recoveries, with the 
amount of solvent used being varied in the region 1 -5  ml, with 3 ml of methanol 
being found to be suitable for elution of 7-OHC. Poor recoveries were obtained 
with the other solvents; hexane, (50:50) diethyl ether/hexane showed recoveries 
in the region 0 - 5 %, Diethyl ether gave values of 30 - 40 % while ethyl acetate 
extracts produced a large number of interfering peaks. An increase in the volume 
of these solvents did not improve the recoveries.
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5.3.2 Assay validation
The method was validated for the determination of 7-hydroxycoumarin by 
extraction using a MIP-SPE over the concentration range 1 0 - 5 0  (ig/ml. 
Electropherograms showing blank and spiked (50 ng/ml) mine samples from the 
validation study are shown in Figure 5.1.
5.3.2.1 Limit o f Detection
The LOD was formed to be found to be 5 ng/ml for 7-hydroxycoumarin.
5.3.2.2 Precision
The precision is expressed as the mean coefficient of variation, determined 
from peak height of the analyte when interpolated as unknowns on the regression 
line. The data presented in Table 5.1 and 5.2 demonstrated the inter- and intra­
assay variations for the method. Inter-assay was determined from four replicate 
runs, from four separate days, while the intra assay was determined in 
quadruplicate over the same concentration range.
160
5.3.2.3 Linearity and accuracy
This is defined by the correlation coefficient of the regression line and 
accuracy is defined by the percentage difference between “added” and “found” 
concentration for Inter- assay values presented in Table 5.1. A correlation 
coefficient of 0.994 or better was obtained.
5.3.2.4 Recovery
The recovery of 7-hydroxycoumarin from urine was measured by 
calculating the percentage difference between the peak heights of extracted 
standards and those of authentic standards in the relevent concentration range. 
The mean recovery was found to be 90.36 + 7.37 %.
5.3.2.5 Selectivity
A number of other coumarins and drug compounds were investigated as 
potential interferents. A number of the coumarins, coumarin-3-carboxylic acid 
and 7-diethylamino-4-methylcoumarin showed some cross reactivity for the 
polymer.
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Tin t c  (m in )
Figure 5.1: Electropherograms of 7-hydroxycoumarin extracted from urine 
and blank urine. Background electrolyte consists o f 0.025 Mphosphate buffer, 
pH  7.5, Temperature 25 °C, Voltage 20 kV.
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TABLE 5.1
Precision and Linearity-INTER-ASSAY
Amount 7-OHC 
added ng/ml
Peak height Amount found 
ng/ml
1 0 0.00353 11.97
2 0 0.00569 19.17
30 0.00876 29.40
40 0 . 0 1 2 0 0 40.20
50 0.01476 49.40
1 0 0.00347 11.77
2 0 0.00594 2 0 . 0 0
30 0.00873 29.30
40 0.01171 39.23
50 0.01556 52.07
1 0 0.00325 11.03
2 0 0.00553 18.63
30 0.00876 29.40
40 0 . 0 1 2 2 1 40.90
50 0.01506 50.40
1 0 0.00303 10.43
2 0 0.00534 18.00
30 0.00839 28.17
40 0.01178 39.47
50 0.01523 50.97
Concentration ng/ml
1 0 . 0 0 2 0 . 0 0 30.00 40.00 50.00
Mean Amount 
Found ng/ml 11.30 18.95 29.07 39.95 50.71
Standard 0.71 
Deviation
0.85 0.60 0.76 1 1 1
Coefficient 6.28 
of variation %
4.49 2.06 1.90 2.19
Difference +1.33 
between added 
and found
-1.05 -0.93 -0.05 +0.71
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TABLE 5.2
Precision and Linearity-INTRA-ASSAY
Amount 7-OHC 
added ng/ml
Peak height Amount found 
Hg/ml
1 0 0.00286 1 1 . 2 0
2 0 0.00547 19.90
30 0.00811 27.20
40 0.01172 40.73
50 0.01497 51.57
1 0 0.00353 10.77
2 0 0.00569 17.97
30 0.00876 28.20
40 0 . 0 1 2 0 0 39.00
50 0.01476 48.20
1 0 0.00329 10.63
2 0 0.00544 17.80
30 0.00910 30.00
40 0.01198 39.60
50 0.01461 48.37
1 0 0.00322 11,07
2 0 0.00589 19.97
30 0.00912 30.73
40 0 . 0 1 2 0 1 40.37
50 0.01566 52.53
Concentration ng/ml
1 0 . 0 0 2 0 . 0 0 30.00 40.00 50.00
Mean Amount 
Found ng/ml 10.29 18.91 29.03 39.93 50.17
Standard 0.27 
Deviation
1.19 1.62 0.78 2 . 2 1
Coefficient 2.62 
of variation %
6.29 5.58 1.95 4.41
Difference +0.92 
between added 
and found
-1.09 -0.97 -0.07 +0.17
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TABLE 5.3
Results for recovery of 7-hydroxycoumarin
7-hydroxycoumarin peak height
Concentration Authentic Extracted Recovery
ug/ml standards standards %
1 0 0.00357 0.00329 92.16
2 0 0.00703 0.00589 77.38
30 0.00972 0.00910 93.62
40 0.01288 0.01198 93.01
50 0.01528 0.01461 95.62
Mean recovery (+ standard deviation) = 90.36 + 7,37 %.
5.4 CONCLUSION
The area of solid-phase extraction as a method of sample preparation is 
increasing in size and in many cases replacing liquid/liquid extraction. The 
number of phases available for this technique is increasing, and these include ion- 
exchange materials, polymers and mixed functional phases and this in turn 
expands the range of components which can be extracted by this technique.
Although polymers have already found use in this area, the use of an MIP 
allows a polymer material to be prepared to a specific component. This would be 
particularly useful if the component is unsuitable for solid-phase extraction by 
any of the materials previously mentioned. This could also be particularly useful 
when a component has to be removed from its metabolites or compounds with 
very similar structures.
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This study shows that a MIP prepared to a 7-hydroxycoumarin allowed it 
to be selectively retained, while allowing endogenous components to be removed. 
It was capable of extracting 7-OHC in the range 10-50 ng/ml. Previous methods 
reported extraction in this range, but, it was necessary to use large amounts of 
solvent and samples. This method overcomes the need for such large amounts of 
solvent. The method was validated in terms of coefficient of variation and 
recovery, linearity and accuracy.
The presented analytical scheme can thus in favourable cases enrich and 
clean-up a sample to a level that allows direct analyte determination upon 
desorption. It should prove to be a suitable alternative to the LLE techniques 
previously described. Possible further work would include the use of other 
monomers/cross-linking monomers to try and increase the selctivity of the 
polymer and examination of the ratio of monomer to template, again to improve 
selectivity.
166
5.5 REFERENCES
1. B. Sellergren, M. Lepisto and K. Mosbach, J. Am. Chem. Soc., 110
(1988)5853.
2. B. Sellergren, Chirality, 1 (1989) 63.
3. A. Moridian and K. Mosbach, J. Mol. Recogn., 2 (1989) 167.
4. L. Fischer, R. Muller, B. Ekberg and K. Mosbach, J. Am. Chem. Soc.,
113 (1991) 9358.
5. G. Vlatakis, L. I. Andersson, R. Muller and K, Mosbach, Nature, 361
(1993) 645.
6 . I. Liska, High Res. Chromatogr., 12 (1989) 577.
7. B. Sellergren, Anal. Chem., 66 (1994) 1578.
8 . S. Cholerton, M. E. Idle, A. Vas, F, J. Gonzalez and J. R. Idle, J.
Chromatogr., 575 (1992) 325.
9. S. Sharifi, H. Michaelis, E. Lotterer and J. Bircher, J. Liq. Chromatogr.,
16 (1993) 1263.
10. D. Egan, R. O’Kennedy, E. Moran, D. Cox, E. Prosser and R. D. Thornes, 
DrugMetab. Rev., 22 (1990) 503.
11. E. Moran, R. O’Kennedy and R. D. Thornes, J. Chromatogr., 416 (1987) 
165.
12. H. S. I. Tan, W. A. Ritschel and P. R. Sanders, J. Pharm. Sci., 65 (1976) 
30.
13. D. A. Egan and R. O’Kennedy, Analyst, 118 (1993) 201.
14. D. P. Bogan, B. Deasy, R. O’Kennedy, M. R. Smyth and U. Fuhr. J.
Chromatogr. B, 663 (1995) 371.
15. J. W. Jorgenson and K. D. Lukacs, Anal. Chem., 53 (1981) 1298.
16. J. W. Jorgenson and K. D. Lukacs, Science, 222, (1983) 266.
167
17. D. T, Boyd, Analysis o f some /^-Adrenergic Agonists in Biological 
Matrices after Evaluation o f Various Extraction Methodologies and 
Determination Procedures, Doctoral thesis, Dublin City University, 1995.
168
CHAPTER SIX
USE OF A MOLECULARLY 
IMPRINTED POLYMER AS A 
CHIRAL SELECTOR IN 
CAPILLARY ELECTROPHORESIS
6.1 INTRODUCTION
As previously mentioned in chapter 5, capillary electrophoresis allows 
the separation of ionic or charged analytes, based on the difference in their 
electrophoretic mobilities. Neutral analytes are not suitable for separation by 
this technique; however, the development of electrokinetic chromatography1 
(EKC) has solved these problems. EKC is a branch of CE which uses the 
technique of CZE in combination with the chromatographic separation 
principles. This involves using a homogenous solution that contains an ionic 
“carrier”, and has found application in the analysis of neutral analytes. This 
technique also offers greatly improved selectivity for the separation of ionic 
compounds.
6.1.1 Micellar electrokinetic chromatography (MEKC)
Micellar electrokinetic chromatography (MEKC) is a mode of EKC in 
which surfactants (micelles) are added to the buffer solution. The charged 
molecules or charged molecular aggregates are employed in EKC as a 
separation carrier or a “pseudo-stationary phase”, which corresponds to the 
stationary phase in conventional chromatography. The separation carrier is 
transported by electrophoresis at a different velocity from the surrounding 
buffer solution. The analyte distributes itself between the carrier and the 
surrounding medium. These surfactants are used in concentrations higher than 
the critical micelle concentration (CMC), and this particular mode has found 
application among the various EKC modes. MEKC has also found use for the 
separation of ionic solutes as well as the neutral or non-ionic solutes. It has, 
therefore, been found suitable in the determination of pharmaceuticals, 
including cationic, anionic and neutral species.4  Apart from the surfactant, 
other parameters can be further manipulated and these include buffer cation, 
ionic strength, current and temperature.
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6.1.2 Mechanism o f  MEKC
The separation principle of MEKC is based on the differential partition 
of the analyte between the micelle and the surrounding aqueous phase, as in 
micellar chromatography (Figure 6 .1). An ionic surfactant (sodium dodecyl 
sulphate, SDS) is added to an operating buffer solution in MEKC, and these 
surfactant molecules form micelles or aggregates above the CMC. The 
hydrophobic end groups orient toward the centre and the charged groups point 
outward towards the surface; the formation of these micelles allows the 
separation of electrically neutral or non-ionic solutes. The system is 
composed of two phases; the micellar phase and the aqueous phase. When an 
anionic surfactant is employed, the micelle migrates toward the positive 
electrode by electrophoresis. However, the strong electroosmotic flow (EOF) 
transports the buffer solution towards the negative electrode due to the 
negative charge on the surface of the fused-silica capillary. The velocity of 
EOF is usually faster than that of the electrophoretic migration of the micelle 
under the neutral or alkaline conditions, resulting in a fast-moving aqueous 
phase and a slow-moving micellar phase.
When a non-ionic solute is injected into the solution, a fraction of it is 
incorporated into the micelle and therefore migrates at the same velocity as 
that of the micelle. The remaining fraction migrates at the velocity of EOF. 
The surfaces of SDS micelles have a large negative charge, giving them a large 
electrophoretic mobility toward the anode. However, most buffers exhibit a 
strong electroosmotic flow towards the cathode. The magnitude of 
electroosmotic flow is slightly greater than that of the micelle migration, 
resulting in a fast moving aqueous phase and a slow moving micellar phase. 
Therefore an electrically neutral solute can be separated by the difference in 
the distribution coefficients between the micellar phase and the surrounding 
aqueous phase.
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+Figure 6.1: Separation principle of micellar electrokinetic chromatography
(MEKC). Surfactant = °  Analyte = L_ 1, Electroosmotic Flow =
1 and Electrophoresis =
MEKC can provide enhanced selectivity for the separation of ionic 
solutes as well as the separation of electrically neutral or non-ionic solutes 
through the ionic interaction between the solute and the micelle. The 
migration velocity in MEKC usually depends on the hydrophobicity of the 
solute. The more hydrophobic the analyte, the stronger it interacts with the 
micelle and hence the slower it migrates compared to the hydrophilic analytes. 
Another useful application of MEKC is optical resolution of a chiral 
compound with a mixed micelle or with a chiral micelle.
6.1.3 Application o f  MEKC (chiral separations)
As previously mentioned in Chapter one, drug enantiomers interact 
quite differently with biological components. These components include 
enzymes, receptors and plasma proteins, and these can lead to differences in 
absorption, distribution, metabolism and elimination of the drug compound; 
therefore, many drug enantiomers show different pharmacological effects. 
Hence it is necessary to have methods that are able to discriminate between the 
two enantiomers; a number of methods utilize HPLC and CZE.
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In CZE, chiral selectivity can be obtained by either adding the chiral 
selector to the running buffer or by immobilization of the chiral selector in the 
capillary. Enantiomeric separation by MEKC utilizes chiral surfactants which 
foim chiral micelles. Most analytes are adsorbed onto the surface of the 
micelle or interact with the polar groups of the surfactants. Therefore, 
surfactants with chiral polar groups have found use for chiral discrimination. 
A number of chiral surfactants are available, but to date only a few of them 
have found use for enantiomeric separations by MEKC; e.g. sodium N- 
dodecanoyl-L-valinate5 and bile salts. 6 There are a number of chiral selectors, 
and these are mainly inclusion complexes, which act by spatially enclosing the 
guest molecule, or at least part of it. In EKC, the most commonly used
* 7 . • • 8 9inclusion compounds are cyclodextrins and its derivatives, or crown ethers 
(previously described in Chapter 1).
6.1.4 Enantiomeric separation by cyclodextrin-modified MEKC
(CD-MEKC)
Cyclodextrin-modified micellar electrokinetic chromatography10 (CD- 
MEKC), is a branch of MEKC in which the CD is added to the micellar 
solution. It was developed for the separation of electrically neutral, highly 
hydrophobic compounds (Figure 6.2). The separation of these substances is 
normally difficult by electrophoretic techniques; however, by this method a 
water insoluble hydrophobic analyte is partitioned between the micelle and
CD. When the analyte is incorporated into the micelle, it migrates with the 
micellar velocity. When it is included in the cavity it migrates with the 
electroosmotic velocity, separation being achieved by differential partition of 
the analyte between the CD and the micelle.
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+Figure 6.2: Schematic of the separation principle of cy clo dextrin-modified 
micellar electrokinetic chromatography (CD-MEKC). Surfactant =
Analyte = \ , Electroosmotic Flow =  Electrophoresis =
*^^m.and cyclodextrin =
/ “
\._
This mode has been found to be suitable for the separation of polycyclic 
aromatic hydrocarbons11 and a number of other compounds including (3-
1 f )
blockers.
Cyclodextrins are commonly used as chiral selectors in CZE and there 
are a number of them available. They absorb very little in the UV region and 
are stable over a wide pH range and are non-toxic. They are reasonably 
soluble and this solubility can be increased further by substitution. The use of 
cyclodextrins dissolved in buffer solutions has been found to be particularly 
effective for separating hydrophobic compounds. Since the CD does not 
interact with the micelle, a CD in the micellar solution should behave as 
another phase in comparison with the micelle, and migrate at an identical 
velocity to that of the bulk solution, as the CD itself is electrically neutral. 
Thus the analyte may be partitioned between three phases, the micelle, the CD 
and the aqueous phase. The micelle migrates at a different velocity from that 
of the CD or the aqueous phase. In CD-MEKC, (3 or y-CD’s and sodium 
dodecyl sulphate are normally used. It should be mentioned that CD-MEKC is 
a different technique from CD-EKC. In CD-MEKC a neutral CD is added to
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the micellar solution, while in CD-EKC an anionic CD derivative without the 
micelle is employed. CD-MEKC is also very effective for enantiomeric 
separation because of the chirality of the CD itself.
13The technique of CD-EKC has been used by Guttman et al. to 
examine the use of hydroxypropyl-P-cyclodexti in as a chiral selector for the 
separation of racemic propranolol. The effects of a number of parameters 
were examined including buffer pH, concentration of chiral selector, applied 
electric field and temperature on the chiral separation. These parameters were 
optimized to obtain the maximum separation of the enantiomers with minimal 
analysis time; Rs = 1.75 in less than 5min.
Palmarsdottir et al.14 also used this technique when examining the use 
of a number of cyclodextrins in the determination of a number of racemic 
compounds including rac-terbutaline monosulphate, raobambuterol, rac- 
terbutaline, rac-brompheniramine, rac-propranolol and rac-ephedrine. They 
examined how resolution, migration time and efficiency could be affected by 
the type, degree of substitution and concentration of the cyclodextrin. The 
cyclodextrins examined included a-cyclodextrin, p-cyclodextrin, dim ethyl-p- 
cyclodextrin and hydroxypropyl-(3-cyclodextrin. They also examined the 
applied voltage and pH of electrolyte and found that the most effective 
parameters for optimizing were pH and cyclodextrin type and concentration. 
The chemically modified (3-CDs proved to be more powerful chiral selectors 
than (3-CD for the compounds examined.
Fanali15 also examined the effects of type of shape and amount of 
cyclodextrins added to the background electrolyte on the migration time and 
the resolution of the enantiomers studied (terbutaline and propranolol). A 
phosphate buffer, pH 2.5, containing 5 mM heptakis(2,6-di-(3-methyl)-J3- 
cyclodextrin or 15 mM P-cyclodextrin gave good resolution for racemic 
terbutaline. The best resolution for propranolol was obtained using 50 mM 
phosphate buffer (pH 2.5) - 4 M urea - 40 mM P-cyclodextrin in 30 % (v/v)
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methanol. Modified CDs have been shown to give a greater possibility of 
resolution for compounds which cannot be resolved using the native CD.
St. Pierre et al.16 also used native and derivatized CDs as CE buffer 
additives while monitoring the effects of pH and cyclodextrin concentration on 
the enantiomers of chlorpheniramine, terbutaline, atropine, metoprolol and 
propranolol. They used three different p-cyclodextrin (BCD) modifiers (BCD, 
2-hydroxypropyl BCD and methyl BCD). Enantioselectivity was obtained for 
propranolol, chlorpheniramine and terbutaline.
Separation of a number of dansyl DL-amino acids by MEKC with and 
without cyclodextrins was examined by Miyashita et al. using a borate 
buffer. The didansyl derivatives migrated slower than the other amino-acids. 
They also found that the addition of SDS to the buffer solutions containing 
either (3-CD or y-CD resulted in the chiral separation of DNS amino acids.
Schutzner et a / . 18 examined the use of diastereomeric derivatives using 
polyvinylpyrrolidone as a buffer additive in capillaiy zone electrophoresis and 
it offered hydrophobic as well as hydrophilic interactions to the analytes. The 
test substances were converted to their diastereomers and separated using 
CZE. The network formed by the linear polymer affected the mobility of the 
diastereomers to a different extent and hence enhanced the selectivity of the 
system.
Wang et al}9 carried out MEKC using a polymerized chiral micelle for 
the separation of (+) - l , l ’-bi-2-naphthol and D,L-laudanosine. A comparison 
study of separation was carried out on the micelle polymer and the 
corresponding non-polymerized surfactant under the same separation 
conditions. The polymerized micelle was found to demonstrate chiral 
recognition. The rigidity of the polymerized micelle was found to improve the 
mass transfer rate and this was in turn found to reduce peak broadening.
Another approach for improving the selectivity of enantiomeric 
separation when CDs are used as chiral additives is the addition of non-chiral 
compounds, e.g. organic solvents15,20 or urea13 or the use of polymers, 21 in the
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chemical environment. The formation of cyclodextrin complexes with 
different guest molecules is not well understood, and there is as yet no way to 
predetermine if a certain type of cyclodextrin can be used for the separation of 
certain enantiomeric pairs of compounds. Therefore the enantioseparation still 
remains a system of trial and error. The use of molecularly imprinted 
polymers could overcome this problem, as the MIP would be prepared 
selectively to one of the enantiomers and this one would have a greater affinity 
for the MIP and hence be retained longer; therefore, the elution order can be 
easily predicted.
Chiral resolution of various racemic amino acid derivatives, peptides, 
other organic acids, and some drug components including timolol2 2  and 
naproxen, 2 3 have been studied on non-covalent molecularly imprinted 
stationary phases. For instance, Kempe et al, 2 4 prepared a MIP to the L- 
enantiomer of an amino acid derivative, and this was found by HPLC to be 
more retarded than its corresponding D-enantiomer. O’Shannessy et al.25 
prepared an MIP to L-phenylalanine, and this was capable of efficient 
enantiomeric resolution of the racemic mixture of the original print molecule. 
The functional monomer used was methacrylic acid and the MIP was capable 
of resolving enantiomers of compounds with structural similarities to the 
original print molecule.
An MIP had previously been prepared to 5-propranolol26 by photo­
initiation and used in a radioligand binding assay. This MIP was utilized in an 
aqueous based assay and showed high substrate selectivity for propranolol in 
the presence of structurally similar (3-blockers. Furthermore, in a toluene- 
based assay a cross-reactivity of 1 % was obtained for the R- enantiomer, 
which was found to give better results than those obtained by biological 
antibodies.
For the determination of the enantiomers of propranolol, it was decided 
to use a micellar system using low concentrations of 2 polymers prepared to S- 
propranolol as additives to the buffer. The two polymers were prepared as
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described in chapter four and will be described as Polymer A (prepared from 
methaciylic acid) and Polymer B (prepared from acryloyl alanine). The test 
compounds included (+) propranolol, (+) norephedrine and (+) 
phenylethylamine, the structures of which are depicted in Figure 6.3.
6.2 EXPERIMENTAL
6.2.1 Reagents and solvents
A number of drug components were used in this study, which included 
(+) propranolol, (+) norephedrine and (+) phenylethylamine, and these were 
obtained from Sigma (St. Louis, MO, USA). HPLC grade methanol and 
acetonitrile were obtained from Labscan Analytical Sciences (Dublin, Ireland). 
Analar grade sodium hydroxide and phosphoric acid were supplied by BDH 
(Poole, UK). Analytical grade dipotassium hydrogen phosphate and 
potassium dihydrogen phosphate were used as buffer salts and were obtained 
from Merck (Darmstadt, Germany). Phosphate buffers of pH 3.0 - 4.5 were 
prepared by mixing appropriate concentrations of phosphoric acid and sodium 
dihydrogen phosphate solutions. Phosphate buffers of pH 5.0 - 8.0 were 
prepared by mixing appropriate concentrations of sodium dihydrogen 
phosphate and disodium hydrogen phosphate solutions.
Sodium dodecyl sulphate (SDS) was purchased from Analar ® 
Biochemical. Standards were prepared from a 1 mg/ml stock solution in 
methanol and prepared in deionized water. The electrolyte solution used was 
0.005 M phosphate buffer (pH 7.0), which was prepared daily. The solutions 
were filtered through a 0.45 (im filter and the polymer was added directly to 
these solutions without further filtration. The polymers were prepared to S- 
propranolol as described in sections 4.3.8 and 4.3.9. All water was purified 
using a Milli-Q-system.
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OCH2CH(OH)CH2NHCH(CH3)2
propranolol
CH(OH)CH(CH3)NH2
norephedrine
NH
I 2
CH(CH )
phenylethylamine
Figure 6.3: Structures of test compounds: propranolol, norephedrine and 
phenylethylamine.
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6.2.2 Apparatus
Electrophoretic experiments were carried out on a P/ACE 5500 system 
(Beckman, High Wycombe, UK), thermostatted at 25 °C. The fused-silica 
capillary tube had an internal diameter of 100 /im, a total length of 47 cm and 
a length of 40 cm from inlet to detector. A voltage of 15 kV was used for the 
separation, and the resulting electropherogram was monitored at 210 nm. The 
samples were loaded by a 3-s pressure injection and the observed current 
varied between 30 and 100 fiA. The capillary was prepared by rinsing with 
0.1 M sodium hydroxide for 1 min followed by buffer solution for 1.2 min. 
Each buffer was allowed to equilibrate on the capillary for 20 min prior to use, 
Electropherograms were recorded using Beckman System Gold software.
6.2.3 Calculations
The resolution for the system without micelles was determined from 
Equation 6.1:
Rs= 2 ( x 2 - xi)/(wi + w2) 6 . 1
where xi and x2  are the migration times of components 1 and 2 , and Wi and w2  
are the peak widths of components 1 and 2 .
If SDS is employed as the surfactant, the electrophoretic migration of 
the anionic micelle is in the direction of the anode. As a result, the overall 
migration velocity is slower compared to the bulk flow of solvent. Since 
analytes can partition into and out of the micelle, when an analyte is associated 
with a micelle its overall migration velocity is retarded. When an uncharged 
analyte resides in the bulk phase, its migration velocity is that of the EOF, 
Therefore analytes which have a greater affinity for the micelle have slower
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migration velocities compared to analytes which spend most of their time in 
the bulk phase; however, in situations where a micellar buffer2 is used, the 
above equation changes to:
Rs=N°'5/4 (a-1/a) (k '2/l+ k '2)  [ ( 1 -t0/tmc)/ (l+ t0/tmck '1)]  6.2
a  = k2' /ki', N = plate number, t0 = migration time of neutral component and
tmc = migration time of the micelle.
Capacity factors ’ were calculated from
k' = tr-to/[to(l-tr/tmc)]  6 .3
6.3 RESULTS AND DISCUSSION
All separation parameters were calculated for both enantiomers. All 
samples were dissolved in water and the sample concentration used for the 
analysis was 50 jig/ml, this was to ensure that adequate peak heights could be 
obtained. Methanol was used as the neutral marker for measurement of
electroosmotic flow (EOF), and quinine hydrochloride was used for
measurement of the micelle flow. In order to bring about chiral separation, a 
difference in electrophoretic mobility between the complexed and the free 
enantiomers is necessary. To see if this difference was present under the 
various experimental conditions in this study, the migration times (tm) of each 
analyte were compared while varying a number of parameters, including pH, 
ionic strength, polymer type, concentration of polymer, and addition of SDS.
According to Rawjee and Vigh, 2 8 when performing chiral analysis of 
enantiomeric drugs containing one asymmetric centre and having only one 
charged functional group in the molecule (acidic or basic), the separation 
buffer pH and the chiral selector concentration are the two most important 
parameters defining chiral selectivity. Using R, S- propranolol, R, S-
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norephedrine and R, S -phenylethylamine as test compounds; the initial buffer 
conditions were selected by varying pH and ionic strength; once established, 
the effects of chiral selector and chiral selector concentration were then 
investigated in terms of resolution of the enantiomers.
6.3.1 Effect o f  pH
The initial step involved the selection of a buffer which would allow 
the elution of the sample components within a short period of time, and give 
rise to suitable peak shape. The buffer found suitable for this was 0.005 M 
phosphate buffer, pH 7.0. The average migration times from duplicate 
injections of each compound are shown in Table 6 .1. From this data, a pH of 
7.0 was selected as it gave reasonable migration times with the best 
corresponding peak shape. Changes in migration time were observed for all 
compounds on changing pH. High values were obtained at low pH for all 
compounds and low values were obtained at high pH. This was due to the 
reduction in electroosmotic flow which is normally observed at low pH. 
Therefore as the pH increases, the EOF increases and this results in shorter 
retention times.
Table 6.1: Effect of pH  on average migration times of the test compounds 
with a background electrolyte of 0.005 M, phosphate buffer; voltage 15 kV; 
temperature 25 °C.
pH R,S-propranolol R,S-norephedrine R,S-phenylethylamine
3.0 6.23 5.37 4.71
4.0 3.66 3.28 3.01
5.0 2.71 2.60 2.44
6.0 2.71 2.75 2.61
7.0 2.28 2.16 2.06
8.0 2.27 2 . 2 1 2.03
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It was observed that the changes in ionic strength affected the migration 
times; increases in ionic strength resulted in increases in migration times. 
However, at these higher concentrations, the electropherograms obtained were 
of poor baseline shape and the peak shapes were ill-defined. The currents 
produced were also extremely high, and would be unsuitable for use, as further 
additions of additives to the background electrolyte (BGE) would result in 
further increases in the current.
Table 6.2: Effect of ionic strength on migration values of R,S-
propranolol, R,S- norephedrine and R,S- phenylethylamine in the 
background electrolyte; phosphate buffer pH 7.0; voltage 15 kV; 
temperature 25 °C.
6.3.2 Effect o f  ionic strength ofphosphate buffer
Ionic
Strength
R,S-propranolol R,S-norephedrine R,S-phenylethylamine
0.005 M 2.28 2.16 2.06
0.010 M 2.46 2.33 2 . 2 2
0.020 M 2.61 2.48 2.61
0.050 M 2.91 2.85 2.74
6.3.3 Effect o f  variation in the concentration o f  MIP
The effect of concentration of chiral selector on enantiomeric resolution 
was investigated next, maintaining the pH of the running buffer at the 
previously defined value of pH 7.0 and the ionic strength at 0.005 M; all other 
separation parameters were kept constant as described above. Two polymers 
were examined; Polymer A was prepared from methacrylic acid and Polymer
183
B was prepared from the monomer (acryloylalanine). The migration times 
were observed to increase as the amount of polymer added increased.
The MIP interacts with the analytes in a number of ways, including 
formation of hydrogen bonds and ionic interactions. Hence, by interacting 
with the MIP, the analyte moves more slowly than the free analyte because of 
its increased mass-to-charge ratio. It is also possible that the analyte has sites 
for specific hydrogen bonding interactions with the -OH group of the polymer, 
as well as Van der Waals interactions between the methyl groups on the 
polymer and hydrophobic groups of the analyte. By varying the types of 
functional groups used as side chains in the polymer, various types of analyte 
interactions with the MIPs can be studied. Tables 6.3.a and 6.3.b present the 
migration times for the enantiomers of the three compounds and the calculated 
Rs values for Polymer A and B, respectively. Figure 6.4 shows the 
relationship between the resolution of the compound wrt the % polymer in the 
CE separation using Polymer A, while Figure 6.5 shows the same plot for 
Polymer B, with the optimum % for Polymer B being found to be 0.05 %. 
Although some selectivity is observed for Polymer A at 0.03 %, the resolution 
value obtained is only 0.330, which in terms of resolution values is quite low. 
In contrast, for polymer B the resolution obtained at 0.05 % is 1.48, which is 
acceptable for separation of two components (Figure 6 .6 ). The modified 
polymer proved to be a more powerful chiral selector than the polymer 
prepared from methacrylic acid for the components studied. This is possibly 
due to the extra side chain on the polymer backbone which incorporates a 
chiral centre. The addition of this group probably allows a more favourable 
interaction with the template enantiomer over its antipode. Further increases 
in polymer concentration resulted in decreases in the migration times, and the 
solubility of the polymer at higher concentrations also decreased.
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Table 6.3.a: Migration times and resolution values of the R- and S- 
enantiomers of propranolol, norephedrine and phenylethylamine using 
Polymer A as a chiral additive in the background electrolyte; 0.005 M, 
phosphate buffer, pH  7.0; voltage 15 kV; temperature 25 °C.
%
polymer
A
propranolol
R- S- Rs
norephedrine 
R- S- Rs
phenylethylamine 
R- S- Rs
0.00 2.287 2.287 0.000 2.162 2.162 0.000 2.063 2.063 0.000
0.01 2.470 2.469 0 . 0 1 0 2.456 2.434 0.023 2.113 2.118 0.043
0.02 2.254 2.253 0 . 0 1 0 2.145 2 . 1 2 1 0.025 1.841 1.849 0.045
0.03 3.136 3.162 0.330 2.941 2.945 0.051 2.706 2.721 0.054
0.05 2.519 2.504 0.088 2.670 2.690 0.130 2.065 2.088 0.065
0.06 2.259 2.251 0.070 2.251 2.235 0,100 2.047 2.049 0 . 0 1 0
% Polymer A
Figure 6.4: Effect of addition of increasing concentrations of polymer A to 
the running buffer; Conditions: 0.005 M phosphate buffer, pH 7.0; 
temperature 25 °C; voltage 15 kV.
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Table 6.3.b: Migration times and resolution values of R- and S-
enantiomers of propranolol, norephedrine and phenylethylamine using 
Polymer B as a chiral additive in the background electrolyte; 0.005 M, 
phosphate buffer, pH  7.0; voltage 15 kV; temperature 25 °C.
%
Polymer
B
propranolol 
R- S- Rs
norephedrine 
R- S- Rs
phenylethylamine 
R- S- Rs
0.00 2.287 2.287 0.000 2.162 2.162 0.000 2.063 2.063 0.000
0.01 2.298 2.304 0.046 2.280 2 . 2 2 0 0.240 1.830 1.850 0 . 2 1 0
0.02 2.390 2.470 0.029 2.320 2.490 0.640 1.636 1.648 0 . 1 1 0
0.03 3.850 3.891 0 . 0 2 0 3.052 2.925 0.300 2.137 2.149 0.070
0.04 2.143 2.208 0.030 2.084 2.091 0.080 1.984 2.027 0.660
0.05 2.453 3.039 1.480 2.341 2.376 0 . 2 0 0 2.217 2.229 0.080
0.06 2.437 2.418 0 . 1 2 0 2.263 2.271 0.060 2.286 2.299 0 . 0 1 0
propranolol 
norephedrine 
plienylethyl amine
0 0.01 0.02 0.03 0.04 0.05 0.06
% Polymer B
Figure 6.5: Effect of addition of increasing concentration of polymer B to 
the running buffer; Conditions: 0.005 M phosphate buffer, pH 7.0; 
temperature 25 °C, voltage 15 kV.
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0.016
0.012
Figure 6.6: Separation of R-, S- propranolol using Polymer B as a chiral 
additive in the background electrolyte. Conditions: 0.005 M, phosphate 
buffer, pH 7.0; voltage 15 kV; temperature 25 °C.
6.3.4 Effect o f  pH  on the resolution o f  the test analytes
For ionizable compounds, the most straight-forward way to affect 
mobility of the free enantiomer is by variation of the pH of the electrolyte 
solution. Another possibility would be to increase the concentration of the 
electrolyte solution (ionic strength) which affects the effective electrophoretic 
mobility of charged molecules. The effect of pH on the resolution and 
migration values was examined (Tables 6 .4.a and 6.4.b for Polymers A and B 
respectively). All other variables were maintained at constant values (0.005 M 
phosphate buffer, Polymer A 0.03 % and Polymer B 0.05 %). The pH range 
examined was 5.0 - 8.0 since below values of 5.0 the migration values became 
very long and the peaks obtained were extremely broad. As seen in Figures 
6.7 and 6 .8 , the resolution shows a maximum at pH 7.0 for propranolol (Rs = 
0.33) for polymer A and (Rs = 1.48) for Polymer B.
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Table 6.4.a: Migration times and resolution values of R- and S-
enantiomers of propranolol, norephedrine and phenylethylamine using 
Polymer A as a chiral additive in the background electrolyte; 0.005 M, 
phosphate buffer, voltage 15 kV; temperature 25 CXJ.
pH
Polymer
A
propranolol 
R- S- Rs
norephedrine 
R- S- Rs
phenylethylamine 
R- S- Rs
5.0 10.42 10.75 0 . 2 0 6.260 6.280 0 . 0 1 8.190 8.140 0.13
6.0 2.520 2.640 0.18 2.270 2.280 0.05 2.190 2.200 0.05
7.0 3.136 3.162 0.33 2.941 2.945 0.05 2.706 2.721 0.05
8.0 2.340 2.350 0.03 2.240 2.260 0.07 1.230 1.210 0.08
pH
Figure 6.7: Effect of change in pH  of the running buffer on separation of 
R- and S- enantiomers of test compounds,; conditions: 0.005 M  phosphate 
buffer, 0.03 % MIP A; temperature 25 °C; voltage 15 kV.
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Table 6.4.b: Migration values and resolution values o f the R- and S- 
enantiomers of propranolol, norephedrine and phenylethylamine using 
Polymer B as a chiral additive in the background electrolyte; 0.005 M  
phosphate buffer, voltage 15 kV; temperature 25 °C.
pH
Polymer
B
propranolol 
R- S- Rs
norephedrine 
R- S- Rs
phenylethylamine 
R- S- Rs
5.0 11.60 11.34 0.16 5.342 5.366 0.09 6.695 7.010 0.34
6.0 7.120 7.220 0.21 4.420 4.450 0.20 5.250 5.260 0.19
7.0 2.455 3.039 1.48 2.341 2.376 0.20 2.217 2.229 0.08
8.0 2.985 2.955 0.17 1.551 1.556 0.01 1.194 1.390 0.02
propranolol 
norephedrine 
phenylethyl amine
9
Figure 6.8: Effect of change in pH of the running buffer on the separation 
of R- and S- enantiomers of the test compounds: conditions: 0.005 M  
phosphate buffer, 0.05 % MIP B; temperature 25 XI; voltage 15 kV.
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6.3.5 Effect o f  concentration o f  SDS
In some separations it is necessary to add further additives to the 
background electrolyte to enhance the separation. The use of surfactants for 
this purpose is fairly commonplace, in particular the use of sodium dodecyl 
sulphate (SDS). This is added up to concentrations where micelle formation 
will occur and therefore, as such produce a ‘pseudo-phase’ for the analytes to 
interact with. The addition of SDS is effective for separating hydrophobic 
compounds, since the MIP will not interact with the micelle, and the MIP in 
the micellar solution should behave as another phase in comparison with the 
micelle. Thus the analyte may be partitioned between three phases: the 
micelle, the MIP and the aqueous phase. Separation can be achieved in the 
MIP-MEKC system because the micelle migrates at a different velocity from 
that of the MIP or the aqueous phase. It is a well known fact that MIPs can 
effect chiral recognition; thus the MIP-MEKC system can also be applied to 
optical resolution.
Based on work by Terabe et a l9 they found it necessary to add a 
surfactant to obtain a separation while using cyclodextrins as their chiral 
additive. As Polymer A showed little enantioselectivity, it was decided to add 
a surfactant to the background electrolyte, therefore small amounts of the 
surfactant sodium dodecyl sulphate (SDS) was added to the buffer solution. 
This was also added to buffer solutions containing Polymer B. Three 
concentration levels were examined, i.e. 0.005 M, 0.01 M and 0.02 M. SDS 
forms micelles at a concentration of greater than 0.005 M SDS and hence 
exists above its critical micelle concentration (CMC) and acts as a pseudo- 
stationary phase. As SDS is anionic it can form ion-pairs with the protonated 
amine groups in the test compounds. Overall increases in SDS concentration 
resulted in increased migration times for the compounds examined. Additions 
above the SDS CMC did not show a large effect on the differentiation of 
migration times between enantiomers (Table 6.5.a and 6.5.b).
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Table 6.5.a: Migration times of the R- and S-enantiomers of propranolol, 
norephedrine and phenylethylamine using Polymer A (0.03 %) as a chiral 
additive in the background electrolyte with various concentrations of SDS; 
0.005 M phosphate buffer pH 7.0; voltage 15 kV; temperature 25 °C.
SDS
Polymer propranolol norephedrine phenylethylamine
A R- S- R- S- R- S-
0.005 M 3.101 3.121 2.540 2.590 2.780 2.760
0.010 M 3.176 3.184 2.843 2.852 2.963 2.968
0.020 M 3.255 3.249 3.143 3.152 3.342 3.350
Table 6.5.b: Migration times of the R- and S-enantiomers of propranolol, 
norephedrine and phenylethylamine using Polymer B (0.05 %) as a chiral 
additive in the background electrolyte with various concentrations of SDS; 
0.005 M, phosphate buffer pH 7.0: voltage 15 kV; temperature 25 X!.
SDS
Polymer propranolol norephedrine phenylethylamine
B R- S- R- S- R- S-
0.005 M 2.790 2.800 2.145 2.150 2.087 2.095
0.010 M 3.000 3.050 2.390 2.380 2.470 2.472
0.020 M 3.234 3.246 2.573 2.585 2.843 2.856
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6.3.6 Effect o f  ionic strength
Using a background electrolyte of phosphate buffer, pH 7.0 and 0.05 % 
Polymer B, the effect of ionic strength on the resolution and migration times 
of the enantiomers was examined. Increases in the ionic strength resulted in 
decreases in the migration times and for propranolol decreases in resolution 
(Figure 6.9).
Table 6.6: Migration values and resolution values of the R- and S-
enantiomers of propranolol, norephedrine and phenylethylamine using 
polymer B as a chiral additive in the background electrolyte; 0.005 M, 
phosphate buffer pH 7.0, voltage 15 kV; temperature 25 °C.
Ionic
Strength
B
propranolol 
R- S- Rs
norephedrine 
R- S- Rs
phenylethylamine 
R- S- Rs
0.005 M 
0.010 M 
0.020 M
3.392 2.980 1.50 
2.470 2.469 0.09 
2.254 2.253 0.01
2.304 2.315 0.060 
2.456 2.434 0.098 
2.145 2.131 0.145
2.322 2.325 0.300 
2.118 2.113 0.150 
1.841 1.842 0.002
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Figure 6.9: Effect of changes in the ionic strength o f the running buffer; 
conditions: phosphate buffer, pH 7.0, 0.05 % Polymer B; temperature 25 
°C; voltage 15 kV
6.3.7 Effect o f  applied voltage on resolution
Examination of the effect of the applied electric field on the chiral 
resolving power was studied next. The BGE used was 0 .0 0 5  M , phosphate 
buffer, pH 7 .0 ,  0 .0 5  % Polymer B. Table 6 .7  gives the results of the migration 
times and resolution values at a number of voltages. The maximum value 
selected was 15  k V , as above this value current problems occurred, probably 
due to the excessive Joule heat which was possibly not being removed from 
the capillary.
0.005 0.01 0.015 0.02
Ionic strength
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Table 6.7: Migration times and resolution values of the R- and S-
enantiomers of propranolol, norephedrine and phenylethylamine using 
Polymer B as a chiral additive in the background electrolyte; 0.005 M  
phosphate buffer pH  7.0, temperature 25 °C.
voltage propranolol 
R- S- Rg
norephedrine 
R- S- Rs
phenylethylamine 
R- S- Rs
5.0 kV
10.0 kV
15.0 kV
16.32 16.54 0.12 
11.54 11.67 0.02 
3.392 2.980 1.50
15.87 15.92 0.21 
10.21 10.48 0.20 
2.304 2.315 0.06
18.11 18.21 0.17 
12.67 12.71 0.01 
2.322 2.325 0.30
6.3.8 Effect o f  temperature on resolution
The final parameter examined was the effect of temperature using the 
same conditions as above. At elevated temperature it was necessary to take 
into account the running buffer conductivity increase resulting in higher 
current, caused by the elevated temperature, thus increasing the Joule heat 
being developed. It was found that 25 °C was the most suitable temperature 
for this separation. Decreasing the temperature would result in significant 
increases in migration times.
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Table 6.8: Migration times and resolution values of the R- and S-
enantiomers of propranolol, norephedrine and phenylethylamine using 
Polymer B  as a chiral additive in the background electrolyte; 0.005 M, 
phosphate buffer pH  7.0; voltage 15 kV.
Temp. propranolol 
R S- Rs
norephedrine 
R- S- Rs
phenylethylamine 
R- S- Rs
25 °C 
30 °C 
35 °C
3.39 2.98 1.50 
5.23 5.24 0.005 
6.64 7.14 0.48
2.30 2.32 0.06 
4.87 5.01 0.088 
5.03 5.07 0.041
2.32 2.33 0.300 
4.92 5.02 0.040 
5.71 5.74 0.039
6.3.9 Organic Modifier
There was an attempted addition of acetonitrile to the background 
electrolyte. However, on allowing the BGE to stand for 1 hour the solutions 
became very cloudy, and hence were unsuitable for use. To date it has been 
used in a number of methods, and levels of up to 1 0  % organic modifier have 
been used.
6.3.10 Blank Polymer
Solutions of blank polymer (prepared without a template) were then 
tested and found unsuitable, as they were extremely insoluble in BGE and
29hence resulted in large background currents. O’ Shannessy et al. found that 
a polymer prepared without a template molecule resulted in the imprint 
molecule eluting at the same time as the non-interacting void marker, 
indicating that the presence of the print molecule in the pre-polymerization 
mixture is essential for subsequent recognition.
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6.4 CONCLUSION
This work describes the use of a MIP prepared to ^-propranolol to 
optimize enantiomeric separations in CE. Other parameters which were varied 
included pH, concentration of phosphate buffer, concentration of SDS, field 
strength and temperature. It was found that a running buffer which gave a 
resolution of 1.48 for the separation of propranolol was phosphate buffer
0.005 M, pH 7.0, MIP 0.05 %. This type of system has an advantage over 
HPLC systems in that only small amounts of chiral agents are required and the 
solvent requirements (if necessary) are typically of the order of 2 0  ml per day. 
MEKC can be more easily utilized to achieve optical resolution especially in 
terms of the preparation of columns and solutions and therefore the use of 
MEKC is expected to increase.
One disadvantage of using polymer particles is the lack of solubility in 
mainly aqueous background electrolytes, however, further modifications of the 
side chains of the monomer/polymer could increase its solubility. Also 
variations in the monomer/cross-linker ratio; and decreases in the amount of 
cross-linker would increase solubility. Indeed the use of cross-linkers other 
than EDMA could improve selectivity. In many cases, the opportunity for an 
increased number of interactions between the analytes and MIP moieties 
ultimately improves enantiomeric separation. Resolution of enantiomers is 
dependent on both the strength and selectivity of the interaction between the 
MIP and the solute enantiomers. Also the possibility of using other surfactants 
could be examined to determine if the resolution values could be expanded.
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CHAPTER SEVEN
CONCLUSIONS AND FUTURE WORK
7.1 CONCLUSIONS
In chapter two, a mixed-mode column was examined to determine its 
retention characteristics. Prior to the advent of prepared mixed-mode columns, 
secondary interaction mechanisms were deemed to interfere with the retention 
mechanisms (particularly silanol groups on C ] 8 and their interaction with amine 
functionalities). However, it has been discovered that by mixing at least two 
phases, both the interactions may be manipulated in the determination of a sample 
containing a number of components. The retention parameters of a Cig/SCX 
column were examined and it was found that the SCX material was responsible 
for the interaction of the strongly basic components and hence retention could be 
modulated by increasing the ionic strength of the buffer or indeed by changes in 
the buffer cation. Therefore problems with long retention times that normally 
occur on Cis materials can be overcome by using a mixed-mode column where 
the choice of buffer can decrease these retention times.
Certain mixtures cannot be analyzed by either the same column, same 
buffer conditions, or by gradient elution. However, the use of mixed-mode 
materials allows mixtures to be analyzed simultaneously. This mixed-mode 
column is then used for the determination of an acidic component and a strongly 
basic component. Under normal C]g conditions, the acidic component would 
elute shortly after the void volume while the strongly basic component would be 
retained, resulting in extremely long retention times. However, the use of this 
phase allows their simultaneous determination, and the assay was validated for 
extraction of the components from plasma by liquid/liquid extraction and column 
switching. As Ci8/SCX is capable of separating both basic and neutral/acidic 
compounds simultaneously, it has application in the determination of drugs of 
abuse. A further application would be in the determination of a pharmaceutical 
product along with its degradation/process impurities, which collectively may not
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be suitable for analysis using either of the phases separately. Future work in this 
area could involve the mixing of another phase into the column or possibly the 
use of materials other than Qg, i.e. phenyl, C8 and CN.
The next section involved the preparation of a polymer by a technique 
known as molecular imprinting to 7-hydroxycoumarin. A number of polymers 
were prepared by varying the amount of solvent used in the polymerization 
reaction, and it was found that decreasing the amount of solvent increased the 
selectivity of the polymer. This was investigated using UV spectroscopic studies 
of the polymers following equilibration with the target compound. Further work 
involved the examination of the polymer selected for selectivity of 7-OHC over 
other members of the coumarin family. The equilibration time and the load 
capacity of the polymer were also examined. The use of UV spectral studies 
allowed the polymers to be examined quickly prior to their use as solid-phase 
extraction materials ensuring that the most suitable polymer was used in the next 
stage.
Also examined were the use of chiral monomers/polymers as molecularly 
imprinted polymers. Although there are a number of monomers available, 
methacrylic acid is the most commonly used. It was decided to try and 
incorporate a chiral centre on the side chain. This was achieved by reacting 
acryloyl chloride with alanine. This monomer was then polymerized by a 
standard method using a molecular imprinting procedure using .S'-propranolol as 
the template molecule. A polymer was then prepared with methacrylic acid, 
again using 5-propranolol. These polymers were then used as chiral additives in
CE. Future work in the area of monomer/polymer preparation could involve 
development of improved simple methods for the preparation of chiral 
monomers/polymers on a large scale from low cost starting materials. Also, 
examination of other cross-linking agent monomers to prepare new copolymers to
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try and increase selectivity even further could be attempted. In addition, the 
polymers could be prepared by photo initiation instead of the thermal method.
An application for these prepared MIPs was their use as solid-phase 
extraction materials. An assay was developed for the extraction of 7-OHC from 
urine and this was validated in the range 10 - 50 fig/ml. It was found to be a cost 
effective and easy way to prepare SPE cartridges for a specific component. These 
would find particular use where it is necessary to remove a specific component 
from its metabolites or from compounds with similar structures. It is also 
necessary to examine their use for extraction from plasma and other biological 
fluids.
Finally, quite a number of MIPs have been prepared for use in 
enantiomeric separation, and quite good resolutions have been obtained. The use 
of the polymer particles prepared previously were examined to determine if they 
were suitable for use as chiral additives. This was determined by adding small 
amounts of the polymers to the buffer used in the determination of the 
enantiomers by CZE. The second polymer (Polymer B) with its added chiral 
centre was found to exhibit better enantioselectivity than its methacrylic acid 
counterpart. It would seem that this polymer offered further points of interaction 
and a change of size in the cavity. Future work in this area would include 
preparation of polymers with different monomers, cross-linkers and copolymers 
of these. These can then be used for a series of test compounds and the points of 
interaction examined to determine which functionalities react best with the 
different monomers. The preparation of polymers with increased solubility 
should further increase their use in both CZE and HPLC as chiral additives.
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